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Epidemiological studies highlight a robust association between advanced paternal age and 
risk for several neuropsychiatric disorders including autism, schizophrenia and bipolar 
disorder. In this study a mouse model was used to investigate behavioural and molecular 
effects of advanced paternal age on the offspring. C57BL/6J females aged 2 months were 
mated with fathers of the same strain of three different ages: 2 months to represent ‘young’ 
fathers, 10 months to represent ‘old’ fathers and 12 months to represent ‘very old’ fathers. 
The offspring were subjected to behavioural tests to investigate their anxiety, locomotion, 
exploration, memory and social interaction. Significant reductions in exploratory, and 
particularly social, behaviours in the offspring of old fathers were observed. The deficit in 
social behaviour is interesting, given that social deficits are a common hallmark across the 
neuropsychiatric disorders associated with advanced paternal age. 
 
A variety of methods were utilised to investigate any molecular changes that might 
underlie the observed paternal age effect. Spermatozoa undergo multiple divisions 
throughout the male lifespan, potentially leading to a higher incidence of de novo genomic 
alterations in the offspring. To investigate whether copy number variation (CNV) was 
associated with advanced paternal age, DNA from the offspring was subjected to genome-
wide CNV analysis using comparative genomic hybridisation (CGH) combined with high-
resolution microarrays. No differences in the number or size of CNVs or the genes affected by 
CNVs between the offspring of young fathers and offspring of old fathers were observed. An 
alternative hypothesis is that epigenetic alterations may explain the relationship between 
advanced paternal age and behavioural alterations in offspring. Some regions of the genome, 
including many imprinted loci and transposable elements escape epigenetic resetting during 
germ cell development. DNA from multiple tissues was quantified for paternal-age associated 
differences in global DNA methylation, in addition to DNA methylation across transposable 
elements and differentially methylated regions (DMRs) associated with brain expressed 
imprinted genes. An increase in global methylation levels with advanced paternal age were 
observed, as well as methylation changes at many individual sites in the imprinted DMRs and 
consistently across DMRs associated with Gnas, Kcnq1ot1 and Mcts2. Finally, microarray-
based gene expression analysis was carried out on RNA from frontal cortex to look for 
transcriptomic differences associated with paternal age. Several genes demonstrated 
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differential expression with advanced paternal age, with enrichment for genes associated with 
cell signalling, inflammatory response and DNA repair. This study provides strong evidence for 
deleterious effects of advancing paternal age on social and exploratory behaviour and 
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1.1 Parental Age in the General Population 
As the average age at which people are having children increases there are many 
implications for health and development. Considerable focus is often placed on the trend for 
increasing maternal age. In North America in 1969, for example, the median age for women to 
have their first child was 21.3 years old but by 1994 this age had increased to 24.4 years old. 
During the same period the percentage of women bearing their first child over the age of 30 
rose dramatically from 4.1% to 21.2% (Heck, Schoendorf et al. 1997). In Europe the mean age 
of women giving birth increased 1.5 years between 1980 and 1993 (Breart 1997) and during 
1998 and 2008 the percentage of births by women in the United Kingdom over 35 years has 
increased from 14.5% to 20.1% (Statistics 2009). Due to developments in fertility treatments 
such as in vitro fertilisation, multiple marriages and social attitude changes to women having 
careers, the age at which many women are having children is increasing.  
 
Men are also fathering children at a later age, in part due to an increase in divorce rates 
and multiple marriages, and social change. In the period between 1998 and 2008, the 
percentage of men fathering children over the age of 40 increased from 10% to 16% in the UK 
(Figure 1.1) (Statistics 2009). There has also been a marked increase in men over the age of 50 
fathering children (Salonia, Matloob et al. 2011). As the reproductive period for men naturally 
lasts longer than for women, whose fecundity declines dramatically after 40, the potential for 






Figure 1.1 - Percentage of UK Births by Father's Age 
Adapted from Review of the National Statistician on births and patterns of family building 
in England and Wales, 2008 (Statistics 2009) 
 
1.2 Parental Age and Disease 
1.2.1 Parental Age, Birth Defects and Cancer 
The full implications of advancing parental age are not known. Most research has focussed 
on the consequences of advanced maternal age, which has been associated with many 
disorders and is strongly linked to negative outcomes related to foetal health and survival. 
Both advanced maternal and paternal age have been shown to contribute to negative birth 
outcomes such as low birth weight (Reichman and Teitler 2006) and a maternal age of over 35 
years increases the risk of spontaneous abortions. When increased maternal age is combined 
with a paternal age of over 40, the risk of spontaneous abortions increases further (de la 
Rochebrochard and Thonneau 2002). Increases in maternal age have been linked to an 
increased incidence of stillbirth (Huang, Sauve et al. 2008) as well as preeclampsia (Jacobsson, 
Ladfors et al. 2004). Advanced maternal age has also been shown to influence the risk of a 
variety of diseases in the offspring. For every 5 year increase in maternal age, a 5% increase in 
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childhood diabetes has been shown (Cardwell, Stene et al. 2010). Advanced maternal age has 
also been associated with an increased incidence of childhood cancers, with the greatest 
effect being for leukaemia and Wilm’s tumour (Johnson, Carozza et al. 2009). A maternal age 
over 40 is associated with an increased incidence of acute lymphoblastic leukaemia (Odds 
Ratio (OR) 1.94) and acute non-lymphoblastic leukaemia (OR 3.07) in the offspring.  
 
Less publicized is the observation that paternal age has also been shown to increase the 
risk of disease and physiological conditions in the offspring. A paternal age of over 45 confers 
substantially increase in risk (Relative Risk (RR) 3.3) for mental retardation of unknown 
aetiology in the offspring when taking mothers age into account (Zhang 1992). Advanced 
paternal age also increases the risk of certain types of cancer and a paternal age of over 45 is 
associated with an increased incidence of retinoblastoma in the offspring resulting from 
assumed de novo germ cell mutations (OR 2.96) (Dockerty, Draper et al. 2001). In addition, 
numerous birth defects have been associated with advancing paternal age; in a study looking 
at birth defects in British Columbia, McIntosh et al showed that a paternal age greater than 40 
was associated with increased risk for birth defects in the offspring. These included neural 
tube defects (RR 1.6), anencephaly (RR 2.0), spina bifida (RR 1.5), hydrocephaly (RR 2.6), 
congenital cataracts (RR 1.6), tracheoesophageal fistula (RR 3.9), reduction defect in upper 
limbs (RR 2.4), reduction defect in lower limbs (RR 3.2) and anomalies of diaphragm (RR 1.8) 
(McIntosh, Olshan et al. 1995).  
 
1.2.2 Parental Age and Risk for Neurological and 
Psychiatric Disease 
Beyond its influence on birth defects and physiological conditions, there is increasing 
evidence to suggest that advanced parental age is associated with the risk of developing 
neurological, behavioural and psychiatric disorders in the offspring. The most notable example 
is the increased risk of Down’s syndrome in the offspring of older mothers. It is widely 
accepted that as the maternal age increases, the risk of the child suffering from Down’s 
syndrome also goes up due to the higher incidence of chromosome 21 trisomy (Hook 1976; 
Huether, Ivanovich et al. 1998). The parental age effect is also seen in more complex 
neurobiological/neuropsychiatric phenotypes. Alzheimer’s disease risk, for example, has been 
shown to be influenced by paternal age, with the offspring of men with a higher paternal age 
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being more likely to develop pre-senile Alzheimer’s disease (Whalley, Thomas et al. 1995) and 
in a separate study, fathers of Alzheimer’s disease patients were significantly older at the 
child’s birth (35.7 years) than the fathers of non-patients (32.6 years) (Bertram, Busch et al. 
1998).  
 
Intelligence has previously been shown to have a relationship with both advanced 
maternal age and paternal age. Parental age shows an inverted u shaped relationship with IQ 
with the offspring of parents younger than 20 and older than 45 showing similar scores. IQ 
scores for advanced parental age groups steadily decrease as the age of the parents increase 
(Malaspina, Reichenberg et al. 2005) (Figure 1.2). Maternal age has also independently been 
associated with intelligence, showing an inverted u shaped relationship with both a decrease 
with low maternal age and advanced maternal age (Zybert, Stein et al. 1978; Fergusson and 
Lynskey 1993). An inverted u shaped curve is also observed between paternal age and 
learning capacity in the offspring. The offspring of fathers aged 17-19 performed worse than 
fathers 40-44 but both groups showed significantly lower learning capacity than the offspring 
of fathers 30 years of age (Auroux, Mayaux et al. 1989).  
 
 
Figure 1.2 - Intelligence and Parental Age 
Raven's Progressive Matrices-R (RPM-R) plotted against parental age. From (Malaspina, 




Although there is convincing evidence for the role of parental age in many disorders, some 
of the strongest evidence relates to the association of advanced parental age with 
neuropsychiatric disorders, specifically autism spectrum disorders (ASD) (Table 1.1), 
schizophrenia (Table 1.2) and bipolar disorder (BD) (Table 1.3). Taken together, 
epidemiological studies provide convincing evidence for the role of parental age in the risk of 
developing ASDs, schizophrenia and BD. 
  
 




N PA Finding MA Finding 
(Gillberg 1980) NA  20 cases 
Fathers average age 34 years in cases compared with 
lower in controls (age not given) 
Mean maternal age 31 years compared with 26 years in 
the controls 
(Mouridsen, Rich et 
al. 1993) 
 NA 328 cases 
Mean age of case fathers was 31.14 years compared 
29.68 years in controls 
Mean mothers age 27.05 in cases compared to 26.67 in 
controls 






At ages 30-34, RR = 2.7 
At ages >35, RR = 3.4 
(Hultman, Sparen et 
al. 2002) 
<30 
408 cases  
2040 controls 
At ages >40, OR = 1.71 At ages >40, OR = 1.84 




481 case sibs 
1313 controls 
Mean age of case fathers was 31.74 years compared 
30.31 years in controls 
Mean age of case mothers was 28.62 years compared 
to 27.01 years in controls 
(Lauritsen, Pedersen 








473 cases  
4730 controls 
No significant association observed At ages >35, OR = 1.3 
(Reichenberg, Gross 
et al. 2006) 
15-29 
Population  of 
378,891 
At ages 40-49, OR = 5.75 At ages >40, OR = 2.68 
(Cantor, Yoon et al. 
2007) 
 NA 
Population  of 
2,492,308 
30-39 54.7% in ASD compared to 41.9% in controls Not investigated 





At ages 35-39, RR = 1.38 At ages 35-39, RR = 1.2 
At ages >40, RR 1.52 At ages >40, RR = 1.27 














                        
 
 





Matsumoto et al. 
2008) 
<29 
84 cases At ages >33, OR = 3.09 No significant association observed 
208 controls 10-year increase in paternal age OR = 2.54  
(Grether, Anderson 




10-year increase in paternal age OR = 1.22 10 year increase in maternal age, OR = 1.38 





At ages 35-44, 39% in ASD compared to 28% in controls Not investigated 
At ages >45, 5% in ASD compared to 3.5% in controls  





No significant association observed 10 year increase in maternal age, OR = 1.6 
 10 year increase in grandmaternal age, OR = 1.66 




1.1 mill controls 
At ages >50, OR = 2.2 No significant association observed 
At ages >55, OR = 4.36  
(Lundstrom, Haworth 
et al. 2010) 
25-34 
Twins 
Sweden: 11,122  
UK: 13,524 
Sweden: At ages 45-50, OR = 1.9 No significant association observed 
Sweden: At ages >51, OR = 3.24  
UK: At ages 45-50, OR1.66  
UK: At ages >51, OR = 3.59  





At ages >40, OR = 2.03 No significant association observed 





At ages >40, OR = 1.78 At ages >40, OR = 1.77 





At ages >30, OR = 2.62 No significant association observed 
(Buizer-Voskamp, 




At ages >40, OR = 1.23 No significant association observed 
(Krishnaswamy, 













                          









N PA Finding MA Finding 
(Hare and Moran 
1979) 
NA  
8000 cases Mean paternal age 34 years compared with 32 years in 
the controls 
Mean maternal age 31 years compared with 29 years in 
the controls 
(Gillberg 1982)  NA 
155 cases 
Average age of fathers older in cases than in controls 
60% of mothers >30 compared with 27% of children in 
controls 
(Kinnell 1983)  NA 
342 cases 
1,817 controls 
Mean paternal age 34 years compared with 32 years in 
the controls 
Mean maternal age 30 years compared with 29 years in 
the controls 





At ages 45-49, OR = 2.02 No significant association observed 
At ages >50, OR = 2.96  






At ages >45 Rate ratio 3.6 Not investigated 





At ages >55, OR = 2.42 At ages >45, OR = 1.43 





At ages 45-54, OR = 1.6 No significant association observed 
At ages >55, OR = 3.8  
10-year increase in paternal age, OR = 1.3  
(El-Saadi, Pedersen et 
al. 2004) 
20-24 
117 cases   
146 controls 
Sweden: At ages >35, OR = 2.42 Denmark: At ages >50, OR = 1.35 
Denmark: At ages 50-54, OR = 1.62  
Denmark: At ages >55, OR = 1.84  





At ages >50, HR = 4.62 No significant association observed 
10-year increase in paternal age, HR = 1.47  





At ages 29-31, OR = 2.08 No significant association observed 
At ages >32, OR = 3.0  














                          









At ages >55, RR = 1.93 No significant association observed 
   10-year increase in paternal age RR 1.15  
(Buizer-Voskamp, 
Laan et al. 2011) 
25-29 
14,231 cases  
56,924 controls 
35-39 OR 1.24 No significant association observed 
>40 OR 1.27  




Paternal age of 41 years higher than in controls Mean maternal age 33 years higher than average 
(Miller, Messias et al. 
2010) 
25-29 
14,568 cases  
3mill controls 
45-49 OR 1.24 Not investigated 
>50 OR 1.79  
(Naserbakht, 





34.5% of case fathers were over 32 years old 
compared to 15% in controls 
11.5% of case mothers were over 32 years old 
compared to 6.5% in controls 
 




N PA Finding MA Finding 





At ages 40-44, OR = 1.96 No significant association observed 
At ages 45-49, OR = 2.32  
At ages >50, OR = 2.63  





10 year increase in paternal age, OR = 1.2 10 year increase in maternal age, OR = 1.23 
At ages 40-44, OR = 1.85  







                          






The association between advanced paternal age and risk of developing neuropsychiatric 
disorders is well established. At least nineteen published studies report an association 
between advanced paternal age and ASD. Some studies report a linear association with 
paternal age (Tsuchiya, Matsumoto et al. 2008; Grether, Anderson et al. 2009) with higher 
paternal age increasing the risk of developing ASD. However, most studies report that once a 
certain paternal age threshold is reached, then risk of offspring-ASD increases dramatically 
before reaching a plateau. Most studies report that the critical age is approximately 40 years 
old and that this risk increases further as paternal age exceeds 50. A potential problem with 
studies of a paternal age greater than 50 is that most are characterised by a very small 
number of cases with fathers in this age category, although this number is generally larger 
than observed in control samples (Gabis, Raz et al. 2010). Furthermore, the average age of 
fathers in cases is consistently estimated to be 1-2 years older than in controls (Mouridsen, 
Rich et al. 1993; Glasson, Bower et al. 2004).  
 
Similarly, at least sixteen published studies report an association between advanced 
paternal age and the risk of developing schizophrenia (or other psychotic disorders). Some 
studies again report a linear effect, with an increase in risk with every 10-year increase in 
paternal age (Zammit, Allebeck et al. 2003; Sipos, Rasmussen et al. 2004; Petersen, Mortensen 
et al. 2010), and overall the average age of fathers in cases is two years older than in controls 
(Hare and Moran 1979; Kinnell 1983). Unfortunately, because different epidemiological 
studies have chosen different thresholds for ‘advanced’ paternal age, it is difficult to define at 
what age the effect starts. However, there is a consistent observation that a paternal age of 
over 45 leads to an increase risk of developing schizophrenia. Some studies report a further 
increase in risk when paternal age increases to over 50 (Malaspina, Harlap et al. 2001; 
Zammit, Allebeck et al. 2003; El-Saadi, Pedersen et al. 2004; Sipos, Rasmussen et al. 2004; 
Miller, Messias et al. 2010), but again the numbers in this group are low.  
 
Two studies report an association between advanced parental age and BD (Frans, Sandin 
et al. 2008; Menezes, Lewis et al. 2010). Both studies find that a paternal age of over 40 is 
associated with an increased risk of developing BD, and one found that this risk continued to 






The studies reviewed above indicate that paternal age contributes to the risk of 
developing a number of psychiatric disorders including ASD, schizophrenia and BD. However, 
it is not just risk of developing these disorders that is affected. For example, looking at 
paternal age in ASD, Lundström and colleagues observed that twin concordance rates also 
varied as a function of paternal age. As the age of the father increases, the twin concordance 
rate between both monozygotic (MZ) and dizygotic twins (DZ) increases (Lundstrom, Haworth 
et al. 2010) (Figure 1.3). The authors report an MZ twin concordance rate approaching 100% 
in two separate cohorts of patients when paternal age was over 40 years. The implications of 
this are that the increasing paternal age is making MZ twins more similar, potentially caused 
by elements in the zygote before it splits, or in the gametes which create the zygote. As the 
same sperm and oocyte produce both members of an MZ twin-pair, the paternal-age 
associated disease-causing factors could result from information contained in the gametes or 
the quality of gametes, which as will be discussed in section 1.4.1, declines with increasing 
age. In DZ twin pairs, the concordance rate increased from 35% with fathers of 25-35 to 70% 
in fathers over 40 years (Lundstrom, Haworth et al. 2010), implying that defects in sperm 
which cause autism (or other disorders) become more common with advancing male age thus 
leading to a greater chance of the development of psychiatric disorders.  
 
 
Figure 1.3 – ASD MZ Twin Concordance Rates with Paternal Age 





Sex-ratios in ASD are also affected by advanced paternal age. The typical sex ratio for ASD 
is heavily male-biased, with 4:1 ratio of males to females (M:F) (Fombonne 2003). A paternal 
age related shift in sex ratios was first shown in a study that found a M:F ASD ratio in the 
offspring of fathers less than 40 years old of 5.6:1 which dropped to 2.3:1 in the offspring of 
fathers over 40 (Reichenberg, Gross et al. 2006). Anello and colleagues also showed that the 
sex ratio varies dramatically as a function of paternal age: the offspring of fathers of less than 
30 years had a ratio of 6.1:1, but this dropped significantly to 1.21:1 with a paternal age of 
over 45 (Anello, Reichenberg et al. 2009). Interestingly, the same effect was not seen with 
maternal age in this study. Paternal age has also been shown to affect the overall sex ratio of 
live births in Caucasian populations, with female offspring being more common in older 
fathers than male offspring (Ruder 1985). Again, these observations hint at potential 
biological mechanisms behind the paternal age effect, and suggest that the manifestation of 
ASD in the offspring of older fathers may be aetiologically distinct to that seen in the offspring 
of younger fathers where sex-specific factors may be more important. 
 
As maternal and paternal age are highly correlated in human populations, identifying 
independent maternal- and paternal-age effects is difficult and it is often not clear whether 
the predominant effect comes from paternal age, maternal age or a combination of both. 
Some of the studies reviewed in this chapter show an advanced maternal age effect as well as 
a paternal age effect (Table 1.1, Table 1.2 and Table 1.3), with some showing a higher mean 
age in cases compared to controls and others having an increased risk with increasing 
maternal age. Although the opportunity for males to sire children at a later age is higher than 
in females for whom the reproductive lifespan is biologically constrained, in human 
epidemiological studies it is not possible to fully elucidate the effect of paternal age 
independently from maternal age and vice versa. Human epidemiological studies are also 
potentially confounded by genetic variation and factors in the environment, and we can only 
draw speculative conclusions about what is truly causing the apparent increased prevalence of 
neuropsychiatric disorders in the offspring of older parents. It has been argued that the use of 
animal models of parental age may be a more powerful tool to disentangle these effects and 
investigate mechanism(s) behind their action (Mill 2007) (see section 1.7). In particular, the 
use of inbred mouse strains, bred for multiple generations to ensure homozygosity, enables 
researchers to control for both between-individual genetic variation and the environment. 





advanced paternal age, with subsequent behavioural and molecular analyses, in order to 
better understand the human epidemiological findings of a link between older fathers and 
neuropsychiatric disorders such as ASD and schizophrenia. 
 
1.3 Clinical Features of ASD, Schizophrenia and BD: Overlap 
in Social Deficits 
ASDs consist of a combination of disorders including autism, Rett syndrome, and Asperger 
syndrome. All ASDs are characterised in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) IV (American-Psychiatric-Association 2000) by multiple symptoms, but are 
mainly defined by impairments or delays in social functioning (Kanner 1968), impairments in 
non-verbal behaviours such as eye contact and facial expression, impaired language and 
communication, as well as repetitive behaviours (Kanner 1968) or a narrow sometimes 
obsessive range of interests (American-Psychiatric-Association 2000) and developmental 
delays in social interaction and imaginative play. According to the DSM IV, schizophrenia is 
diagnosed when a patient displays two or more of symptoms of delusions, hallucinations, 
disorganized speech, grossly disorganized or catatonic behaviour and negative symptoms, 
such as affective flattening, lack of additional, unprompted content in speech, a general lack 
of desire, drive, or motivation to pursue meaningful goals. It is also characterised by social 
impairments and being socially withdrawn (Mueser, Bellack et al. 1991). Bipolar disorder (BD) 
is characterised in the DSM IV by one or more manic episodes and episodes of depression. 
Bipolar patients also display social phenotypes of shyness or social anxieties (Simon, Otto et 
al. 2004). 
 
One hypothesis about why there is a similar paternal age effect common to multiple 
neuropsychiatric disorders (i.e. ASD, schizophrenia and BD) is that paternal age mediates a 
behavioural phenotype common to all three disorders (i.e. social behavioural deficits) rather 
than being independently associated with each disorder. Evidence for this hypothesis comes 
from studies examining social functioning traits in non-disease cohorts, which conclude that 
with increasing paternal age, the chance of the offspring having impaired social functioning 
increases (Weiser, Reichenberg et al. 2008) (Figure 1.4). Compared to the reference age of 25-





not observed with advanced maternal age. In a similar study into autism-like traits associated 
with paternal age, a u shaped relationship in social scores was observed in two independent 
samples of twins with autism with both the offspring of old and young fathers scoring highly 




Figure 1.4 – Parental Age and Risk of Social Functioning Deficits in Male Adolescents  
OR of impairment in social functioning plotted against parental age. Adapted from 
(Weiser, Reichenberg et al. 2008). 
 
1.4 Potential Mechanisms of Parental Age Effects 
The potential mechanism by which the paternal age effect is mediated has yet to be 
elucidated although there are many hypotheses, many of which are explored in the course of 
this thesis. In human males, it is estimated that there are 30 cell divisions of germ-cells before 
puberty then a further 23 divisions every year. There are also a further four mitotic and two 
meiotic divisions before the sperm are fully formed. This equates to 610 chromosomal 
replications by the age of 40 and 840 replications by age 50 (Crow 2000). In contrast, female 
germ-cells only undergo 24 divisions in their entire development from primordial germ-cells to 
mature cells regardless of the woman’s age. This includes 22 mitotic divisions, which occur in 





maturity to create the first polar body (Figure 1.5). This difference in the number of cell 
replications undertaken before mature germ-cells are produced suggests potential differences 
in the mechanisms by which parental age effects become manifest in males and females. 
Some mechanisms by which the paternal age effect, the focus of this thesis, could be 
mediated are discussed briefly below.  
 
Figure 1.5 - Germ Cell Development in Humans 
Cell divisions and stages to the development of mature gametes (Pitman 2001) 
a) Female gametes undergo 22 mitotic and 2 meiotic divisions to mature oocytes 
b) Male gametes undergo 30 mitotic divisions before puberty then one stem-cell 





















1.4.1 Changes in Sperm Quality with Advancing Male Age 
It had been observed that sperm quality declines with increasing male age. Advanced 
male age was found to negatively correlate with seminal volume (Eskenazi, Wyrobek et al. 
2003; Levitas, Lunenfeld et al. 2007; Cardona Maya, Berdugo et al. 2009; Hammiche, Laven et 
al. 2010), rapid progressive motility (Centola and Eberly 1999; Jung, Schuppe et al. 2002; 
Eskenazi, Wyrobek et al. 2003; Cardona Maya, Berdugo et al. 2009), percent of motile 
spermatozoa (Centola and Eberly 1999; Eskenazi, Wyrobek et al. 2003; Wyrobek, Eskenazi et 
al. 2006; Levitas, Lunenfeld et al. 2007), spermatozoa concentration (Jung, Schuppe et al. 
2002; Levitas, Lunenfeld et al. 2007; Cardona Maya, Berdugo et al. 2009), percentage of 
spermatozoa with tail defects (Centola and Eberly 1999; Jung, Schuppe et al. 2002), 
percentage with head defects (Jung, Schuppe et al. 2002), the pH of seminal fluid (Jung, 
Schuppe et al. 2002), total sperm count (Centola and Eberly 1999; Jung, Schuppe et al. 2002; 
Eskenazi, Wyrobek et al. 2003; Levitas, Lunenfeld et al. 2007; Cardona Maya, Berdugo et al. 
2009) and most interestingly for genetic research, positively correlated with a higher 
percentage in the sperm DNA fragmentation index or sperm chromatin structure analysis 
(Sartorelli, Mazzucatto et al. 2001; Wyrobek, Eskenazi et al. 2006; Hammiche, Laven et al. 
2010). The sperm DNA fragmentation index is a ratio expressed as a percentage of the sperm 
DNA with both unfragmented dsDNA and fragmented ssDNA (Evenson, Jost et al. 1999). This 
decline in semen and sperm quality could potentially be the cause of transmission of the 
paternal age effect through the occurrence of genomic alterations such as de novo copy 
number variations (CNVs).  
 
1.5 De Novo Copy Number Variations  
CNVs are defined as deletions or duplications between 1Kb and 5Mb in size (Sebat, 
Lakshmi et al. 2004) and are a cause of major structural variation in the genome. There are 
three main mechanisms identified for the creation of CNVs: non-allelic homologous 
recombination (NAHR), non-homologous end joining (NHEJ) and fork stalling and template 
switching (FoSTeS), and these are discussed in detail in the introductory section to Chapter 4. 
 
In 2004, two landmark studies showed that CNVs were more common in the human 





containing genomic imbalances among unrelated individuals. Twenty-four variants were 
found to be present in over 10% of the individuals that were examined. Half of these regions 
were found to overlap with genes, and many coincided with segmental duplications or gaps in 
the human genome assembly (Iafrate, Feuk et al. 2004). Sebat et al showed that large-scale 
copy number polymorphisms (CNPs) (CNVs 100kbs and greater) contribute substantially to 
genomic variation between normal humans. Using comparative genomic hybridisation (CGH) 
microarray analysis they revealed a total of 221 copy number differences representing 76 
unique CNPs containing genes involved in a number of pathways and functions including 
neurological function and genes known to be associated with disease (Sebat, Lakshmi et al. 
2004). 
 
CNVs account for more between-individual base pair variation than any other form of 
mutation, and have likely played an important role during evolution.  Cheng et al presented a 
global comparison of differences in content of segmental duplication between human and 
chimpanzee. They determined that 33% of human duplications are not duplicated in 
chimpanzee, including some which are known to cause disease in humans and estimated a 
genomic duplication rate of 4-5Mb per million years since divergence. Importantly, the 
changes identified were shown to result in gene expression differences between the humans 
and chimpanzees (Cheng, Ventura et al. 2005).  
 
Rare CNVs of large effect, often occurring de novo, have been implicated in a wide-range 
of complex neuropsychiatric disorders including disorders associated with advanced paternal 
age such as ASD (Marshall, Noor et al. 2008; Glessner, Wang et al. 2009; Fernandez, Roberts et 
al. 2010), schizophrenia (Stefansson, Rujescu et al. 2008; St Clair 2009; Ingason, Rujescu et al. 
2011) and BD (Zhang, Cheng et al. 2009). Autism patients have previously been shown to have 
a higher incidence of de novo CNVs (10%) than in controls (1%) and 1st degree unaffected 
relatives (Sebat, Lakshmi et al. 2007). In schizophrenia it has been observed that novel CNVs 
are present in a significantly higher percentage of cases than controls (International 
Schizophrenia Consortium 2008; Walsh, McClellan et al. 2008; Xu, Roos et al. 2008), and 
higher still in early-onset cases (Walsh, McClellan et al. 2008).  The occurrence of CNVs in 
cases has been shown to be 1.15 fold higher in cases than in controls that show on average 





increased burden of CNVs, especially in cases of early-onset. Zhang et al showed that 
singleton CNVs that occur only once in a dataset were seen in 12.3% of controls compared 
with 16.2% of bipolar patients that had a first incidence of mania below the age of 18 (Zhang, 
Cheng et al. 2009). Also it has been shown that BD patients have an increased overall burden 
of CNVs than in controls and higher between early-onset cases and late-onset cases (Priebe, 
Degenhardt et al. 2011). Together, these studies suggest that CNV burden could mediate the 
paternal age effect where individuals that show a higher incidence of de novo CNVs are 
subject to gene dosage problems or deletions of coding regions of genes. CNVs located in 
candidate genomic regions were observed in 10-20% of observed autism cases in two 
separate studies (Jacquemont, Sanlaville et al. 2006; Sebat, Lakshmi et al. 2007) but consistent 
CNVs affecting candidate genes have been speculated to account for an even higher 
percentage (Beaudet 2007). The role of CNVs in the mediation of the paternal age effect will 
be investigated using a mouse model in Chapter 4. 
 
1.6 Epigenetics 
An alternative hypothesis is that the paternal age effect is mediated by epigenetic 
(literally “above” genetics from the Greek “epi”) changes to the genome that are potentially 
transmitted via the male germline. The term ‘epigenetics’ was first coined by the British 
biologist Conrad Waddington in 1942 to describe the underlying developmental mechanisms 
by which a single genotype produces the diverse range of cellular phenotypes observed in an 
organism (Waddington 1942). More recent definitions see epigenetics as the study of 
reversible changes in gene function that occur independently of changes in DNA sequence 
(Riggs, Martienssen et al. 1996). Epigenetic processes are essential for normal cellular 
development and differentiation, and allow the long-term regulation of gene function through 
non-mutagenic mechanisms (Henikoff and Matzke 1997). Once established, epigenetic marks 
can be stably inherited through mitosis down cell lineages although, as will be described in 
more detail below and in Chapter 5, they can also be dynamically regulated in response to 
developmental, environmental, and stochastic factors. A glossary of epigenetic terms is found 







Table 1.4 - Glossary of Epigenetic Terms 
Term Definition Key 
Reference(s) 
Epigenetics The heritable, but reversible, regulation of various 
genomic functions that occur independently of the DNA 
sequence. Epigenetic regulation is primarily mediated by 
DNA methylation, physical changes to chromatin 





Chromatin The complex of DNA, histones, and other proteins that 
make up chromosomes. Chemical modifications to both 
DNA and histone proteins are important in regulating the 
structure of chromatin. Condensed chromatin 
(heterochromatin), in which the DNA and histone 
proteins are tightly packed, acts to block the access of 
transcription factors and other instigators of gene 
expression. Open chromatin (euchromatin) allows 





The addition of a methyl group at position 5 of the 
cytosine pyrimidine ring in CpG dinucleotides in a 
reaction catalyzed by DNA methyltransferases. DNA 
methylation disrupts the binding of transcription factors 
and attracts methyl-binding proteins that are associated 
with gene silencing and chromatin compaction. 
(Jaenisch and 
Bird 2003)  
Histone 
Modifications 
Covalent post-translational histone modifications that 
occur at specific residues include acetylation, 
methylation, phosphorylation, SUMOylation, and 
ubiquitylation. These modulate gene expression via 
alterations in chromatin structure. Like DNA methylation, 
histone modifications are highly dynamic and actively 




An epigenetic process that alters the expression of genes 
in a parent of-origin specific manner. Genomic imprinting 
is fundamental to normal mammalian development and 
growth. 
(Davies, Isles et 
al. 2005) 
X-inactivation X-chromosome inactivation silences genes on one X-
chromosome in females to ensure dosage compensation 
with males via a process involving hypermethylation of 
CpG islands. X-inactivation in any given cell is typically 
random and, once established, is maintained so that the 
inactivated allele is transcriptionally silenced for the 





Epigenetic signals are transmitted mitotically through cell 
lineages, but are generally assumed to be reset during 
gametogenesis and thus not transmitted meiotically. 
Evidence is mounting, however, that the epigenetic 
marks of at least some mammalian genes are not fully 
erased during meiosis and may therefore constitute the 






The most studied and best understood epigenetic modification to the genome is DNA 
methylation, and this is the focus of the experiments presented in Chapter 5 of this thesis. 
Other epigenetic modifications include the numerous post-translational modifications 
(including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation) to the 
N- termini tails of the core histone proteins around which DNA is wrapped to form 
nucleosomes, and small non-coding RNAs (ncRNAs), which are believed to underpin chromatin 
remodelling and be important in epigenetic memory (Mattick and Makunin 2006). Like DNA 
methylation, histone modifications are highly dynamic and actively regulated by a host of 
catalytic enzymes, such as histone acetyltransferases (HATs) and histone deacetylases 
(HDACs), which add and remove acetyl groups respectively (Saha and Pahan 2006). While 
often investigated independently, epigenetic modifications to DNA and histones are not 
mutually exclusive, and clearly interact in a number of ways; it is apparent that the 
classification of epigenetic mechanisms in terms of either gene activation or suppression is 
too simplistic (Berger 2007). The methyl-binding protein MeCP2, for example, binds 
specifically to methylated cytosines, attracting histone deacetylases which deacetylate 
histones (Robertson and Wolffe 2000), and a recent study has shown that histone H3 residues 
unmethylated at the lysine 4 position recruit DNA methyltransferases resulting in de novo 
DNA methylation (Ooi, Qiu et al. 2007). 
 
DNA methylation refers to the addition of a methyl group to the 5th carbon position of the 
cytosine pyrimidine ring (Figure 1.6). DNA methyltransferases (DNMTs) are the family of 
enzymes which catalyze the methylation of DNA (Kim, Samaranayake et al. 2009) and to date, 
four have been identified (Weber and Schubeler 2007). These are DNMT1 which maintains 
DNA methylation during replication by copying the DNA methylation of the parental DNA 
strand onto the newly synthesized strand (Leonhardt, Page et al. 1992), DNMT2 which has a 
weak ability to methylate DNA and is more likely an RNA methyltransferase (Goll, Kirpekar et 
al. 2006) and DNMT3a and DNMT3b, which are responsible for DNA methylation occurring de 
novo (Okano, Bell et al. 1999). DNMT3a and DNMT3b also work with DNMT1 to maintain the 







Figure 1.6 - DNA Methylation: Cytosine to 5-Methylcytosine 
 
DNA methylation occurs primarily at CpG dinucleotides, although recent studies have 
revealed a noticeable amount of non CpG DNA methylation in embryonic stem cells (Lister, 
Pelizzola et al. 2009). CpG dinucleotides occur at a lower frequency in mammalian genomes 
than expected, only accounting for ~1% of the human genetic sequence (Lander, Linton et al. 
2001) because methylated cytosines are liable to spontaneous deamination to thymine 
residues (Coulondre, Miller et al. 1978; Bird 1980). The majority of CpG sites in the 
mammalian genome (70-80%) are methylated; with the exception of those located in CpG-rich 
regions termed ‘CpG islands’, which are often associated with the promoter regions of 
constitutively expressed housekeeping genes (Gardiner-Garden and Frommer 1987). The 
definition of a CpG island is somewhat arbitrary; they were originally defined as a region at 
least 200bp in length, a GC content over 50% and an observed/expected CpG ratio of greater 
than 60% (Gardiner-Garden and Frommer 1987). This was later redefined with more stringent 
criteria as a region at least 500bp in length, a GC content greater than 55% and an 
observed/expected CpG ratio that is greater than 65% to lessen the overlap of CpG islands 
with repetitive elements (Takai and Jones 2002), although many databases such as the UCSC 
genome browser still use the earlier criteria (Kent, Sugnet et al. 2002). CpG islands roughly 
cover 40% of all mammalian gene promoters (Larsen, Gundersen et al. 1992) and are 
generally hypomethylated. DNA methylation at these CpG islands has been the predominant 
focus of epigenetic research and is associated with chromatin remodelling and reduced gene 
expression at proximal genes (Jaenisch and Bird 2003).  It is increasingly apparent, however, 
that DNA methylation at CpGs occurring outside promoter CpG islands (~70% of total CpGs), 
also has an important role in regulating genomic function, particularly during development 
(Shen, Chow et al. 2006). For example, recent genome-wide analyses have highlighted the 





(Medvedeva, Fridman et al. 2010), and CpG island ‘shores’, which are CpG rich regions up to 
2kb away from CpG islands (Irizarry, Ladd-Acosta et al. 2009).  
 
DNA methylation provides a dynamic mechanism influencing the developmental 
regulation of gene expression (Fang, Wang et al. 2003; Xiang, Zhao et al. 2008). For example, 
gene expression is often negatively correlated with DNA methylation across promoter CpG 
islands because methylated DNA prevents the binding of certain transcription factors (Bird 
and Wolffe 1999). Furthermore, highly methylated regions bind methyl-CpG-binding domain 
proteins (MBDs), which can act as adaptors between methylated DNA and histone-modifying 
enzymes and chromatin remodelling proteins. MECPs recruit histone-modifying enzymes to 
stretches of methylated DNA (Hendrich and Tweedie 2003). The resulting closed and 
compacted chromatin structure (heterochromatin) blocks the binding of transcription factors 
and thus represses gene transcription (Jenuwein and Allis 2001). Inversely, low DNA 
methylation at gene promoters leads to an open chromatin structure (euchromatin) and is 
often associated with higher levels of gene expression (Figure 1.7).  A classic example of the 
silencing role of DNA methylation is seen in the agouti (Avy) mouse model. A reduction in DNA 
methylation at an intracisternal-A particle (IAP) upstream of the Agouti gene leads to a change 
in coat colour from brown to yellow by increasing transcription from a cryptic promoter in the 






Figure 1.7 - Epigenetic Modifications and Chromatin Structure 
(Pidsley and Mill 2011) 
a) DNA is wrapped around a histone core, forming a nucleosome. DNA methylation 
at CpG dinucleotides and covalent modifications to histone tails alter the physical 
structure of the chromosome  
b) Heterochromatin (closed chromatin structure) and euchromatin (open chromatin 
structure) 
 
1.6.1 Epigenetic Changes in Complex Neuropsychiatric 
Disease 
Epigenetic processes in the brain have been associated with a range of biological and 
cognitive processes including neurogenesis (Ma, Marchetto et al. 2010), brain growth and 
development (Pidsley, Dempster et al. 2010), learning and memory (Lubin, Roth et al. 2008), 
drug addiction (Renthal and Nestler 2009), neurodegeneration (Migliore and Coppede 2009), 
and circadian rhythm (Nakahata, Grimaldi et al. 2007). It has been widely speculated, 
therefore, that epigenetic dysfunction in the central nervous system may be involved in a 
spectrum of psychiatric disorders including those epidemiologically-linked with advanced 
paternal age. DNA methylation differences at specific loci have been observed in autism 







(Carrard, Salzmann et al. 2011) and major psychosis (Mill, Tang et al. 2008; Dempster, Pidsley 
et al. 2011). The role of DNA methylation in psychiatric conditions is further reviewed in 
section 5.2.3. 
 
1.6.2 Genomic Imprinting 
Across the majority of the mammalian genome, DNA methylation is assumed to be 
complementary on both alleles, although there are several exceptions where this is not the 
case and DNA methylation is allele-specific. The first example is that in some cases DNA 
methylation is directly influenced by DNA sequence variation in cis and consequently shows 
Mendelian inheritance patterns (Schalkwyk, Meaburn et al. 2010). A second example, is seen 
in females where DNA methylation coordinates the random silencing of either the maternally- 
or paternally-derived X-chromosome to ensure dosage-compensation with males via the 
process of X-chromosome inactivation (XCI). A third type of allele-specific methylation is 
associated with regulating the monoallelic expression of imprinted genes. In most cases 
autosomal gene expression occurs from both alleles (i.e. paternal and maternal) equally, but 
at a small number of loci gene expression only occurs from one allele in a parental-origin-
specific manner.  
 
These genes are known as imprinted genes and occur in three variations. Some are 
expressed from only the maternally inherited allele and silenced on the paternally allele, some 
are only expressed from the paternally inherited allele and silenced on the maternal allele and 
some are isoform dependant whereby the allele which is expressed depends on the transcript 
of the gene. Imprinted genes are thought to have evolved with the placenta although parental 
effects on gene expression are also recognised to occur in insects (Crouse 1960) and plants 
(Kermicle 1970). The ‘parental conflict’ hypothesis, one of several theories to explain the 
evolution of genomic imprinting, postulates that imprinted loci evolved to regulate the 
competing interests of the parents while the developing offspring is in-utero (Moore and Haig 
1991). The father’s interest lies in providing the offspring with a high level of nutrients, thus 
ensuring survival and strong progeny. The mother’s interests lie also in self-preservation and 
ensuring she has as much nutrients as she needs to survive also. Imprinted loci such as the 
IGF2 are a good example of this struggle. IGF2, which is maternally imprinted and thus 





By silencing the maternal allele and providing mono-allelic expression of this gene, the mother 
can ensure the offspring receive an adequate nutrient intake without compromising her 
survival (Haig and Graham 1991; Wilkins and Haig 2003).  
 
The number of imprinted genes of different status is shown in Table 1.5. There are ~65 
confirmed imprinted genes in humans and ~75 in mouse, with considerable (but not 
complete) overlap (Jirtle 2006). The actual number of imprinted loci across the genome is 
likely to be higher; computational analyses suggest there may be over 600 (Luedi, Hartemink 
et al. 2005) and genome-wide studies of allele specific methylation suggest that additional 
imprinting DMRs may exist (Kerkel, Spadola et al. 2008; Schalkwyk, Meaburn et al. 2010). 
Furthermore, a recent study by Gregg et al uncovered evidence for widespread imprinting-like 
monoallelic expression across the brain (Gregg, Zhang et al. 2010), supporting the notion that 
these effects may be particularly important for neurobiological function (Wilkinson, Davies et 
al. 2007).  
 
Table 1.5 - Imprinted Genes in Human and Mouse 
The number of known classically-imprinted genes as well as predicted and unverified 
imprinted genes (Jirtle 2006) 
Status Human Mouse 
Conflicting Data 7 2 
Imprinted 65 75 
Not Imprinted 8 3 
Predicted 111 2 
Provisional Data 6 2 
Unknown 15 9 
Total 212 93 
 
Many imprinted genes are situated near CpG islands, which are the target for the 
epigenetic modifications driving parental-origin-specific gene expression. These differentially 





allele, and are often important for the control of imprinted genes. The grouping of imprinted 
genes within clusters allows them to share common regulatory elements such as DMRs, and 
when a DMR controls the monoallelic expression of one or more genes, it is known as an 
imprinting control region (ICR). This occurs in the case of IGF2 and H19 two reciprocally 
imprinted genes, which are regulated by the same ICR. On the maternal allele the ICR is 
unmethylated and allows the binding of CTCF. This blocks enhancers from binding to the 
promoter of IGF2 and allows expression of H19. On the paternal allele, the ICR is methylated 
and so CTCF does not bind. This allows the enhancers downstream of H19 to bind to the 
promoter of IGF2 and enable expression (Figure 1.8) (Kurukuti, Tiwari et al. 2006). As will be 
discussed later in the chapter, altered patterns of DNA methylation across ICRs have been 
implicated in the aetiology of several neuropsychiatric diseases and may escape complete 
epigenetic reprogramming during gametogenesis (section 5.2.3). 
 
 
Figure 1.8 - IGF2/H19 ICR 
The IGF2/H19 ICR has a downstream enhancer that activates either IGF2 or H19. In the 
maternally inherited allele, the ICR is unmethylated allowing for the binding of CTCF and blocks 
enhancers from accessing IGF2, causing the activation of H19 instead (a). In the paternal allele 
the ICR is methylated stopping the binding of CTCF and allows the enhancers to activate IGF2 














Imprinted genes are involved in a variety of functions and many play a critical role in 
normal growth and development especially during gestation (Fowden, Sibley et al. 2006). 
Many classically-imprinted genes are expressed in the central nervous system and are known 
to play an important role in brain development (Wilkinson, Davies et al. 2007), behaviour 
(Tilghman 1999; Wilkinson, Davies et al. 2007; Curley, Mashoodh et al. 2010), and cognitive 
processes including language development and social function (Skuse, James et al. 1997). It 
has been demonstrated that loss of imprinting at the IGF2 gene in the cerebellum is 
correlated with brain weight in males (Pidsley, Dempster et al. 2010), an interesting 
observation given the association between brain size and disorders such as schizophrenia 
(Harrison, Freemantle et al. 2003). Of note, several studies report that inter-individual 
differences in IGF2 methylation may be environmentally mediated, particularly by prenatal 
exposure to famine (Heijmans, Tobi et al. 2008), which is of particular relevance given the 
known link between prenatal factors (including nutrition) and the risk of developing 
psychiatric illness as an adult. Any dysfunction in genetic imprinting could be extremely 
detrimental, causing over- or under-expression of a normally monoallelically-expressed gene 
or the expression of a gene from the wrong allele. Prader-Willi syndrome and Angelman 
syndrome, for example, both derive from the same deletion on chromosome region 15q11-13 
(containing the paternally expressed genes SNRPN and NDN, and the maternally expressed 
gene UBE3A) but are characterised by very different symptoms. Prader-Willi syndrome, which 
is caused by a paternally-inherited deletion, was first described in 1956 and is characterised by 
obesity, dysmorphic appearance, short stature, underdeveloped genitals, developmental 
delays, mental retardation and behavioural problems (Cassidy 1997). Angelman syndrome, 
which is caused by a maternally inherited deletion, was first described in 1965 and is 
characterised by brachycephaly, dysmorphic appearance, hypopigmentation, jerky movement, 
delayed motor milestones, epilepsy and unusually happy disposition (Clayton-Smith and 
Pembrey 1992).  
 
Of relevance to this project, low sperm counts have been associated with abnormal genetic 
imprinting and are more likely to transmit imprinting errors (Marques, Carvalho et al. 2004) or 
abnormal DNA methylation at imprinted sites (Kobayashi, Sato et al. 2007). As men of older 
age typically have lower sperm counts than men of a younger age (section 1.4.1), the potential 
for older fathers to pass on imprinting errors to their offspring may be higher. Several studies 





parental-origin-specific manner, with opposite effects associated with maternally- and 
paternally-inherited alleles (Meaburn, Schalkwyk et al. 2010). For example, polymorphisms at 
the human IGF2/H19 region have been shown to have a parent-of-origin specific association 
with placental and foetal growth (Adkins, Somes et al. 2010), and recent data shows that 
similar effects are observed for brain growth phenotypes and potentially neuropsychiatric 
disease (Pidsley, Dempster et al. 2012). Furthermore, parent-of-origin effects have been 
observed in autism (Cook, Lindgren et al. 1997; Schroer, Phelan et al. 1998), schizophrenia 
(Crow, DeLisi et al. 1989; Asherson, Walsh et al. 1994; Ohara, Xu et al. 1997) and bipolar 
disorder (McMahon, Stine et al. 1995). Many disease-associated risk-variants are located near 
known imprinted regions; in schizophrenia the 15q14-q14 region has been implicated 
(Freedman, Coon et al. 1997) which is in close proximity to the deletion seen in Prader-
Willi/Angelman syndrome (Mann and Bartolomei 1999), and CNVs at the 15q locus have also 
been shown in autism (Cook, Lindgren et al. 1997; Schroer, Phelan et al. 1998). In Chapter 5, I 
will explore whether epigenetic changes at DMRs associated with several brain-expressed 
imprinted regions are associated with advanced paternal age. 
 
1.6.3 Epigenetic Reprogramming and Transgenerational 
Epigenetic Inheritance 
Mammalian germ line cells undergo extensive epigenetic reprogramming during 
development and gametogenesis to allow for zygotes to acquire totipotency of their cells 
(Sasaki and Matsui 2008). The overview of epigenetic programming in mouse is shown in 
Figure 1.9. Widespread erasure of DNA methylation occurs in early embryogenesis and DNA 
methylation marks are re-established in two phases. Once the genomes of the PGCs have 







Figure 1.9 – Epigenetic Reprogramming in Mouse 
Pattern of epigenetic reprogramming in germ cells during development of the gametes. 
Epigenetic reprogramming starts at E7.25 with the erasure of imprinting marks at E11. 
Imprinting is re-established at E13.5 in males and after birth in females. (Sasaki and Matsui 
2008) 
 
The first stage occurs before the development of the germ line cells and gives rise to the 
pattern of somatic cell like DNA hypermethylation in the cells of the pre-implantation embryo. 
Remethylation of the germ line cells occurs at different times in males and females. In males 
remethylation occurs at the prospermatogonia stage and precedes re-entry of the cells into 
mitosis (Kafri, Ariel et al. 1992). In females remethylation occurs during the growth of the 
oocytes (Kafri, Ariel et al. 1992). These then develop into all the somatic cells of the body. The 
second phase of the establishment of DNA methylation occurs in the primordial germ cells 
(PGCs). PGCs become demethylated in early development and the remethylation starts in 
prospermatagonia (Figure 1.10). This methylation pattern is hypomethylated compared to the 
somatic cells (Ariel, Cedar et al. 1994; Trasler 1998; Li 2002; Saitou, Barton et al. 2002; Santos 
and Dean 2004; Rousseaux, Caron et al. 2005; Biermann and Steger 2007; Oakes, La Salle et al. 
2007). After fertilisation of the oocyte, the paternal genome is demethylated. Both the 







Figure 1.10 – Epigenetic Reprogramming in Germ Line Cells 
Primordial Germ Cells become demethylated early in development. Remethylation begins 
in prospermatogonia in male germ cells and after birth in growing oocytes (Reik, Dean et al. 
2001) 
 
As summarised above, it is traditionally assumed that the epigenome is completely erased 
and re-established in the germ-line in order to allow totipotency in the developing embryo 
(Reik, Dean et al. 2001). Some recent studies, however, suggests that this resetting in 
primordial germ cells is not complete and there are elements which escape the total “wiping” 
of epigenetic information (Figure 1.11a). In particular, transposable elements such as IAP, 
long-interspersed nuclear element-1 (LINE-1), some imprinted loci and other elements in the 
genome (Figure 1.11b) have been shown to escape this resetting and retain some epigenetic 
modifications in the germ cells (Popp, Dean et al. 2010). These elements could provide a 
potential vehicle for transgenerational epigenetic inheritance. Although controversial, the 
notion that epigenetic marks may be heritable during meiosis in humans and thus potentially 
transmitted across generations (Klar 1998; Rakyan and Whitelaw 2003; Richards 2006) 
potentially blurs the demarcation between epigenetic- and DNA sequence–based inheritance, 
and challenges the assumption that the ‘heritable’ component to complex traits and disorders 
is entirely genetic. Therefore, if epigenetic differences arise as a function of advanced paternal 
age (either stochastically or environmentally), it is plausible that these changes could be 
transmitted to their offspring and potentially influence phenotype in the next generation. 







Figure 1.11 – Methylation Profile of Cells 
Adapted from (Popp, Dean et al. 2010) 
a) Methylation profile in cells during development 
b) Methylation of loci in E13.5 male primordial germ cells 
i. Dazl, H19, Lit1 (Kcnq1ot1) imprinted loci 
ii. IAP, Line-1 Transposable elements 
iii. Major and minor satellite repeats 
 
1.6.4 Environmentally- and Stochastically-Induced 
Epigenetic Variation 
There is mounting evidence to suggest that epigenetic processes can be influenced by 
exposure to a range of environmental insults (Jirtle and Skinner 2007; Dolinoy and Jirtle 2008). 
DNA methylation, for example, has been shown to vary as a function of numerous nutritional, 
chemical, physical, and psychosocial factors. Imprinted genes have been shown to be 
particularly susceptible to epigenetic changes in response to the environment (Jirtle, Sander 
et al. 2000). Several studies report that inter-individual differences in methylation across 
DMRs regulating the monoallelic expression of imprinted domains may be environmentally 





mediated. Individuals conceived during the Dutch Hunger Winter Famine of 1944–1945, for 
example, were found to be hypomethylated at the IGF2 DMR on chromosome 11 (Heijmans, 
Kremer et al. 2007). In addition, random stochastic and developmental epigenetic changes are 
also likely to be important. Experiments tracking the inheritance of epigenetic marks through 
generations of genetically-identical cells in tissue-culture, for example, have indicated that 
there is considerable infidelity in the maintenance of methylation patterns in mammalian 
cells, and that de novo methylation events are fairly common during mitosis (Riggs, Xiong et 
al. 1998; Ushijima, Watanabe et al. 2003). As epigenetic processes are integral in determining 
when and where specific genes are expressed, such epigenetic metastability, environmentally- 
or stochastically-induced, may have profound phenotypic effects on gene expression in the 
cell.  
 
These environmental and stochastic changes to the epigenome may explain the 
observation of epigenetic drift with age. There is a growing body of evidence suggesting that 
epigenetic variation in somatic cells is strongly associated with age (Flanagan, Popendikyte et 
al. 2006; Fraga and Esteller 2007; Siegmund, Connor et al. 2007; Bjornsson, Sigurdsson et al. 
2008; Christensen, Houseman et al. 2009; Koch and Wagner 2011). At birth MZ twins have a 
very similar epigenetic profile, but as they age they exhibit increasing epigenetic differences 
(Fraga, Ballestar et al. 2005). Fraga and colleagues examined DNA methylation and histone 
acetylation in 80 pairs of MZ twins, ranging from 3 to 74 years of age, using a combination of 
global and locus-specific methods (Fraga, Ballestar et al. 2005). They found that one-third of 
MZ twins had a significantly dissimilar epigenetic profile, with older twins and those with a 
history of non-shared environments being the most disparate, suggesting that environmental 
factors may shape the epigenome over the life-course.  
 
Of particular relevance to the study of advanced paternal age, sperm cells have also been 
shown to exhibit age-related DNA methylation changes (Flanagan, Popendikyte et al. 2006). 
Using a genome-wide approach to assess DNA methylation in sperm DNA from donors of a 
wide age range, 175 separate loci were identified that show age related changed in 
methylation; 88 showed a negative correlation with age, and 87 showed a positive association 
with age. The same study highlighted significant within-individual and between-individual 





genes (Flanagan, Popendikyte et al. 2006). It is therefore reasonable to assume that with more 
cell divisions in older male germline cells, there is the potential for more environmentally- 
and/or stochastically-induced DNA methylation changes. Given the evidence discussed above 
regarding transgenerational epigenetic inheritance, it is plausible that some of these changes 
are passed on to subsequent generations. This hypothesis will be explored further in Chapter 
5. 
 
1.7 Current Animal Models of Parental Age 
As previously discussed, animal models are powerful tools for investigating potential 
mechanisms involved in the development of disease. Currently there are only a small number 
of studies which look at the effects of paternal age in animal models. The first such study was 
by Auroux et al (Auroux 1983) who looked at behaviour in the offspring of rats of a variety of 
ages up to 23 months compared to the offspring of rats 2.5 months of age. They found that 
learning capacity, measured using an electrical stimulus learning task, was decreased in the 
offspring of older rats. The effect was continuous in male offspring, with the highest 
impairment being observed in the offspring of 22 month old fathers. 
 
Garcia-Palomares et al (Garcia-Palomares, Pertusa et al. 2009) investigated paternal age in 
C57BL/6JIco mice, studying self-righting in postnatal day 4-6 pups, passive-avoidance and 
spontaneous motor activity. The offspring of old fathers showed decreased ability to self-right 
as pups, as well as reduced spontaneous motor activity in the home cage task and reduced 
passive-avoidance learning by using a light-dark box electric shock. A subsequent study by 
Foldi et al (Foldi, Eyles et al. 2010) in C56BL/6J mice showed that the female offspring of older 
fathers spent more time in the open arms of the elevated plus maze, increased exploration in 
the holeboard task and spent less time immobile in the forced-swim task. 
 
From these studies, there is evidence for a change in behavioural phenotype associated 
with advanced paternal age. Only one of these studies looked at social behaviour but found 





human literature or the hypothesis that paternal age is associated with a social deficit 
(Weiser, Reichenberg et al. 2008).  
 
1.8 Conclusions 
From reviewing the epidemiological data looking into the role of parental age on the risk 
of developing psychiatric disease, it is clear that parental age effects are associated with the 
development of ASD, schizophrenia and BD and for all three disorders the evidence to support 
the paternal age effect is more consistent than with maternal age. Given the link between 
advancing paternal age and social deficit in adolescent males in the general population, and 
the common social deficits seen across ASD, schizophrenia and BD, it is plausible that paternal 
age may not be necessarily directly related to each disorder but rather mediate the social 
deficit phenotype shared across them all. 
 
The potential mechanism(s) underlying the paternal age effect are not known. Two 
plausible mechanisms include an increased burden of de novo CNVs or epigenetic changes 
occurring in the male germline. Recurrent de novo CNVs have been shown to cause a large 
percentage of cases of ASD, schizophrenia and BD and the higher rate of CNVs is expected 
with advanced paternal age due to a higher mutation rate and increased DNA fragmentation 
in sperm of older males. Although no conclusive association has been reported between 
paternal age and CNV load, this is a potential cause of the paternal age effect that warrants 
further investigation.  
 
Epigenetic dysfunction is another plausible mechanistic route between advanced paternal 
age and risk for neuropsychiatric disease, in particular with regard to imprinting dysfunction 
and DNA methylation across transposable elements which are known to be labile in relation 
to age and potentially escape total epigenomic reprogramming during gametogenesis. For 
example, because the sperm of older fathers have more time to be exposed to environmental 
insults and accrue stochastic alterations over multiple cell divisions before fertilisation, the 






1.9 Aims of the Thesis 
In this thesis I hope to establish an animal model of advanced paternal age to investigate 
whether any specific behavioural effects are observed in the offspring of older fathers. In 
particular, I am interested to explore where any observed behavioural changes are specific to 
social phenotypes or whether advanced paternal age has a more general effect on behaviour. 
I will then use this model to explore the potential mechanism(s) by which the paternal age 
effect is mediated. This includes investigating whether advanced paternal age causes a greater 
load of de novo CNVs or a higher rate of recurrent CNVs using a genome-wide assessment of 
genomic variation. I also aim to explore epigenetic changes associated with advanced paternal 
age, by examining global changes in DNA methylation, and also focussing on DMRs regulating 
the transcription of brain expressed imprinted genes and transposable elements such as IAP 
and LINE-1 elements. Finally, using genome-wide gene expression analysis, I aim to uncover 
transcriptomic differences between the offspring of older and young fathers to potentially 
identify candidate genes for the cause of the paternal age effect and the disorders it affects.




Chapter 2 - General Materials & Methods  





This section will provide details about general methods that are used across multiple 
chapters throughout my thesis and will be referred back to where relevant. Additional 
methods specific to individual chapters will be described throughout the thesis. 
 
2.2 Extraction of Nucleic Acids  
DNA and RNA was isolated from a variety of tissue sources including spleen, brain and 
sperm, and used in a range of methodologies throughout the research presented in this 
thesis. The general principal of nucleic acid purification is to remove all proteins and other 
impurities to leave only pure high molecular weight DNA or RNA that can be used for 
downstream processes. Depending upon the method of extraction and the tissue used, up to 
30ug of DNA can be obtained from each 10mg of animal tissue. A variety of methods can be 
used for isolating DNA and RNA, and below I outline the methods used in this thesis. 
 




Extraction Method Experiment 
Spleen DNA Qiagen DNeasy (Section 2.2.1) 
CNV (Chapter 4) 




Qiagen AllPrep RNA/DNA Extractions 
(Section 2.2.2) 
Epigenetics (Chapter 5) 
Expression (Chapter 6) 
Cerebellum DNA Phenol-Chloroform (Section 2.2.3) Epigenetics (Chapter 5) 
Hippocampus DNA Phenol-Chloroform (Section 2.2.3) Epigenetics (Chapter 5) 
 
2.2.1 Qiagen DNeasy Columns 
All extractions were carried out on between 20mg of frozen tissue and using a protocol 
adapted from the standard Qiagen DNeasy protocol (Qiagen 2011). Before starting, buffers 




were prepared by adding 25ml 100% ethanol to AW1 and 30ml 100% ethanol to AW2. Using a 
clean scalpel 20mg of tissue was excised from main sample and put in a clean eppendorf tube. 
The excised tissue was then homogenised with a DNase free, sterile, plastic pestle. 180µl of 
ALT buffer and 20µl Proteinase K (PK) (20mg/ml) was added to the homogenised sample and 
drawn up into a pipette tip to wash any tissue remaining from the pestle, the sample was then 
mixed by vortexing. The homogenised sample with PK was incubated at 56oC in a water bath 
for 2-3hrs with vortexing every 30mins until tissue was completely lysed. After the tissue was 
completely lysed, it was vortexed for 15secs. 200µl of buffer AL was then added to the lysed 
tissue and mixed by vortexing followed by the addition of 200µl of 100% ethanol, the sample 
was then mixed again by vortexing.  
 
The sample was then pipetted on to the DNeasy mini spin column sat on a 2ml collection 
tube. The column was spun at 8000rpm for 1min. The collection tube was discarded and put 
column on new collection tube to which 500µl of buffer AW1 was added and the column was 
then spun again at 8000rpm for 1min. Again the collection tube was discarded and the column 
put on new collection tube. 500µl of buffer AW2 was added to the column and spun at 
8000rpm for 3mins. The final collection tube was discarded and the column put on to a clean 
eppendorf tube. 50µl of DNase free water was applied directly to the membrane of the spin 
column and incubated for 3 minutes at room temperature after which it was spun at 8000rpm 
for 1min. Another 50µl of DNase free water was applied directly to the membrane of the spin 
column and incubated for a further 3 minutes and spun at 8000rpm for 1min. Samples were 
then quantified using NanoDrop NO-1000 using the DNA-50 analysis type checking 260/280 
ratio was over 1.8 and 260/230 ratio was around 2. The quality and integrity of DNA was also 
checked using a 0.8% agarose gel using gel electrophoresis (Figure 2.1) (section 2.5). 





Figure 2.1 - Example of spleen DNA extracted using Qiagen DNeasy protocol 
Ladder used is ΦX174 DNA-HaeIII ladder  
 
2.2.2 Qiagen AllPrep RNA/DNA Extractions 
DNA extractions for the frontal cortex were carried out using the Qiagen AllPrep RNA/DNA 
kit using a protocol modified from the manufacturer’s standard method to maximise yield 
from brain tissue. 30mg of frontal cortical tissue was homogenized on dry ice with a DNase 
free, sterile, plastic pestle. 350µl of RLT buffer was added after which the lysate was passed 
through a 20-gauge needle 10 times. The lysate was centrifuged for 3 minutes at 13000rpm. 
The supernatant was carefully pipetted off and transferred to an AllPrep DNA spin column 
placed in a 2ml collection tube. The spin column and tube were then centrifuged for 30 
seconds at 13000rpm. The flow through was then pipetted back on to the DNA spin column 
and centrifuged for a further 30 seconds at 13000rpm. The AllPrep DNA spin column was 
placed on to a new collection tube, and stored on ice until later DNA purification steps.  
 
350µl of 70% ethanol was added to the flow through from the DNA spin column and 
mixed well by pipetting. This was then transferred to an RNeasy spin column placed in a 2ml 
collection tube and centrifuged for 15 seconds at 13000rpm. The flow-through was discarded 
and 700μl of Buffer RW1 was added to the RNeasy spin column then centrifuged 15 seconds 
at 13000rpm. The flow through was again discarded and 500μl Buffer RPE was added to the 
RNeasy spin column and centrifuged for 15 seconds at 13000rpm. The flow through was 
discarded and another 500μl of Buffer RPE was added to the RNeasy spin column and 




centrifuged for 2 minutes at 13000rpm. The RNeasy spin column was placed on a new 2ml 
collection tube and centrifuged at 13000rpm for 1 minute to fully remove any residual liquid. 
The RNeasy spin column was placed on a new 1.5ml collection tube and 30μl of RNase-free 
water was directly added to the spin column membrane and centrifuged for 1 minute at 
13000rpm to elute the RNA. Another 30µl of RNase-free water was directly added to the spin 
column membrane and centrifuged for 1 minute at 13000rpm. For long term storage 75µl of 
100% ethanol was added to the RNA, and the precipitated sample stored at -80oC. 
 
500μl Buffer AW1 was added to the AllPrep DNA spin column and centrifuged for 15 
seconds at 13000 rpm. The flow through was discarded and 500μl Buffer AW2 was added to 
the AllPrep DNA spin column and centrifuged for 2 minutes at 13000rpm. The AllPrep DNA 
spin column was placed on a new 1.5ml collection tube and 100μl RNase-free water was 
added directly to the spin column membrane and incubated at room temperature for 5 
minutes. This was then centrifuged for 1 minute at 13000rpm to elute the DNA. Another 50µl 
of RNase-free water was added directly to the spin column membrane and incubated at room 
temperature for 5 minutes. This was then centrifuged for 1 minute at 13000rpm to elute the 
DNA.  
 
DNA and RNA samples were quantified using a Nanodrop spectrophotometer and checked 
for an OD230nm/OD280nm of over 1.8. The DNA and RNA were then checked on a 0.8% 
agarose gel for size and fragmentation (Figure 2.2) (section 2.5). RNA was also assessed using 
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2.2.3 DNA Extraction using Phenol-Chloroform 
All extractions were carried out on between 10mg and 50mg of frozen tissue. Before 
starting, lysis buffer (10mM Tris-HCl, 0.1M EDTA, 0.5% SDS) was made and autoclaved. Using a 
clean scalpel, tissue was excised from the main sample and put in a clean eppendorf tube. The 
excised tissue was then homogenised using a DNase free, sterile plastic pestle. 300ml of lysis 
buffer and 3.3ul PK (18.5mg/ml) were then added to the homogenised tissue and the samples 
were incubated for 16 hours in a water bath set at 50oC. After the incubation, samples were 
spun down and pipetted up and down with a p1000 pipette to break up any unlysed tissue. 
Another 1.65ul PK (18.5mg/ml) was added to the sample followed by another hour at 50oC in 
the water bath. To inactivate the PK, samples were incubated in the water bath at 65oC for 30 
minutes after which samples were cooled to room temperature. 
 
Lysed samples were transferred to phase lock tubes made by adding vacuum grease to a 
2ml eppendorf tube and spun down. 300ml of phenol-chloroform-isoamyl alcohol (PCI) 
buffered to pH 7.5 was added to the phase lock tube and the samples were inverted 20 times 
then spun in a centrifuge at 13000rpm for 15 minutes. The aqueous layer was carefully 
pipetted off the top of the phase lock layer and put in clean eppendorf tube. 300ml of 
chloroform was then added to the removed aqueous layer and inverted 20 times after which 
the sample was spun in the centrifuge at 13000rpm for 15 minutes. The aqueous layer was 
carefully pipetted off the interphase layer and put into a clean eppendorf tube and another 
300ml of chloroform was added and inverted 20 times. The sample was spun again in 
centrifuge at 13000rpm for 15 minutes. The aqueous layer was carefully pipetted off and put 
in a clean eppendorf tube. 75ul of 10M Ammonium acetate (NH4Ac) and 600ml ice cold 100% 
ethanol were added to each sample which are inverted slowly 20 times and then left at -20oC 
in the freezer for 1 hour.  
 
After the incubation, samples were spun in a centrifuge at 13000rpm for 15 minutes. The 
supernatant was removed and 1ml of 70% ethanol was added then the sample was spun in a 
centrifuge at 13000rpm for 10 minutes. The supernatant was again removed and eppendorfs 
were inverted open on tissue allowing the pellet to air dry for 1 hour. Samples were 
resuspended in 100ul of DNase free water. Samples were then quantified using NanoDrop NO-
1000 using the DNA-50 analysis type checking 260/280 ratio was over 1.8 and 260/230 ratio 




was around 2. Quality and size of DNA was checked using a 0.8% agarose gel using gel 
electrophoresis (section 2.5). 
 
2.3 Sodium Bisulfite Conversion 
The 'gold standard' method for mapping methylated cytosines involves the treatment of 
genomic DNA with sodium bisulfite; this process converts unmethylated cytosines to uracils 
(and subsequently, via PCR, to thymidines), while methylated cytosines are resistant to 
bisulfite and remain unchanged (Clark, Harrison et al. 1994) (Figure 2.3). After sodium bisulfite 
treatment, DNA regions of interest are amplified and interrogated to identify C → T transitions 
or stable C positions, respectively corresponding to unmethylated and methylated cytosines in 
the native DNA. Numerous methods of analyzing bisulfite-modified DNA have been described 
(see section 5.4.6).  
 
 
Figure 2.3 - Bisulfite Conversion of Unmethylated Cytosine Residues  
(Wikipedia 2011) 
 
Sodium bisulfite conversion was performed using the EZ-96 DNA Methylation Kit from Zymo 
Research (ZymoResearch 2011). First, the CT Conversion Reagent was prepared by adding 
7.5ml of DNase free water and 2.1ml of M-Dilution Buffer which was then mixed at room 
temperature by vortexing for 10 minutes. M-Wash Buffer was prepared by adding 144ml of 
100% ethanol to the 36ml of concentrate. 500ng of high molecular weight DNA was diluted in 
45µl DNase free water (11.1ng/µl) in a conversion plate. 5µl of the prepared M-Dilution Buffer 
was added to each well of the conversion plate and mixed by pipetting. The conversion plate 




containing the samples was incubated on a thermocycler at 37oC for 15 minutes. After the 
incubation, 100µl of the prepared CT Conversion Reagent was added to each sample and 
mixed by pipetting. The conversion plate was then incubated in the dark at 50oC for 16 hours 
using a thermocycler after which the plate was incubated at 2oC for 10 minutes. 
 
400µl of M-Binding Buffer was added to each well of the Silicon-A Binding Plate on a 
Collection Plate then the samples from the conversion plate were added into the wells of the 
Silicon-A Binding Plate containing the M-Binding Buffer. This was mixed by pipetting then 
centrifuged at 4000 x g for 5 minutes after which the flow through was discarded. 500µl of M-
Wash Buffer was added to each well and centrifuged at 4000 x g for 5 minutes. 200µl of M-
Desulphonation Buffer was added to each well and incubated at room temperature for 20 
minutes after which the plate was centrifuged at 4000 x g for 5 minutes. 500µl of M-Wash 
Buffer was added to each well and centrifuged at 4000 x g for 5 minutes. Another 500µl of M-
Wash Buffer was added to each well and centrifuged for 10 minutes 4000 x g to fully dry the 
membranes of the Silicon-A Binding Plate.  
 
The Silicon-A Binding Plate was placed on to an elution plate and 30ul of M-Elution Buffer 
was applied directly to the binding matrices of the Silicon-A Binding Plate. It was then 
centrifuged for 3 minutes at 4000 x g to elute the DNA. Another 30ul of M-Elution Buffer was 
added directly to the binding matrix in each well of the Silicon-A Binding Plate and centrifuged 
for 3 minutes at 4000 x g to elute the DNA. Samples were then quantified using NanoDrop 
NO-1000 using the ssDNA-33 for single stranded analysis type checking 260/280 ratio was 
over 1.8 and 260/230 ratio was around 2. DNA was then plated out for polymerase chain 
reaction (PCR) using 1µl of converted DNA and stored at -20oC. For longer term storage, plate 
was stored at -80oC as bisulfite treated DNA is less stable due to being single stranded DNA 
(ssDNA). 
 
2.4 Polymerase Chain Reaction (PCR) 
PCR is used to amplify short sections of DNA to produce large amounts of a target-specific 
sequence using short priming sequences of ssDNA. The main elements of PCR and their 




function are outlined in Table 2.2. For each specific PCR, different annealing temperatures are 
required as well as different amounts of magnesium chloride (MgCl2), which is determined by 
MgCl2 titration.  Below is listed a standard PCR recipe on which all PCRs in my thesis are based 
on. Assay-specific optimised protocols (where relevant) are given in the relevant sections of 
the thesis. Qiagen Hot-Star Taq was used in bisulfite PCRs as hot-start PCR thermocycling 
conditions are optimal for bisulfite PCR reactions.  
 
PCR Mix      1x 
10 X Reaction Buffer    1µl 
Magnesium Chloride (25 mM)   0.2µl 
Deoxynucleoside triphosphates (dNTPs) (2.5mM) 0.2µl 
Qiagen Hot Star Taq Polymerase (5 units/µl)  0.05µl 
Primer Mix (10uM)     1µl 
Water      6.55µl 
DNA (10ng/µl)     1µl 
 
Table 2.2 - Table of PCR Components and their Function 
Component Function 
Genomic DNA 
Provides the template for amplification. In the case of bisulfite-PCR 
amplification, bisulfite-converted genomic DNA is used as the reaction 
template 
PCR Buffer Contains agents to maintain an optimum pH for amplification 
MgCl2 
Provides required divalent cations and stabilizes DNA strands. Lower 
concentrations of MgCl2 also lead to more specific PCRs 
Primers 
Small sequences of ssDNA complementary to the region of interest which 
anneal to the DNA to provide an initiation site for PCR 
Taq Polymerase 
Enzyme which allows for subsequent amplifications of DNA due to 
thermostability. Produces complementary strand to template strand 
beyond the primers 
dNTPS 
Free individual nucleotide bases which are used to form the 
complementary strand by the Taq polymerase 
 
After the PCR mix was made and plated out, the samples were then transferred to a 
thermocycler and the below PCR cycling program was used. The annealing temperature 
defines the temperature at which the primers anneal to the DNA template strands. The initial 




95oC incubation is required to activate the Hot Star Taq polymerase. The second 95oC at the 
start of each cycle is required to denature the DNA strands into ssDNA. Cooling to the 
annealing temperature causes the primers to anneal to the relevant region of DNA to be 
amplified and is sequence-specific, for example varying as a function of the GC content of the 
primer sequences. Annealing temperatures are critical for optimal PCR amplification: if they 
are set too high, the primers won’t anneal to the DNA and no amplification will occur. If they 
are too low, the primers will anneal to DNA with low specificity and will result in non-specific 
amplification. The 72oC at the end of each cycle instigates the extension step and allows for 
the Taq polymerase to build the complementary strand beyond the primers using the dNTPs. 
Cycling Conditions 
95oC    15 minutes 
95oC    20 seconds 
 Annealing Temperature  20 seconds     35 times 
72oC    30 seconds 
72oC     3 minutes 
4oC    10 minutes 
 
All PCR primers were designed for an annealing temperature of 55oC but some PCRs 
required optimizing by adjusting the annealing temperature or the amount of MgCl2 added 
due to weak or no PCR product or non-specific amplification. Again, assay-specific conditions 
are given in the relevant sections of the thesis. 
 
2.5 Agarose Gel Electrophoresis 
Agarose gel electrophoresis provides a quick method for the analysis of DNA quality and 
to assess PCR products based on their size. By applying an electrical charge across the gel, 
negatively charged DNA moves towards the positive terminal. Agarose powder is melted in 1 x 
Tris-borate-EDTA (TBE) buffer and the concentration of agarose is used to control the speed at 
which DNA moves through the gel. Large DNA molecules (such as those expected after 
successful DNA extraction) migrate relatively slowly and so are generally checked on a 0.8-
1.0% agarose gel. Small DNA fragments (such as after sonication or shearing) normally move 




through gels quickly and so are checked on a higher concentration gel of ~3%. The PCR 
products assessed in this thesis were generally checked on a 1.5-2% gel. DNA bands were 
visualised by the addition of ethidium bromide, which integrates into double-stranded DNA 
and is visible under UV light. All DNA was run against a ΦX174 DNA-HaeIII ladder unless 
otherwise stated and loaded with Orange G loading dye. 




Chapter 3 - Behavioural Assessment in a Mouse Model of 
Advanced Paternal Age 
 





Previous epidemiological studies have reported paternal age to be a risk factor for several 
human neuropsychiatric disorders including ASD, schizophrenia and BD. A common 
phenotype across all these disorders is social dysfunction. It is not known if other factors such 
as maternal age, other environmental factors such as prematurity or genetics contribute to 
the manifestation of this phenotype. To control for genetics, environment and maternal age, 
and to investigate any behavioural changes associated with paternal age, male C57BL/6J mice 
of three different ages (2 months, 10 months and 12 months) were bred with 2 month old 
C57BL/6J females and the resulting offspring were tested for locomotor activity, anxiety, 
exploration, short and long term memory and social interaction in a battery of behavioural 
tasks. It was observed that the offspring of old (10 month old) fathers engaged in significantly 
less exploratory and social behaviour than the offspring of standard breeding age males (2 
months old). These observations provide evidence that advanced paternal age in mouse is a 
contributing factor to behavioural changes without variations in maternal age, living 
environment or genetics.  
 
3.2 Introduction 
As discussed in detail in the introductory chapter (section 1.2.2), advanced paternal age 
has previously been reported as a risk factor for ASD, schizophrenia and BD. ASDs are 
characterised by multiple symptoms but primarily by impairments or delays in social 
functioning, as first described by Kanner in 1968 (Kanner 1968). Deficits in social behaviour 
are also a characteristic of other psychiatric disorders. Social impairment and being socially 
withdrawn are clinical symptoms of schizophrenia (Mueser, Bellack et al. 1991) and shyness 
or social anxieties are characteristics of BD (Simon, Otto et al. 2004). As previously discussed, 
however, it is not known whether paternal age is directly associated with ASD, schizophrenia 
and BD, or whether it is a risk factor for the common phenotype of social dysfunction that 
transcends all these disorders.  
 
As the association between paternal age and psychiatric conditions has only been 
observed in epidemiological human studies, there are many limitations. First, a limitation in all 
human based studies is the potential confounding effect of genetic variation. There are many 




studies into the genetic causes of ASD, schizophrenia and BD but separating any inherited 
genetic effects from purely paternal age effects is very difficult, especially given the link 
between de novo mutations and paternal age (section 1.5). Although many candidate genes 
and genomic regions have been identified for ASD (Vorstman, Staal et al. 2006; Ingason, Kirov 
et al. 2011), schizophrenia (Stefansson, Rujescu et al. 2008; Stone, O’Donovan et al. 2008) and 
BD (Serretti and Mandelli 2008; Zhang, Cheng et al. 2009) (section 1.5), genetic associations 
are characterised by considerable heterogeneity and small effect sizes, and none has been 
shown to be directly causal for any of these complex disorders. Furthermore, genetic variation 
in the general population could possibly confound any associations with paternal age via 
mechanisms such as population stratification. As genetic variation cannot be easily controlled 
for in human studies, it cannot be determined if any/all of the observed paternal age effects 
observed are confounded by genetic variation.  
 
Second, the effect of the environment also needs to be taken into account. For example, 
foetal distress (Glasson, Bower et al. 2004), smoking during pregnancy (Hultman, Sparen et al. 
2002), preterm birth  and low birth weight (Kolevzon, Gross et al. 2007) have all been 
suggested as risk factors for the development of ASD. In schizophrenia, social-economic status 
(Werner, Malaspina et al. 2007), prenatal malnutrition (Susser, Neugebauer et al. 1996) and 
early exposure to cannabis (Andreasson, Allebeck et al. 1987) have all been reported as risk 
factors and in BD, stressful life events are a risk factor (Alloy, Abramson et al. 2005). In human 
epidemiological studies it is extremely difficult to control for the effect of specific 
environmental exposures, whether they have been previously considered a risk factor or not. 
Again, as all environmental exposures cannot be controlled for, it is not entirely clear if 
paternal age effects could be the result of correlated environmental influences rather than, or 
in addition to, genetic variation. 
 
Third, many paternal age effects are reported in conjunction with maternal age effects 
and so it is not clear whether maternal age is the true risk factor for the development of these 
disorders instead of paternal age (Lopez-Castroman, Gomez et al. 2010) or whether it is the 
combination of both advanced maternal and paternal ages (Gillberg 1980; Croen, Najjar et al. 
2007; Durkin, Maenner et al. 2008; Grether, Anderson et al. 2009). Although late fatherhood 
often coincides with advanced maternal age, this doesn’t explain the more consistent 




epidemiological findings seen with paternal age than with maternal age (Lauritsen, Pedersen 
et al. 2005; Reichenberg, Gross et al. 2006). Furthermore, advanced paternal age is likely to be 
more of a widespread risk factor in the general population due to extended male fertility 
compared to women.  
 
For the reasons discussed, the development of an animal model would be extremely 
useful in determining the true role of advanced paternal age in mediating behavioural changes 
associated with psychiatric disorders. In animal models genetic variation can be controlled by 
using inbred strains established over multiple generations to create animals which are 
homozygous at all loci except the sex chromosomes, minimising the amount of genetic 
variation due to SNPs and VNTRs. The use of animal models also means that the environment 
can be tightly controlled and any large variations in diet, temperature, humidity, light 
exposure and stressful events can be avoided. Any environmental events which could 
potentially cause changes in behaviour can be recorded and taken into account when 
analysing behavioural results. Finally, the effect of maternal age can be directly controlled for 
and the outcome of only paternal age observed by breeding males of various ages with a 
consistent age of female. In using animal models, many of the limitations of human 
epidemiological studies can thus be overcome.  
 
As well as overcoming epidemiological limitations, the utility of animal models has many 
other benefits for this study. As mice are small mammals, the breeding, gestation and 
development of test animals can be carried out quickly whilst still controlling for previously 
discussed issues. Typical breeding age for mice starts around two months and male breeders 
are generally retired after 7–8 months when they are considered past their reproductive peak, 
so advanced paternal age does not have to be defined by large intervals in age. Animals are 
also useful because measures of specific behaviours can be selected that are of interest for 
the disorders being studied. For example, because a common phenotype in ASD, 
schizophrenia and BD relates to deficits in social interaction, social behavioural tasks were 
selected for this study. Other behaviours can also be tested to see if there are more general 
effects of paternal age, or whether these are limited to specific behaviours. 
 




Autistic-like reductions in social behaviour have been previously modelled in rodents. In 
their study, Moy et al showed that certain strains of mouse (such as DBA/2J and A/J) show less 
preference for social interactions and engage in less overall social activity (Moy, Nadler et al. 
2004). Previous animal studies of paternal age have found that advanced paternal age has a 
detrimental effect on behaviour although only one looked at social behaviour (Foldi, Eyles et 
al. 2010) and found that it is affected. Some behavioural changes previously shown to 
associate with advanced paternal age are reduced learning capacity (Auroux 1983), decreased 
ability to self right on postnatal day 4-6, reduced spontaneous motor activity and reduced 
passive-avoidance learning (Garcia-Palomares, Pertusa et al. 2009). Other behaviours shown 
to be affected by advanced paternal age in animal models which are not detrimental are 




The overall goal of this chapter is to investigate whether advanced paternal age is 
associated with behavioural changes in the offspring using a rodent model that allows us to 
control for parental genetic variation, fluctuations in maternal age or changes to environment. 
A secondary aim was to explore whether any behavioural changes observed are limited to 




3.4.1 Breeding Strategy 
All animals were bred and maintained in the Biological Services Unit at the Institute of 
Psychiatry, Kings College London using stocks purchased from Charles River Laboratories 
(Margate, U.K.). All housing and experimental procedures were performed in accordance with 
the UK Home Office Animals (Scientific Procedures) Act 1986. C57BL/6J inbred mice were used 
in this study as it is the most commonly used strain of laboratory mouse and was the first 
strain to have its genome completely sequenced. Therefore, the genome of this strain is also 
well characterised and annotated in genome browsers. It has been used in many previous 




behavioural studies and performs well in the tasks chosen including the social behaviour and 
discrimination tests (Moy, Nadler et al. 2004).  
 
For breeding, females aged two months were primarily bred with males of two different 
ages; ‘young males’ of normal breeding age of two months and ‘old males’ (retired breeders), 
10 months old. Furthermore, females were bred with a smaller number of older retired 
breeders or ‘very old males’, 12 months in age (Figure 3.1). 14 out of 15 breeding pairs 
produced usable litters where more than one male offspring was born, four litters for young 
male breeders (and one producing no offspring), six litters for old male breeders and four 
litters for very old male breeders. The average litter size within the young and old male groups 
was seven (male to female ratio 1:1) and in the very old male group the average litter size was 
eight. The total progeny generated was 40 mice in the young fathers group, 44 mice in the old 
fathers group and 31 in the very old male group. Of these there were 19 males in the young 
father group, of which one had to be culled due to abnormal development, 24 in the old 
father group and 12 males in the very old father group, of which one had to be culled due to 
hydrocephaly (Table 3.1). Only male offspring were kept due to the sex ratio in autism being 




Figure 3.1 - Diagram of Breeding Strategy 






























                          










Pair ID Group Breeder ID Sex Age (months) Litter born Litter size M F Comments 
1 Young Male 
21 F 2 
02/12/08 7 4 3  
11 M 2 
3 Young Male 
27 F 2 
03/12/08 9 2 7 
 
13 M 2  
4 Young Male 
30 F 2 
01/12/08 10 6 4 x2 cages of 3 offspring 
14 M 2 
5 Young Male 
33 F 2 
03/12/08 0 0 0 
 
15 M 2  
6 Young Male 
36 F 2 
02/12/08 8 7 1 
x2 cages of 3 offspring 
16 M 2 1 male runt culled 
8 Very Old Male 
22 F 2 
02/12/08 7 3 4 1 male culled (hydrocephaly) 
2B M 12 
10 Very Old Male 
28 F 2 
01/12/08 8 3 5 
 
6B M 12  
13 Very Old Male 
37 F 2 
03/12/08 8 3 5 
 
































                          




Table 3.1 Continued 
Pair ID Group Breeder ID Sex Age (months) Litter born Litter size M F Comments 
14 Very Old Male 
40 F 2 
01/12/08 8 3 5 
 
14B M 12  
15 Old Male 
23 F 2 
01/12/08 6 3 3 
 
1 M 10  
16 Old Male 
26 F 2 
01/12/08 7 4 3 
 
2 M 10  
17 Old Male 
29 F 2 
01/12/08 7 4 3 
 
3 M 10  
18 Old Male 
32 F 2 
02/12/08 10 5 5 
 
4 M 10  
19 Old Male 
35 F 2 
01/12/08 7 5 2 
 
5 M 10  
20 Old Male 
38 F 2 
01/12/08 7 3 4 
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The offspring were weaned aged 4–5 weeks and group housed with their siblings unless 
males in the litter exceeded 4, in which case the litter was split in two. Mice were individually 
housed for two weeks prior to testing. Mice were housed in standard cages measuring 
30.5×13×11 cm, with food and water available ad libitum. The housing room was maintained 
on a standard light/dark cycle with white lights on from 08:00 to 20:00. Ambient temperature 
in all rooms was maintained at 21±2°C with 45% humidity. 
 
3.4.2 Offspring Behavioural Testing 
Two to three males were randomly selected from each litter for behavioural testing giving 
12 offspring from the young and old father breeding groups and nine from the very old father 
breeder group.  Mice were randomised within their groups for testing. Offspring were aged 12 
weeks at the start of testing and all testing took place during the light phase with a light level 
less than 30 lux in the test room. Each apparatus was wiped clean with 1% Trigene® between 
subjects to avoid olfactory cueing behaviours. Behaviours for all tests were recorded on 
videotapes for further detailed analysis. Mice were returned to their home cage at the end of 
each test. The tests were carried out as per the schedule in Table 3.2. 
 
  




Table 3.2 - Behavioural Testing Diary 






23 Open Field   Batch 1 
24 Novel Object 0hr and 1hr trial Batch 1 
25 Novel Object 24hr trial Batch 1 
26       
27 Holeboard   Batch 1 





1       
2 Open Field   Batch 2 
3 Novel Object 0hr and 1hr trial Batch 2 
4 Novel Object 24hr trial Batch 2 
5       
6 Holeboard   Batch 2 
7       
8       
23 Social Investigation and Discrimination Habituation Batch 1 
24 Social Investigation and Discrimination 0hr and 1hr trial Batch 1 
25 Social Investigation and Discrimination 24hr trial Batch 1 
26       
27       
28       
29       
30 Social Investigation and Discrimination Habituation Batch 2 





1 Social Investigation and Discrimination 24hr trial Batch 2 
2 Animal Cull     
3 Animal Cull     
4       
5       
6 Animal Cull     
7 Animal Cull     
8 Animal Cull     
9 Animal Cull     
 




3.4.3 Open Field 
The open field task (Hall 1951) measures the behaviour of a test animal in a novel 
environment. It is designed to measure locomotor activity, exploration and can also be used 
as a measure of anxiety. The task creates an environment where the animal’s natural drive to 
explore conflicts with its avoidance of an unfamiliar arena. Typically mice engage in 
thigmotaxic behaviour (staying close to the walls of the arena) with reduced exploration of the 
open, central area of the open field.   
 
The open field was a square white acrylic box with dimensions 72cm × 72cm × 33 cm. The 
animal was placed in the outer part of the arena facing an outer wall and allowed to freely 
explore the arena for 5 minutes. A video camera placed above the arena allowed movement 
to be tracked using an automated tracking system (Ethovision, Noldus Information 
Technologies). The number of faecal boli and urination were recorded at the end of the test. 
Concentric squares of equal distance from the periphery were defined in Ethovision as the 
‘outer’, ‘middle’ and ‘central’ zones in order to determine the number of entries into, and 
time spent in, these zones of the arena. In addition, the latency to enter the inner zones as 
well as locomotor activity (distance moved and average speed) in all three zones of the arena 
was measured by the tracking system (Figure 3.2). 





Figure 3.2 - Photograph of the Open Field Arena  
The arena is divided in Ethovision into outer, middle and centre 
 
3.4.4 Novel Object Exploration and Discrimination 
The novel object task was used to determine short and long term memory by introducing 
animals to previously unseen objects and measuring the time they spend exploring the objects 
(Ennaceur and Delacour 1988). During the task the animals were exposed to three very 
different objects spread over three trials. The amount of time the animals spend sniffing and 
investigating the objects can be interpreted as a measure of exploration, and the amount of 
time spent with the different objects can be used as a measure of discrimination based on 
previous recall of an object. The same arena used in the open field task was used for the novel 
object task as mice had been exposed to this arena in the previous task, with the aim of 
maximising exploration of the objects and not the (now familiar) arena. Three pairs of 
different objects were used for this task. The three objects were yellow pots; china cups and 
metal tube were made of different materials (plastic, china and metal respectively) and 
differed in height, shape and colour. A video camera placed above the arena allowed 




movement to be tracked using an automated tracking system (Ethovision, Noldus Information 
Technologies). The number of faecal boli and urination were recorded at the end of the test. 
The arena was divided virtually in Ethovision as in the open field task, see Figure 3.3.  
 
 
Figure 3.3 - Photograph of Novel Object arena 
The arena is split in Ethovision into inner and outer and the areas around the objects into 
separate areas 
 
The test animal was placed in the outer part of the arena facing an outer wall and allowed 
to freely explore the arena for 5 minutes. In the first trial, two identical, novel objects were 
placed 10 cm apart in the centre of the arena and the time spent exploring each object was 
hand coded using the Ethovision software. The second trial was carried out one hour later, 
designed to measure short-term memory and used one of the objects from the first trial 
(which was now a familiar object) and an unfamiliar object (the novel object). The third trial 
was carried out 24 hours after the second trial (to test long-term memory) using the novel 




object from the second trial (now becoming the familiar object in this trial), and a new, 
unfamiliar object (Figure 3.4). Exploration of the object was defined as approaching the object 
and having physical contact; sniffing the object, turning the head towards it even for a brief 
period, touching it with the forepaws. Passive contact with the object (e.g. when the animal 
was sitting immobile but close to the object) was not considered to be object exploration. The 
order of object presentation and object location in the arena (left of right) were 




Figure 3.4 - Example of Object Configuration in the Three Trials of Novel Object 
In the first trial, two identical objects are presented to the animal to investigate 
exploration. In the second trial (1hr later), an object from the first trial plus a novel object are 
placed in the arena. In the third trial (24hrs after the second trial) the novel object from the 
second trial and a new novel object are placed in the arena. 
 
3.4.5 Holeboard 
The holeboard test is used to measure activity and exploration in a novel arena (Boissier 
and Simon 1962; Boissier, Simon et al. 1964; Nolan and Parkes 1973). The number of times the 
mouse pokes its nose into the holes and the time spent nose poking is used as a measure of 
exploration. The Truscan Photo Beam Activity System (Coulbourn Instruments, Whitehall, PA) 
was used, which consists of an arena (25.4cm x 25.4cm) and a nose poke floor with 16 holes in 
a 4×4 array with sensor rings to track movement and nose poking. The beams were spaced 
1.52 cm apart providing a 0.76 cm spatial resolution. Each mouse was placed in the arena and 
the movement, the number of, and the time spent, nose poking was recorded automatically 
by beam breaks for 5 minutes using the Truscan program.  
 
           0hr           1hr           24hr 




3.4.6 Social Investigation and Discrimination 
The social investigation and discrimination test is used to assess short and long term 
memory as in the novel object task, but also to investigate social interaction of a test mouse 
to a conspecific mouse. The social behaviour of the test mice towards a juvenile conspecific 
was assessed in a series of 5 minute trials (Winslow 2003). The test mouse was habituated in 
an arena (36cm ×20cm × 14cm) for 5 minutes, after which a male juvenile C57BL/6J 
conspecific (aged 4 weeks) was introduced for a further 5 minutes. Juvenile mice were used to 
minimise any aggression. During this trial, social behaviour including social sniffing (head and 
upper body of the conspecific),  anogenital sniffing and allogrooming by the test mouse 
towards the conspecific was scored from videotape by an observer blind to the group factor of 
paternal age (Figure 3.5).  Following/chasing and aggressive behaviours of the test mouse 
toward the conspecific mouse were also scored. One hour after the initial trial, the original 
familiar conspecific mouse and a second, novel conspecific mouse were introduced to the test 
mouse and behaviours were scored again (to test short-term memory). 24 hours after the 
second trial, a novel conspecific mouse was introduced to the test mouse as well as the novel 
mouse from the second trial, now the familiar animal (to test long-term memory). All 
behaviours were recorded and rescored for social behaviour at a later date and also rescored 
by an independent scorer to check for scoring consistency.  
 





Figure 3.5 - Photograph of Social Behaviour Task 
Smaller mouse with marking on tail is conspecific. 
a) Sniffing 
b) Anogenital sniffing 
 
3.4.7 Statistical Analysis 
Behaviours measured in the social interaction task, holeboard, novel object and open field 
were compared using a one-way ANOVA (main factor of paternal age) and Student’s t-test, 

























Following behavioural testing, mice were culled by cervical dislocation and decapitated. 
Ovaries were removed from female breeders and testis and epididymis were removed from 
male breeders and offspring. Brains from the offspring were removed and the cerebellum, 
frontal cortex, striatum, hippocampus and hypothalamus were dissected out (Figure 3.6). The 
remaining brain tissue was also stored. Whole brains were removed from female and male 
breeders and half were flash frozen in dry ice and half stored in PFA/sucrose. All other tissues 





Figure 3.6 - Mouse Brain Maps  
Diagram highlighting the regions dissected from mice in this study. Created using Allen 














For the graphs of the behavioural results presented in the section below, n = 12 for 
offspring of young males, n = 12 for offspring of old fathers and n = 9 for offspring of very old 
fathers. The results are presented separately for each of the three test groups (offspring of 
young, old or very old father) as well as for the offspring of young fathers (n = 12) versus a 
combination of the old and very old groups (fathers over 10 months old (n = 21)). Error bars 
on all graphs presented show standard error mean (SEM). * is used to signify a p-value below 
0.05, + is used to signify a p-value between 0.1 and 0.05. 
 
3.5.1 Body Weights 
Data from both behaviourally-tested and test-naïve mice are presented below. No 
differences were observed in the weights of the offspring between groups at 8 weeks (F (2, 
49) = 1.02, p = 0.37), 9 weeks (F (2, 49) = 1.10, p = 0.34) or 11 weeks (F (2, 49) = 1.44, p = 0.25) 
(Figure 3.7). 
 
Figure 3.7 - Weights of Offspring by Group 
Young Father n = 18, Old Father n = 23, Very Old Father n = 11 
 
3.5.2 Open Field 
Results of the open field task between the three groups are shown in Figure 3.8. Offspring 
of old fathers were significantly less exploratory in the open field task, taking longer to enter 




the central zone of the arena than the offspring of young fathers (t = 1.7837, d.f. = 22, p =
0.04) (Figure 3.8c). There were no significant differences observed between the offspring of 
very old fathers and the offspring of young fathers (t = -0.81, d.f. = 19, p = 0.19). There were 
no significant differences in the time spent in the middle (F (2,30) = 0.57, p = 0.57) or central 
zones (F (2,30) = 0.88, p = 0.43) (Figure 3.8e), the frequency of entries into the middle (F (2,30) 
= 0.43, p = 0.65)  or central zone (F (2,30) = 0.33, p = 0.72)  (Figure 3.8d), the speed of 
movement (F (2,30) = 0.56, p = 0.58) (Figure 3.8b) or in the total distance moved during the 
task (F (2,30) = 0.39, p = 0.68) between any of the groups (Figure 3.8a).  
 
Results of the open field task between the offspring of young fathers and offspring of 
fathers over 10 months are shown in Figure 3.9. When offspring of young fathers were 
compared to offspring of fathers over 10 months (combining the offspring of old and very old 
father groups), most of the results remain the same although the significance between the 
groups in the latency to enter the middle zone was no longer significant (t = -1.3493, d.f. = 31, 
p = 0.16) (Figure 3.9c). 
 





Figure 3.8 - Results of measures from the Open Field task 
a) Total distance moved by group in each area of the arena 
b) Average speed by group in each area of the arena  
c) Latency to enter the two central areas of the arena by group  
d) Number of times entering the two central areas of the arena by group 













Figure 3.9 - Results of Open Field Task: Young vs. >10 Months Fathers 
a) Total distance moved by group in each area of the arena 
b) Average speed by group in each area of the arena  
c) Latency to enter the two central areas of the arena by group  
d) Number of times entering the two central areas of the arena by group 













3.5.3 Novel Object Exploration and Discrimination 
Results of the novel object task between the three groups are shown in Figure 3.10. No 
effect of paternal age was observed in the measures of exploration or locomotor activity in 
the novel object task (Figure 3.10a-f). In measures of discrimination, the offspring of old 
fathers were better at distinguishing between the novel and familiar object in the 1hr task as 
they spend more time exploring the novel object than the familiar one compared to the 
offspring of young fathers and very old fathers which did not discriminate between objects 
(Figure 3.10g&h). However, overall levels of exploration were very low in this task, especially 
during the 24hr trial when most of the animals did not approach the objects at all (data not 
shown). Therefore it is difficult to draw any conclusions from the data except for the 
locomotor activity measures (distance moved) where reasonable levels of activity were 
observed but there were no  significant differences between groups (Figure 3.10a). 
 
Results of the novel object task between the offspring of young fathers and offspring of 
fathers over 10 months is shown in Figure 3.11. When the offspring of young fathers were 
compared to offspring of fathers over 10 months the results are the same as those from the 
three group comparison. Again the fact that the animals did not spend much time exploring 
the objects means that conclusions cannot be drawn from this data except to say there were 
no differences in locomotor activity between the two groups (Figure 3.11a) as in the 
comparisons between the three groups. 
 






Figure 3.10 - Results of the Novel Object Task 
a) Distance moved in areas of arena in 0hr and 1hr task 
b) Average Speed during 0hr and 1hr tasks 
c) Latency to approach objects in 0hr and 1hr tasks 
d) Frequency of rearing in 0hr and 1hr tasks 
e) Frequency of object visits during 0hr and 1hr tasks 
f) Time spent rearing during 0hr and 1hr tasks 
g) Time spent with objects during 0hr and 1hr tasks 



















































Figure 3.11 - Novel Object Task Results: Young vs. Fathers >10 Months  
a) Distance moved in areas of arena in 0hr and 1hr task 
b) Average Speed during 0hr and 1hr tasks 
c) Latency to approach objects in 0hr and 1hr tasks 
d) Frequency of rearing in 0hr and 1hr tasks 
e) Frequency of object visits during 0hr and 1hr tasks 
f) Time spent rearing during 0hr and 1hr tasks 
g) Time spent with objects during 0hr and 1hr tasks 
















































3.5.4 Holeboard  
The results of the holeboard task in the three groups are shown in Figure 3.12. Offspring 
of old fathers demonstrated reduced exploration in the holeboard task compared to the 
offspring of young fathers, making fewer nose pokes (t = 2.29, d.f. = 22, p=0.03) (Figure 3.12b) 
and spending less time nose poking (t = 2.3, d.f. = 22, p = 0.03) (Figure 3.12c). No significant 
differences were seen between the offspring of very old fathers and the other two groups. No 
significant differences were evident in the total distance moved (F (2, 30) = 1.25, p = 0.30) 
(Figure 3.12a) or centre entries (F (2, 30) = 0.14, p = 0.86) in the holeboard arena between the 
three groups (Figure 3.12d). 
  
 
Figure 3.12 - Results of Holeboard Task 
a) Total distance moved during task by group 
b) Time spent nose poking by group 
c) Total number of nose pokes by group 
d) Total centre entries by group 
 




The results of the holeboard task between the offspring of young fathers and offspring of 
fathers over 10 months is shown in Figure 3.13. The offspring of fathers over 10 months 
performed significantly fewer nose pokes (t = 1.96, d.f. = 31, p = 0.04) (Figure 3.13c). There 
was also a trend for significance in the total time spent nose poking (t = 1.65, d.f. = 31, p = 
0.07) between the groups (Figure 3.13b). The distance moved (t = 1.38, d.f. = 31, p = 0.14) 




Figure 3.13 - Results of Holeboard Task: Young vs. Fathers >10 Months  
a) Total distance moved during task by group 
b) Time spent nose poking by group 
c) Total number of nose pokes by group 
d) Total centre entries by group 
 




3.5.5 Social Investigation and Discrimination  
The results of the social investigation task for the three groups are shown in Figure 3.14. 
The offspring of old fathers engaged in significantly less overall social investigation than the 
offspring of young fathers, (t = 2.23, d.f. = 22, p = 0.03) (Figure 3.14d). The main differences 
were seen in social sniffing between offspring of young fathers and offspring of old fathers (t = 
2.38, d.f. = 22, p = 0.03) (Figure 3.14a). This is the main contributor to the overall reduction in 
total time spent in social behaviour. There were no significant differences in overall locomotor 
activity. No significant differences were seen in the time spent engaging in total social 
behaviour between the offspring of very old fathers and the offspring of young fathers (t = 
1.69, d.f. = 19, p = 0.14), and offspring of old fathers (t = -0.64, d.f. = 19, p = 0.52). Even though 
the differences between the offspring of young fathers and offspring of very old fathers are 
not significantly different, the total time in social behaviours is still reduced in the offspring of 
very old fathers (Figure 3.14d). Values from the second scorer for the total time spent in social 
behaviour was also significant (t = 2.19, d.f. = 22, p = 0.03), although the second scorer did not 
split the behaviours by different type. 
 





Figure 3.14 - Results of the Social Investigation Task 
a) Time spent in social sniffing behaviour 
b) Time spent allogrooming  
c) Time spent in anogenital sniffing behaviour 
d) Total time spent in all social behaviours 
 
 
Social discrimination in the 1hr and 24 hr task between the three groups is shown in 
Figure 3.15. In the 1hr trial, offspring of old fathers spent a significantly larger percentage of 
time than the offspring of young fathers with the novel conspecific mouse than the familiar 
mouse (Figure 3.15a) (t = -2.51, d.f. = 22, p= 0.02), but there was no significant discrimination 
during the 24hr trial (Figure 3.15b) (t = 0.445, d.f. = 22, p = 0.66). There were no differences 
between the offspring of very old fathers and the offspring of young fathers in either the 1hr 
(t = -1.41, d.f. 19, p = 0.15) or 24hr trial (t = 0.22, d.f. = 19, p = 0.82). 




       
Figure 3.15 - Conspecific Discrimination in 1hr and 24hr Social Behaviour Task 
a) 1hr after original social investigation task 
b) 24hrs after original social investigation task 
 
The results of the social behaviour task between the offspring of young fathers and 
offspring of fathers over 10 months is shown in Figure 3.16. When comparing the offspring of 
young fathers with offspring of fathers over 10 months, a similar result to the previously 
shown analysis is observed. The offspring of fathers over 10 months spend significantly less 
time in social sniffing behaviour (Figure 3.16a) (t = -0.29, d.f. = 31, p = 0.05) and anogentical 
sniffing (Figure 3.16c) (t = -1.68, d.f. = 31, p = 0.04) and less overall time in social activity 
(Figure 3.16d) (t = 2.05, d.f. = 31, p = 0.02) than the offspring of young fathers. A trend 
towards a significant difference was seen in time spent in time spent in allogrooming 
behaviour between the offspring of young fathers and offspring of fathers over 10 months (t = 























































Figure 3.16 - Results of Social Investigation Task: Young vs. Fathers >10 Months  
a) Time spent in social sniffing behaviour 
b) Time spent allogrooming  
c) Time spent in anogenital sniffing behaviour 
d) Total time spent in all social behaviours 
 
Social discrimination in the 1hr and 24 hr task between the offspring of young fathers and 
offspring of fathers over 10 months is shown in Figure 3.17. The offspring of fathers over 10 
months discriminated between the novel and familiar mouse in the 1hr trial better by 
spending more time with the novel mouse than the famiiar mouse compared to the offspring 
of young fathers (Figure 3.17a) (t = -2.13, d.f. = 31, p = 0.03), but again there was no significant 
discrimination in the 24hr trial (Figure 3.17b) (t = 0.14, d.f. = 31, p = 0.88). 





Figure 3.17 - Conspecific Discrimination in 1hr and 24hr Social Behaviour Task: Young vs. 
Fathers >10 months  
a) 1hr after original social investigation task 
b) 24hrs after original social investigation task 
 
3.6 Discussion  
3.6.1 Behavioural Outcomes of Advancing Paternal Age 
In this chapter, an investigation into whether advancing paternal age is associated with 
changes in behaviour in the offspring. The primary observation is that the offspring of older 
fathers engaged in significantly less social and exploratory behaviour than the offspring of 
young fathers. Significantly less social behaviour was seen in the offspring of fathers over 10 
months when combining the offspring of old and very old fathers, compared to the offspring 
of young fathers. Locomotor measures in all tests were similar between all three groups in the 
open field, novel object, holeboard and social behaviour tasks. Behavioural changes were 
limited to time spent in social interaction in the social behaviour task, latency to explore in the 



















































that other factors were controlled, paternal age is likely to be the cause of these behavioural 
outcomes most significantly in social behaviours.  This observation is particularly interesting 
given the known social deficits observed in ASD, schizophrenia and BD as discussed at the 
beginning of this chapter and in section 1.3. 
 
Differences between offspring of very old fathers and the offspring of young fathers were 
not observed as consistently as in the offspring of old fathers, although in many cases the 
direction of effect was the same.  In the social behaviour task the offspring of very old fathers 
did not engage in significantly less or more social behaviour than the offspring of young 
fathers (t = 1.68 , d.f. = 19 , p = 0.13), or old fathers (t = 0.64 , d.f. = 19 , p = 0.52) although 
when combined with the offspring of old fathers, the reduction was significant.  One reason 
for the difference in the offspring of old fathers and not very old fathers could be due to the 
smaller number of animals in this group. The very old father group has 25% less animals than 
the young father and old father groups and so the power to detect differences in this group is 
reduced. The smaller group size is due to less litters being born to the very old fathers. 
However, these observations do partly fit with the previous human literature. For example in 
ASD, where increasing paternal age increases the risk of developing autism until age 44 when 
the risk levels out and even drops slightly at age 50-59 and then increases again after age 60 
(Grether, Anderson et al. 2009) (Figure 3.18). In order to test this further, more groups of 
breeders of older than 12 months would need to be used.  





Figure 3.18 - Parental Age and Autism Risk 
Maternal and Paternal age and risk of autism in California residents births 1989-2002 
Adapted from Grether et al (2009) (Grether, Anderson et al. 2009) 
 
A second reason for the less severe behavioural changes between the offspring of very old 
fathers and the offspring of young fathers could be due to differences in the father’s 
environment. The very old fathers were purchased from Charles River at a separate time and 
could possibly be part of a different batch of animals from the other two groups. This could 
mean there are very slight differences in genetics due to CNVs or point mutations established 
at the beginning of the breeding line. Whether the behaviour was caused by environment, 
group size, and small genetic variations or as a parallel to the evidence from some studies is 
not clear.  
 
It is unfortunate that the novel object task appeared to be not successful in the current 
study. The animals in all groups displayed limited exploration of the objects and during the 
24hr trial very few animals approached the objects at all. The C57BL/6J strain has previously 
been shown to perform well in this task but this could be a consequence of single housing. It 
has previously been shown that single-housed mice perform worse in the novel object task 




than groups housed animals (Voikar, Polus et al. 2005) although this only affected the 
discrimination ratio and not the total amount of time exploring the objects. As the novel 
object task was unsuccessful, there was only one measure of short and long term memory 
from the social behaviour task but this task was more designed to look at social behaviour 
rather than memory and so having a purely memory based task would have been more 
informative. Also as we saw a difference in social investigation, there is a potential confound 
in the use of the social investigation for a memory task. 
 
3.6.2 Animal Studies of Paternal Age 
Although there are currently few comparable studies looking at the effects of paternal age 
on the behaviour of rodents, some comparisons can still be made with the results of this 
study.  A summary of results across all rodent studies of paternal age to date is given in (Table 
3.3). The first rodent study to look at the behavioural effects of paternal age showed that 
offspring of older fathers in rat (6 months) had decreased learning capacity than the offspring 
of standard age rats (2.5 months), and that the offspring performed worse in these task as 
paternal age increased further (10-23 months) (Auroux 1983).  
 
In a separate study looking at developmental and behavioural effects of advanced 
paternal age in mice (Garcia-Palomares, Pertusa et al. 2009), offspring of fathers of 120 weeks 
showed a decreased ability to self right on postnatal day 4-6 but this effect was lost by 
postnatal days 7-10. The offspring in this group also had reduced spontaneous motor activity 
in a 60 minute trial and reduced passive-avoidance learning. The authors observed no 
differences between the offspring of their standard breeding age group of 12 weeks and the 
offspring of fathers of 70 weeks and 100 weeks. It is difficult to draw direct comparisons with 
the present study due to the very different ages of the breeding males and the tasks used, but 
the consistent differences between offspring of standard and old breeders provides further 
evidence for a phenotypic difference caused by advanced paternal age.  
 
Foldi et al’s (Foldi, Eyles et al. 2010) study looking at advanced paternal age in mice is the 
most similar to this study but differs in some methodology. Their results showed that the 




offspring of old fathers spend less time on the open arms in the elevated plus maze indicating 
they were more anxious than the offspring of younger fathers. The offspring of old fathers 
were also more exploratory in the holeboard task and spent less time immobile in the forced 
swim task (Foldi, Eyles et al. 2010) where animals are put in a narrow cylinder of water with 
no escape and the amount of time spent immobile is recorded. This task has been proposed to 
measure behaviours related to depression. As the offspring of the advanced paternal age 
group were less immobile, it was suggested they experienced reduced depression-like 
behaviour. However, when split by sex, the effect was only seen in females and was not 
significant in males.  
 
They also observed no differences between the offspring of young fathers and advanced 
age father group in the social behaviour task. This could be due to a number of reasons. First, 
the method of measuring social behaviour used in Foldi et al’s study did not permit direct 
physical contact as the conspecific animals were separated from the test animal by 
perforated, transparent dividers. Second, the two ages they selected for their breeders were 4 
months for the standard groups and 12-18 months for the old group. As previously discussed, 
weaker effects were observed in our study in the very old father group which was the closest 
in age to Foldi’s advanced paternal age group. In the Foldi et al study, the main behavioural 
effects were seen in female mice and therefore direct comparisons with our study cannot be 
made as only male mice were tested. Even though the effect of advanced paternal age was 
only seen in female offspring, it still provides extra evidence for the hypothesis that advanced 





Table 3.3 - Summary of Paternal Age Studies 
  
(Smith, Kember et al. 2009) 
(this study) 
(Auroux 1983) 
(Garcia-Palomares, Pertusa et 
al. 2009) 
(Foldi, Eyles et al. 2010) 
Animal  Mouse (C57BL/6J)  Rat (Wistar)  Mouse (C57BL/6JIco)  Mouse (C57BL/6J) 
Sex 
Tested 
 Males  Males and Females  Males and Females  Males and Females 
Father's 
Ages 
 2 months  2.5 months  12 weeks  4 months 
 10 months  6 months  70 weeks  12-18 months 
 12 months  10 months  100 weeks  
  14 months  120 weeks  
  18 months   
  22 months   
Tests 
 Open Field  Spontaneous Activity  Righting Reflex  Elevated Plus Maze (EPM) 
 Novel Object  Learned Avoidance  Spontaneous Motor Activity  Holeboard 
 Holeboard   Passive-Avoidance  Social Behaviour 
 Social Behaviour     Forced-Swim  




























                          






Table 3.3 Continued 
  (Smith, Kember et al. 2009) (Auroux 1983) 
(Garcia-Palomares, Pertusa et 
al. 2009) 
(Foldi, Eyles et al. 2010) 
Results 
 Increased latency to middle in 
Open Field (10 months) 
 Reduced learning capacity 
with increasing paternal age 
 Decreased ability to self right 
on postnatal day 4-6 in 120 
week group 
 Increased time in open arms 
in EPM (females only) 
 Reduced exploration in 
Holeboard (10 months) 
 
 Reduced spontaneous motor 
activity for 120 week group 
 Increased exploration in 
Holeboard (females only) 
 Reduced overall social 
interaction in Social Behaviour 
task (10 and 12 months) 
 
 Reduced passive-avoidance 
learning in 100 and 120 week 
group 
 Less time immobile in Forced-
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There are several limitations to our study. First, only three different ages of male breeders 
were used making it difficult to determine whether the paternal age related affects on 
behaviour on linear or threshold dependant. As observed in some other studies discussed, 
having groups of increasing paternal age would allow the observation of potentially more 
extreme changes in behaviour and give an indication of breeding ages that are critical for the 
development of more severe phenotypes. Also the offspring of very old male group was 
significantly smaller than the other two groups and sired by a different batch of fathers. 
Therefore, the strongest conclusions should be drawn from the comparison between the 
offspring of young and old fathers. As different females were used for creating the offspring 
for the different groups we cannot sully rule out the effect of maternal care on the cause of 
behavioural changes. Variations in maternal care have been previously shown to affect 
behaviour in the offspring (Curley, Champagne et al. 2008) although this is unlikely to be an 
issue in the current study as litter effects were not observed.  
 
The strongest result was in social behaviour but only one measure of social behaviour was 
used in the current study. As shown in Foldi et al’s study, there are a number of ways to carry 
out a social behaviour or social preference test. Utilising the Y maze and dividers is one 
method (Foldi, Eyles et al. 2010) of measuring which animal the test mouse spends more time 
investigating. Also separating the arena into sections using dividers and holding conspecific 
mice under a round wired cage and measuring the time the test mouse spends in each area of 
the arena (Moy, Nadler et al. 2004). Allowing direct physical contact between mice in the 
social discrimination task could be a limitation if any aggression occurs and perhaps even the 
potential for an aggressive encounter may result in more avoidance behaviour in the test 
mice. Although significant differences were observed in the open field, holeboard and social 
behaviour tasks, a large number of tests were performed and so there is an issue of multiple 
testing. Since the significance level was set at 0.05, we would expect 5% of all findings to occur 
by chance. 156 tests between the three groups in all tasks were observed and so 7-8 of all 
values could be by chance. 
 
As the only learning tasks included the behavioural battery (novel object) did not work, it 
is not possible to speculate as to whether there may be any learning deficits or memory 








related to advancing paternal age in this study as shown in other studies looking at paternal 
age (Auroux 1983; Garcia-Palomares, Pertusa et al. 2009). Running the 24hr discrimination 
using the objects/conspecifics from the 1hr session could be a confound as requires the mice 
to forget the first set of objects/conspecifics and ideally this test should include an extra 0 hr 
session between  the 1hr and 25 hr trials.  
 
Only male offspring were used in the study due to the sex bias in autism where the ratio 
of male to female sufferers is 4:1 although as previously discussed this ratio drops with 
advancing paternal age (Anello, Reichenberg et al. 2009). However, we may be missing more 
convincing phenotypic changes associated with paternal age by not using females as there is 
evidence for female related social deficits in other studies (Foldi, Eyles et al. 2010). Paternal 
age effects are also seen in schizophrenia and BD as previously discussed and in these 
disorders the sex ratios are more balanced. Schizophrenia has a male to female ratio of 1.42:1 
(Aleman, Kahn et al. 2003) and in BD the ratio is roughly equal (Robins, Helzer et al. 1984).  
 
3.6.4 Conclusion 
In conclusion, the behavioural data presented here provides evidence for the role of 
paternal age in the development of social deficits in resulting offspring. Taking into account 
other rodent paternal age studies and epidemiological finding, it is possible to conclude that 
paternal age is responsible for phenotypic changes in the offspring. The mechanism behind 
this association is unclear, but may provide important insight into the causes of several 
psychiatric disorders. Understanding the molecular changes associated with advanced 
paternal age is the focus for the remainder of my thesis. 








Chapter 4 - Genome Wide Analysis of Copy Number 
Variants in a Mouse Model of Advanced Paternal Age 









De novo copy number variations (CNVs) are speculated to be a potential mechanism 
mediating the observed epidemiological association between advanced paternal age and the 
risk of developing neuropsychiatric disorders including ASD, schizophrenia and BD. Older 
males have been previously shown to have a larger incidence of CNVs and other chromosomal 
abnormalities in their sperm than younger males, in both humans and mice. As CNVs are 
aetiologically-associated with ASD, schizophrenia and BD, the increased rate of CNVs in older 
fathers may also mediate the association between advanced paternal age and disease risk. In 
this study, the offspring of young (2 month old) and old (>10 months old) fathers were 
analysed for CNVs using CGH on high-resolution genome-wide Nimblegen microarrays. The 
male and female breeders were also assessed in an attempt to differentiate inherited CNVs 
from de novo CNVs. It was observed that the incidence of inherited or de novo CNVs, their 
size, and the number of genes affected does not appear to be associated with advanced 
paternal age. Of note, however, the overall burden of CNVs was larger than anticipated 
indicating either that the rate of CNVs is larger than initially thought in inbred mouse strains 
or that methodological differences result in different estimates across studies. 
 
4.2 Introduction 
4.2.1 Copy Number Variation Background 
As discussed previously in section 1.5, CNVs are defined as polymorphic deletions or 
duplications between 1Kb and 5Mb in size (Freeman, Perry et al. 2006), representing one of 
the major types of structural variation in the genome. An analysis of 270 individuals from four 
different ancestral populations found that 12% of their combined genome was covered by the 
observed CNVs (Redon, Ishikawa et al. 2006), and approximately 0.4% of inter-individual 
genomic variation in the population is estimated to be due to CNVs (Kidd, Cooper et al. 2008). 
Two unrelated individuals from the same population are estimated to differ in CNVs by 
between 5.9 and 6.3Mb, accounting for approximately 0.2% of the genome (McCarroll, 
Kuruvilla et al. 2008). CNVs can be either inherited (when one parent has an existing CNV 
which is transmitted on to their offspring), or de novo (where the CNV occurs spontaneously 
during gametogenesis or the development of the offspring and is not present in either 








parent). De novo CNVs can occur by a variety of mechanisms, which are discussed later in this 
section. 
 
CNVs can be represented by either duplications (where the genome contains one or more 
extra copies of a specific region of the genome) or deletions (where a region of the genome is 
represented by fewer copies than expected, i.e. less than two on autosomal chromosomes). A 
related type of polymorphism are ‘copy neutral variations’ such as ‘inversions’ (where a region 
of the genome is present as expected but is inverted), and ‘translocations’ (where a region of 
the genome is present as expected but has been moved to another chromosomal locus). More 
complex rearrangements, including combinations of the above mentioned types, are also 
possible. Some genes have been found to be highly variable in copy number, being present in 
the genome at between zero and 13 copies (Dalen, Dahl et al. 1998). 
 
In humans, it has been hypothesised that there could be as many as 100 new point 
mutations per generation (Drake, Charlesworth et al. 1998). Although most of these are likely 
to occur in areas of non-coding DNA or be synonymous, some are likely to occur in coding 
regions and be non-synonymous but non-lethal so that they are introduced into the 
population. The frequency of de novo CNV events was traditionally suspected to be less 
frequent than the occurrence of point mutations, however this has been shown to be 
potentially untrue based on the incidence of disease-related rearrangements. The rate of 
point mutations is estimated to be 0.5–3.7 x 10-8  per nucleotide per generation with the 
combined rate of all mutations to be on average 1.8 x 10-8 per nucleotide per generation 
(Kondrashov 2003). Based on the prevalence of genomic disorders caused by known 
rearrangements, such as DiGeorge syndrome, Williams-Beuren syndrome, Smith-Magenis 
syndrome, Prader-Willi syndrome and Angelman syndrome, the estimate of de novo CNV rates 
is  1 × 10−4 in the population, and is thus potentially much higher than that of de novo point 
mutations in individual human autosomal dominant traits (Inoue and Lupski 2002). 
 
In a recent study characterising the occurrence of de novo CNVs in humans, nine CNVs 
were observed in 722 transmissions, equating to a rate of 1/80 CNVs per individual (Itsara, Wu 
et al. 2010). The rates are also likely to be higher than previously speculated due to the 








number of CNVs recently described in both disease free cohorts of humans (Iafrate, Feuk et al. 
2004; Sebat, Lakshmi et al. 2004; Sharp, Locke et al. 2005; Tuzun, Sharp et al. 2005) and 
common inbred laboratory mouse strains (Li, Jiang et al. 2004; Graubert, Cahan et al. 2007; 
She, Cheng et al. 2008; Watkins-Chow and Pavan 2008; Yalcin, Wong et al. 2011). Although, on 
a genomic level, CNVs are relatively abundant in both human and mice, individual CNVs do not 
occur at a high frequency in the population. This infers that although CNVs are common, a 
particular CNV probably occurs at low frequency in the population (Itsara, Cooper et al. 2009). 
However, since some regions of the genome appear to be hotspots for de novo CNVs (e.g. 
repetitive regions such as those close to centromeres), it is likely that recurrent CNVs in 
specific locations do occur. These reoccurring CNVs could be of interest in terms of the 
development of disease and the maintenance of deleterious conditions in the population.  
 
There are three primary mechanisms identified for the creation of CNVs: i) non-allelic 
homologous recombination (NAHR), ii) non-homologous end joining (NHEJ) and iii) fork 
stalling and template switching (FoSTeS). NAHR occurs during chromosome alignment along 
the metaphase plate during meiosis. This can cause loss or gain of segments of the 
chromosome in the gametes as well as inversions (Figure 4.1). It can also occur in mitosis 
leading to a mosaic population of somatic cells, a pattern that has been implicated in cancer 
(Notini, Craig et al. 2008). Duplicated sequences can lead to the misalignment of 
chromosomes and occurs at region-specific DNA blocks usually of 10-300kb in size with >95% 
homology. The human genome appears to have a larger proportion of duplicated regions than 
other organisms, suggesting that humans are more prone to recurrent CNVs. NAHR is 
postulated to be the most common way that de novo CNVs arise (Roth and Wilson 1986). 
 









Figure 4.1 – Schematic of Recombination Events 
a) Recombination occurring at the same site on sister chromatids 
b) Non-Allelic Homologous Recombination at misaligned chromatids 
 
The second mechanism implicated in the creation of CNVs is non-homologous end joining 
(NHEJ) (Lieber, Ma et al. 2003), which occurs when there are double strand breakage (DSB) 
events, and functions throughout the cell cycle act to repair such lesions (Figure 4.2). With no 
homology between stands, Ku70/80 (proteins that binds to DNA double-strand break ends 
and are essential for DNA repair) and the DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) attach to DNA and produce blunt ends. This leaves an “information scar” at the 
rejoining site as ends are edited by either cleavage or the addition of nucleotides. NHEJ is a 
relatively frequent event due to the highly repetitive nature of the genomes of multicellular 
eukaryotes and because homologous recombination is too slow when sister chromatids are 
not aligned. NHEJ is considered to be a major mechanism in rejoining translocated 
chromosomes in cancer (Elliott and Jasin 2002). Combined with DSB homologous repair, NHEJ 
is also used to explain duplications. It is not clear how frequently DSB occurs in humans, and 
therefore it is unknown how common NHEJ really is, although inherited defects in NHEJ are 
known to account for ~15% of human severe combined immunodeficiency (Lieber, Ma et al. 
2003). 










Figure 4.2 – Non-Homologous End Joining 
 
The third mechanism in the creation of CNVs is fork stalling and template switching 
(FoSTeS) (Hastings, Lupski et al. 2009). This occurs during mitosis and can account for 
complicated rearrangements. No extensive homology is required for FoSTeS to happen, but it 
occurs at sites of microhomology (4-15bp). When the replication forks stall, the 3′ primer end 
of a DNA strand can change templates to a ssDNA template in a nearby replication fork. This 
causes the loss of looped out regions, resulting in one segment of the genome moving to 
another. This mechanism can apply to both genic and single exon rearrangements and 
indicates a link to gene evolution and potentially the mechanism behind exon shuffling (Figure 
4.3). 










Figure 4.3 - Fork Stalling and Template Switching 
a) Replication occurring on two sections on DNA 
b) DNA loops out on the lagging strand of one section of DNA 
c) Microhomology on the other section of DNA causes replication of the first DNA 
strand to continue on to it 
d) Results in DNA from the second section becoming part of the first and a loss of 









































CNVs have been shown to occur more frequently close to the telomeres and centromeres 
than other areas of the genome (Nguyen, Webber et al. 2006), potentially due to the 
repetitive nature of the DNA sequence in these regions and the reliance on repetitive 
sequence and regions of homology for two of the primary mechanisms underlying the 
creation of CNVs, NAHR and FoSTeS (Roth and Wilson 1986; Hastings, Lupski et al. 2009). 
 
CNVs have been shown to have a strong effect on the expression of the genes they 
encompass. They have been found to account for 17.7% of the total detected genetic 
variation in the levels of gene expression in individuals from the HAPMAP project (Stranger, 
Forrest et al. 2007). In inter-crossed mouse studies, it was found that 83% of the genes 
predicted to be within CNVs were differentially expressed (Orozco, Cokus et al. 2009). 
According to the most recent version of the Database of Genomic Variation 
(http://projects/tcag.ca/variation), which defines structural variation involving segments of 
DNA that are >1kb in healthy individuals, there are 23,893 different CNVs at 15,931 loci 
throughout the human genome, suggesting that direct transcriptomic consequences resulting 
from these variants are likely to be widespread. 
 
Studies in mice report more than 600 associations between CNVs and gene expression; of 
note, most of the CNVs causing transcriptional changes are mapped to regions outside of 
actual transcribed regions, indicating that CNVs do not need to directly affect the gene 
sequence to cause alterations in its expression (Cahan, Li et al. 2009). In fact, CNVs have been 
shown to alter the expression of genes up to 0.5Mb away, although genes directly in the 
vicinity of a genomic alteration show a greater gene expression change (Henrichsen, 
Vinckenbosch et al. 2009). Nearly 30% of the expression level variation between different 
strains of mice are hypothesised to be caused by CNVs (Cahan, Li et al. 2009). From these 
studies, it can be concluded that CNVs not only alter the expression of genes in the direct 
vicinity of the CNV, but also interfere with the expression of other nearby (and more distal) 
loci. This causes problems for research into the role of CNVs in phenotypic variation and 
disease, because it may not be necessarily clear how structural variation maps onto 
phenotypic variation. 








4.2.2 Copy Number Variations in Disease 
As expected for such a major type of genomic variation, CNVs have been shown to play an 
important role in the aetiology of many diseases. Several Mendelian disorders, for example, 
have been shown to be caused by structural genomic variations including leukodystrophy, 
which is caused by a duplication in the protein lamin B1 gene (Padiath, Saigoh et al. 2006), and 
hereditary pancreatitis, caused by a duplication in PRSS1 (Le Marechal, Masson et al. 2006). 
Recently, there has been mounting interest about the role of CNVs in complex disease 
(WellcomeTrustSangerInstitute 2011).  
 
Genomic alterations are a hallmark of many types of cancer and there are several rare 
CNVs that may be responsible for a high cancer risk (Kuiper, Ligtenberg et al. 2010). 
Immunodeficiency disorders are another area where CNVs have been shown to play a role. 
Systemic lupus erythematosus has been found to be associated with CNVs in C4A/C4B (Yang, 
Chung et al. 2007) and CCL3L1 (Mamtani, Rovin et al. 2008), and psoriasis, rheumatoid 
arthritis and type 1 diabetes with a CNV in CCL3L1 (McKinney, Merriman et al. 2008). 
Furthermore, increased HIV resistance is associated with CNVs in DEFB104 (Milanese, Segat et 
al. 2009) and CCL3L1 (Gonzalez, Kulkarni et al. 2005).  
 
4.2.3 Copy Number Variation in Psychiatric Disease 
Of particular relevance to this study is recent data showing that the risk of many 
psychiatric disorders, including those linked to advanced paternal age, are associated with 
structural genomic variation; both at specific sites in the genome and via an overall increased 
in CNV burden across the genome of affected individuals. Of note, much of the risk appears to 
be with de novo CNVs. To date, the variants associated with neuropsychiatric disease 
generally appear to be individually rare, but highly penetrant where they occur. Some of the 
evidence linking CNVs to autism, schizophrenia and BD is presented below. 
 
Autism patients have been shown to have a higher incidence of de novo CNVs (~10%) than 
controls (~1%) and in 1st degree unaffected relatives (Sebat, Lakshmi et al. 2007). They are 
believed to play a role in ~7% of cases of ASD (Marshall, Noor et al. 2008), with the most 








common recurrent CNV observed in autism only occurring in 1-2% of cases (Weiss, Shen et al. 
2008). For autism, CNVs appear to be more associated with sporadic cases than multiplex 
(familial) cases (Morrow 2010). Several recurrent CNVs have been associated with autism (see 
Table 4.1), and there are examples of both inherited and de novo events mediating risk. Some 
CNVs associated with autism are not necessarily recurrent with regard to their exact location, 
but act to disrupt a specific gene. An example of this is with NRXN1 where CNVs affecting the 
gene are significantly more common in ASD patients than the general population, but the 
location of the CNV differs across affected individuals (Kim, Kishikawa et al. 2008). The most 
widely researched region of the genome in terms of CNVs in ASD is the 15q11-13 locus. This 
region has been found to contain duplications in a number of studies and still remains a major 
candidate region for the development of ASDs, especially when maternally inherited (Cook, 
Lindgren et al. 1997; Cook, Courchesne et al. 1998; Sebat, Lakshmi et al. 2007). CNVs in some 
other regions of the genome have been identified in multiple studies of ASD, including 
16p11.2 (Sebat, Lakshmi et al. 2007; Marshall, Noor et al. 2008; Weiss, Shen et al. 2008).  
 
Table 4.1 – Examples of ASD Related Genes and Regions Containing CNVs 
* Denotes where only genes affected are given instead of loci  
+ Denotes where loci affected do not give exact details of genes involved 
Study Locus Genes 
(Ghaziuddin and Burmeister 1999) 2q37+   
(Serajee, Zhong et al. 2003)  7q31 GRM8  
(Vorstman, Staal et al. 2006) 2q37+   
5p15+   
11q25+   
16q22.3+   
17p11.2+   
18q21.1+   
18q23+   
22q11.2+   
22q13.3+   
Xp22.2–p22.3+   








(Ullmann, Turner et al. 2007) 16p13.1+   
(Bakkaloglu, O'Roak et al. 2008)  7q11.22 AUTS2 
 7q35 CNTNAP2 
(Kumar, KaraMohamed et al. 2008) 16p11.2+   
(Fernandez, Morgan et al. 2008)  3p26.2-p26.3* CNTN4 
(Kim, Kishikawa et al. 2008)  2p16.3+ NRXN1 
(Morrow, Yoo et al. 2008) 4q28.3 PCDH10 
3q24 NHE9 
(Weiss, Shen et al. 2008) 16p11.2+   
(Doornbos, Sikkema-Raddatz et al. 2009) 15q11.2+   
(Glessner, Wang et al. 2009) 2p16.3* NRXN1 
3p26.2-p26.3* CNTN4 






2q24.3* AK123120  
(Moreno-De-Luca, Mulle et al. 2010) 17q12+   
(Roohi, Montagna et al. 2009) chr3p26.3 CNTN4 
(Sykes, Toma et al. 2009) 22q13.3 SHANK3 
(Strom, Stone et al. 2010) 17q21.33* CACNA1G 
 
In schizophrenia, it has been observed that de novo CNVs are present in a significantly 
higher percentage of cases than controls (International Schizophrenia Consortium 2008; 
Walsh, McClellan et al. 2008; Xu, Roos et al. 2008), and the frequency is higher still in early-
onset cases (Walsh, McClellan et al. 2008). In a separate study, the overall occurrence of CNVs 
has been shown to be 1.15 fold higher in cases than in controls (Stone, O’Donovan et al. 
2008). De novo CNVs have been shown in some studies to be significantly associated with 
sporadic cases of schizophrenia, but play less of a role in familial cases (Xu, Roos et al. 2008). 
Other studies, however, suggest that individual rare inherited CNVs are still more common in 
familial cases compared to controls (Xu, Woodroffe et al. 2009). These findings suggest that 








these CNVs are rare in the population as a whole but more common in schizophrenia cases 
either due to de novo events or because they have been inherited from affected parents. 
Some examples of genes affected by CNVs associated with schizophrenia are listed in Table 
4.2. Again, these CNVs are individually rare; the most common CNV (22q11.2) is only seen in 
0.3% of schizophrenic cases (International Schizophrenia Consortium 2008). Genes disrupted 
by CNVs in schizophrenia include DISC1 and DISC2 (Millar, Wilson-Annan et al. 2000; 
Blackwood, Fordyce et al. 2001; Chubb, Bradshaw et al. 2008), PDE4B (Millar, Pickard et al. 
2005; Millar, Mackie et al. 2007), NPAS3 (Kamnasaran, Muir et al. 2003; Pickard, Pieper et al. 
2006; Pickard, Christoforou et al. 2009), NXRN1 (International Schizophrenia Consortium 2008; 
Vrijenhoek, Buizer-Voskamp et al. 2008; Rujescu, Ingason et al. 2009; Ikeda, Aleksic et al. 
2010) and CHRNA7 (International Schizophrenia Consortium 2008; Stefansson, Rujescu et al. 
2008). 
 
Table 4.2 - Schizophrenia Related Genes and Regions Containing CNVs 
* Denotes where only genes affected are given instead of loci  
+ Denotes where loci affected do not give exact details of genes involved 
Study Locus Genes 
(Millar, Wilson-Annan et al. 2000) 1q42.2  DISC1,  DISC2 
(Riley, Makoff et al. 2000) 15q13-14 CNTNAP 
CHRFAM7A 




(Moon, Yim et al. 2006) 3q13.12 CD47 
14q32.33 IGHV3, IGHV4, IGHV7 
15q15.1+   
Xq23 LOC441513 
22q11.2+   
(Friedman, Vrijenhoek et al. 2008) 7q34-35.1+   
(International Schizophrenia 1q21.1+   








Consortium 2008) 2p16.3 NRXN1 
7q35 CNTNAP2 
12p11.23+   
15q13.1 APBA2 
15q13.3 CHRNA7 
16p12.1-12.2+   
22q11.2+   
(Kirov, Gumus et al. 2008) 2p16.3+   
15q13.1+   
16p12.2+   
17q22+   
(Mizuguchi, Hashimoto et al. 2008) 15p12 HCN1, MRPS30 
11p13 HIPK3 
17p12 PMP22 
(Stefansson, Rujescu et al. 2008) 1q21.1 GJA8 
22q11+   
15q11.2 CYFIP1 
15q13.3 CHRNA7 
(Vrijenhoek, Buizer-Voskamp et al. 
2008) 
 2p16.3 NRXN1 
 2p25.3 MYT1L 
 5p15.2 CTNND2 
 9q33.1 ASTN2 











19q13.12 ZNF Cluster 








22q11.2+   
(Bruce, Sachs et al. 2009) 5p15.1 ANKH 
(Ingason, Rujescu et al. 2011) 16p13.1 NTAN1, NDE1 
(McCarthy, Makarov et al. 2009) 16p11.2+   






22q11.2+   
(Rodriguez-Santiago, Brunet et al. 
2010) 
16p13.3 SSTR5 
22q11.23 GSTT1, GSTT2 
(Rujescu, Ingason et al. 2009) 2p16.3 NRXN1 
(Glessner, Reilly et al. 2010)  9q34.4* CACNA1B 
 10q11.21* RET 
 18q12.3* RIT2 
 16p11.2* DOC2A 
(Ikeda, Aleksic et al. 2010) 1q21.1+   
16p13.1+   
 2p16.3* NRXN1 
(Mulle, Dodd et al. 2010) 3q23 PAK2, DLG1 
(Levinson, Duan et al. 2011) 3q29+   
7q36 VIPR2 
(Vacic, McCarthy et al. 2011)  7q36.3* VIPR2 
 
Although BD has also been associated with an increased burden of CNVs (Zhang, Cheng et 
al. 2009), the evidence is considerably weaker than for either ASD or schizophrenia, and is 
primarily in the context of early-onset forms of the disorder (Priebe, Degenhardt et al. 2011). 
This is interesting because BD, like autism and schizophrenia, is also associated with advanced 
paternal age. There is little evidence that CNVs associated with schizophrenia also confer a 
risk for BD;  in some cases, schizophrenia-associated CNVs are actually less common in BD 
than in controls (Grozeva, Kirov et al. 2010; McQuillin, Bass et al. 2011) although in Grozeva et 
al’s study, the number of CNVs in BD was not increased compared with controls and was 








significantly less than in schizophrenia cases (Grozeva, Kirov et al. 2010), and in McQuillin et 
al’s study the rate of CNVs in BD cases was lower than in controls (McQuillin, Bass et al. 2011). 
Some examples of genes affected by CNVs associated with BD are listed in Table 4.3. 
Table 4.3 – Bipolar Disorder Related Genes and Regions Containing CNVs 
Study Loci Genes 
(Wilson, Flibotte et al. 2006) 1p34.3 GRIK3 
14q23.3 AKAp5 
22q12.3 CACNG2 
(Lachman, Pedrosa et al. 2007) 3q13.3 GSK3β 
 
From the studies discussed above and others, there is overall strong evidence to support 
the role of CNVs in ASD, schizophrenia and BD. All three disorders show evidence for the role 
of recurrent CNVs, rare CNVs, de novo CNVs and overall load of CNVs in their aetiology. Many 
studies show consistent or overlapping regions containing CNVs, whereas others show 
‘exclusive’ CNVs that are not found in other studies.  CNVs at some loci are recurrent across 
multiple disorders such as 1q21.1, 15q13.3, 16p11.2 and 22q11.2, which have been associated 
with both schizophrenia and autism (Weiss, Shen et al. 2008), and 1p34.3, 14q23.3 and 
22q12.3, which have been seen in both schizophrenia and BD (Wilson, Flibotte et al. 2006). 
This suggests that in some instances these disorders may share common aetiological 
pathways. 
 
If CNVs are responsible for the development of psychiatric disease, the mechanism behind 
this link has to still be elucidated. Either CNVs could lead to a general impairment in cognitive 
function as an intermediate phenotype, ultimately resulting in disorders such as autism and 
schizophrenia, or specific CNVs could be directly responsible for the disorder itself either 
individually or as a pleiotropic factor (O'Donovan, Kirov et al. 2008). Interestingly, brain 
expressed genes appear to be more protected from CNV induced gene expression changes 
than genes expressed in other tissues (Henrichsen, Vinckenbosch et al. 2009). The parent-of-
origin of CNVs may be of importance in the development of disease. For example, in a recent 
CNV screen of patients with intellectual disability, 76% of the phenotype-associated de novo 
CNVs were on the paternally inherited allele, especially CNVs over 1Mb and deletions (Hehir-








Kwa, Rodriguez-Santiago et al. 2011), indicating that CNVs inherited from the father could be 
a larger contributor to the development of psychiatric disease. This observation could have 
implications for understanding the mechanism(s) involved in mediating the paternal age effect 
in neuropsychiatric disorders. 
 
4.2.4 Copy Number Variations and Paternal Age 
As male germline cells undergo significantly more divisions than female germline cells (section 
1.4), the potential for more de novo mutations coming from the father is greater than from 
the mother (Crow 1999). This includes both point mutations and CNVs. The incidence of de 
novo CNVs in the offspring has been previously hypothesised to increase with advancing 
paternal age (Walter, Intano et al. 1998), and evidence from evolutionary sequence data 
indicates that the overall rate of deleterious mutation observed in older fathers may be high 
enough to have a large effect on human well-being (Crow 2000). 
 
The link between advanced paternal age and structural genomic variation has not been 
widely explored. Paternal age has been shown to be associated with a higher incidence of 
balanced translocations occurring in the sperm (Thomas, Morris et al. 2010), although this 
observation has not been ubiquitously reported (Thomas, Durkie et al. 2006). In mice, older 
males have been shown to have an increased incidence of sperm mutations than younger 
mice (Walter, Intano et al. 1998). To date, however, only one association has been reported 
between the offspring of older fathers and the offspring of younger fathers in humans, finding 
that increased paternal age was only associated with an increased burden of CNVs not flanked 
by segmental duplications (Hehir-Kwa, Rodriguez-Santiago et al. 2011). Only one study in mice 
has been previously undertaken. In this study, seven de novo CNVs were observed in six 
offspring of fathers 12-18 months old and no de novo CNVs in the offspring of fathers three 
months old (Flatscher-Bader, Foldi et al. 2011). The paucity of research into this area 
highlights the need for further studies into the link between advanced paternal age, increased 
CNV burden, and risk of neuropsychiatric disease. 
 









By systematically investigating CNVs across the genome in the offspring of mice of two 
different ages (two months and ten months), the aims of this chapter were to i) investigate 
whether paternal age is associated with an increased incidence of CNVs in the offspring and ii) 
whether there are any recurrent CNVs occurring in the context of advanced paternal age. 
Where any de novo CNVs are identified, I aimed to assess their relevance to the paternal-age 
associated behavioural changes reported in Chapter 3 via functional pathway analyses. 
 
4.4 Methods 
Several methods have been developed for the detection of CNVs across the genome. The 
earliest forms of detection employed cytogenetic approaches and fluorescence in situ 
hybridization (FISH), which uses fluorescent probes that bind to specific regions of the 
genome that can be visualised using fluorescence microscopy. There are limitations to these 
approaches; FISH can only be used to visualise large structural changes to the genome and it 
does not have the resolution to identify smaller CNV events such as those commonly 
associated with complex disease phenotypes. Furthermore, the target regions have to be 
already known and so this approach cannot be used to screen the genome for de novo events. 
Microarray-based methods such as CGH and high-resolution SNP arrays have revolutionised 
CNV analysis as they allow detection of smaller events across multiple individuals and can be 
either targeted towards regions of interest or used to screen the entire genome. CGH arrays 
compare hybridisation to a high-resolution oligo microarray between a sample versus a 
common reference which are labelled by different dyes (in this study, Cy-3 and Cy-5). 
However, they are subject to background noise problems and are potentially subject to a high 
number of false positives (and negatives). The recent development of next generation 
sequencing approaches will enable the characterisation of the genome for CNVs at a much 
higher resolution, allowing the better identification of break points with less false positive 
results. However, this method is still very expensive and not feasible for large numbers of 
samples. Specific CNVs can also be assessed using quantitative PCR (qPCR), but this approach 
is less useful in the analysis of complex phenotypes because individual CNVs are rare and are 
ideally identified using a genome-wide screen. For this study we decided that the optimal 
strategy was to use array-CGH, employing high-resolution microarrays spanning the mouse 
genome.  








4.4.1 Array Specifications 
The arrays used in this study were Nimblegen Mouse CGH 3x720K Whole-Genome Tiling 
Arrays. These arrays contains over 720,000 probes covering the mouse genome based on the 
UCSC mm9 mouse genome build and can run three samples in parallel on a single array. In this 
array the probe length is 50-75mer and median probe spacing of 3537bp. 
 
4.4.2 DNA Extraction 
Spleen DNA was extracted using the Qiagen DNeasy extraction method as outlined in 
section 2.2.1. All DNA samples underwent stringent quality control assessment using gel 
electrophoresis (section 2.5) and Nanodrop spectrometry before being used in the 
subsequent array-CGH experiments. All included samples were of high structural fidelity and 
showed no evidence of degradation. 
 
4.4.3 DNA Labelling 
DNA was labelled using a protocol adapted from the Roche Nimblegen Dual Colour 
labelling kit (Figure 4.4) (Nimblegen 2011). All reagents were thawed on ice and Cy3- and Cy5-
Random Nonamers were kept protected from light at all time. To prepare random nonamers, 
1.75µl β-Mercaptoethanol was added to 998.25µl of Random Prime Buffer in a fume hood 
then 462µl of the Random Primer Buffer with β-Mercaptoethanol was added to Cy3-Random 
Nonamers and Cy5-Random Nonamers. The resuspended Nonamers were then made into 
40µl aliquots in small PCR tubes and stored at -20oC until needed. 1.5μg of the test sample 
DNA was added into 40μl Cy3-nonamer PCR tube and the reaction volume made up to 80μl 
with DNase free water. 1.5μg of the common reference sample DNA (an unused female 
breeder) was added into 40μl Cy5-nonamer PCR tube and the reaction volume made up to 
80μl with DNase free water. The samples were heat-denatured in a thermocycler at 98°C for 
10 minutes and then immediately placed in an ice water bath for 2 minutes. The dNTP/Klenow 
master mix was prepared and amounts per sample were as below: 
 
 








dNTP Mix (10 mM each dNTP)  10µl 
Klenow Fragment (3'->5' exo-) 50U/µl 2µl 
Water     8µl 
Total     20µl 
 
20μl of the dNTP/Klenow master mix was added into each PCR tube and pipette–mixed 
before being incubated for 2 hours at 37°C in the thermocycler with the heated lid. After 
removing the samples from the thermocycler, 10μl of Stop Solution was added to each tube 
followed by the addition of 11.5μl of 5M Sodium Chloride (NaCl). All 121.5µl of sample was 
then added to 1.5ml eppendorf tube containing 110μl of 100% isopropanol which was then 
vortexed and incubated for 10 minutes at room temperature protected from light. After 
incubation the tubes were spun in a centrifuge at 13000rpm for 10 minutes. The supernatant 
was carefully removed from the tube with a pipette and discarded before the pellet was 
rinsed with 500μl of 80% ice cold ethanol then centrifuged at 13000rpm for 2 minutes. The 
supernatant was removed with a pipette and discarded. The pellet was then dried in a 
SpeedVacuum at 2000rpm at 65oC. 









Figure 4.4 – An Outline of the DNA Labelling Protocol for Array-CGH  
(Nimblegen 2011) 
a) Begin labelling protocol with double-stranded test and reference DNA  
b) Denature double-stranded DNA and anneal Cy3- and Cy5- random primers (9mers) 
c) Synthesis begins as the Klenow fragment extends  from random primers 
d) Primer extension, strand displacement, and amplification 
e) Remove free nucleotides (dNTPs) and other components 
f) Test and reference samples were combined, denatured and hybridized to the array 
 
4.4.4 Array Hybridization 
After the test and common reference samples were labelled they were prepared for 
hybridization to the microarray. The pellets were rehydrated with 25μl of DNase free water 
and allowed to dissolve fully then vortexed and spun down to collect contents at the bottom 
of the tube. The concentration of each sample was measured using the NanoDrop NT-1000 




















arrays. 31μg of the test sample and common reference sample were combined in a 1.5ml tube 
and the sample mix then dried in the SpeedVacuum at 2000rpm 65oC. The sample was then 
rehydrated using 5.6μl of DNase free water, vortexed and spun down to collect at the bottom 
of the tube. The hybridization Solution Master Mix was made per array as below. 
 
2X Hybridization Buffer  35µl 
Hybridization Component A  14µl 
Alignment Oligo   1.4µl 
 
14.4μl of Hybridization Solution Master Mix was added to each sample tube and vortexed 
for 15 seconds then spun down. The tubes containing the sample mix were then incubated in 
a heat block at 95°C for 5 minutes and placed in the Hybridization System preheated to 42°C. 
The HX3 Mixer was assembled on to the array using the Precision Mixer Alignment Tool 
(PMAT) (Figure 4.5). The mixer was sealed using the braying tool on the 42oC hybridisation 
station.  
 
Figure 4.5 - PMAT with Mixer and Array 
 
To load the sample, the array was placed into a hybridization chamber and using a positive 
displacement pipette, 18μl of Hybridization mixture was loaded into the array through each of 
the HX3 mixer fill ports (Figure 4.6). The array was then hybridised for 72hrs at 42°C. 









Figure 4.6 - HX3 Mixer and Array Assembly 
 
4.4.5 Washing  
After the arrays were hybridised they were washed to remove unhybridised sample. Wash 
buffers were prepared as below. 
Mixer Removal Wash 
Water    225ml 
10X Wash Buffer I   25ml 
1M DTT    25ul 
 
Slide Washing  
Water    22.5ml 
10X Wash Buffer I, II or III  2.5ml 
1M DTT    2.5ul 
 
The Mixer removal wash was heated to 42oC and poured into the removal bath. The 
assembled array with mixer was removed from the Hybridization System and put into the 
Disassemble Array Tool (DAT) and then placed together into 42°C Wash I to remove the mixer 
from the array (Figure 4.7). The slide was removed from the DAT and placed into the slide rack 
in room temperature Wash I and the 2 minute wash was begun by shaking array washer 
vigorously. The arrays was removed from Wash I and placed in room temperature Wash II and 
vigorously washed for 1 minute. The array was removed from Wash II and placed in room 








temperature Wash III and washed for 15 seconds. The array was then spun dry using an Array-
It slide dryer for 30 seconds. 
 
 
Figure 4.7 - Using Disassemble Array Tool  
 
4.4.6 Scanning 
The array was loaded into a dual laser (532nm and 635nm) GenePix 4000B scanner face 
down and the scanning parameters controlled using the GenePix software. The array was 
preview scanned and the laser voltage parameters adjusted to optimise the array image. The 
array was then fully scanned and both images saved for quality control and analysis. 
 
4.4.7 Nimblescan Analysis and Data Cleaning 
Data pre-processing steps were carried out using the NimbleScan Software v2.6. As the 
microarrays used in my experiments were 3x720k probe arrays, data from three samples was 
contained in each image file. The first step was to ‘burst’ the images so only one sample was 
analysed at a time. To burst images, files to be burst were selected in the Burst Multiplex 
Image option, and opened with the Multiplex annotation file provided with the arrays. Once 
burst, images for both colour channels (532nm and 635nm) were aligned and checked so that 
raw intensity data and probe signal data could be obtained (Figure 4.8). The data were then 
analysed using the Nimblescan CGH-segMNT algorithm to identify copy number changes by 
comparing the log2 ratio data of the two colour channels.  









Figure 4.8 – Nimblescan Array Alignment Showing an Example Scan  
 
As an initial quality control step, array results were initially checked to ensure they 
showed the correct profile across probes on the sex chromosomes. As the common reference 
sample was female, male samples were expected to show a clear deletion spanning the 
majority of probes on the X chromosome (except for the pseudo-autosomal region) and 



























Figure 4.9 - Example Log2 Graphs of Female and Male 
Since the common reference sample used in my array-CGH experiments was female, a 
female hybridised against the reference will show no copy number change across the X-
chromosome, with a noisy signal pattern across the Y-chromosome. A male sample shows an 
apparent deletion across the X-chromosome and a noisy duplication across the Y-chromosome. 
Examples of possible CNVs in the reference sample can also be seen in this figure. 
 
4.4.8 Further Microarray Quality Control 
For further quality control (QC), raw intensity values were log2 transformed and plotted 
to identify samples with large variations in intensity or extremes of intensity values (Figure 
4.10).  Since all arrays are run against a common reference, the analysis involves no 
















Figure 4.10 – Boxplot of Intensities from all Arrays 
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Samples were plotted against their reference to assess the overall correlation between 
colour channels, both with sex chromosomes (Figure 4.11a) and without (Figure 4.11b). This 
was to check for sex differences where applicable, because, as described, the common 
reference for all samples was female. As the reference sample was the same across all arrays, 
the log2 intensities were plotted against a single reference array’s signal (PA52) to assess 
array quality. The plots were correlated across the vast majority of samples, and any arrays 
showing a poor correlation were removed from further analysis (Figure 4.12).  
 
          
Figure 4.11 – Correlation of Log2 Intensities - Male Samples vs. Female Reference 
Reference (_r) and sample (_s) plotted to show their correlations 
a) With sex chromosomes – High correlation but many outliers which are probes on 
the sex chromosomes as reference is female and sample is male. 
b) Without sex chromosomes. 
 
a)                                                    b) 
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Figure 4.12 – Plot of Log2 Intensities of Reference versus Reference 
All reference log2 intensities were plotted against the reference from PA20 (x-axis) to 
check for correlations. As the reference for all arrays was the same female sample, probe 
intensities should be highly correlated with any variance due to technical/experimental factors. 
 
4.4.9 Analysis 
Data cleaning and analysis was carried out using the Partek® Genomics Suite™ (2008). 
First the data was subjected to GC wave correction to remove any methodological based 
“waviness” of the array data (Figure 4.13), allowing for more precise calling of peaks in the 
CNV data (Diskin, Li et al. 2008). Waviness is a common problem in CGH and SNP genotyping 
array CNV experiments (Marioni, Thorne et al. 2007). Once the data was smoothed a 
segmentation analysis was applied to compare each probe to adjacent probes and identify 
regions of copy-number change.  
 









Figure 4.13 – Example of a ‘Wavy’ Array, Pre-Correction 
Wave artefacts were observed in some arrays. These samples were wave corrected using a 
function within the Partek software. 
 
De novo CNVs were identified by excluding CNVs that were clearly present in (and thus 
presumably inherited from) either parent. Genes affected by CNVs were annotated using 
Galaxy (Blankenberg, Von Kuster et al. 2010; Goecks, Nekrutenko et al. 2010). Galaxy is an 
open, web-based platform for data intensive biomedical research. It is linked to UCSC genome 
browser and in this instance was used to find genes intersecting the chromosomal positions of 
observed CNVs. Chromosomal positions were loaded into Galaxy using the UCSC genome 
browser table browser (Kent, Sugnet et al. 2002) and intersected with the entire mouse 
genome (mm9). This output was then combined back with the entire de novo CNV list. 
 
Due to the possibility of probe location error (e.g. resulting from repetitive regions), any 
CNV that had an overlap with a CNV in either parent was classed as inherited and removed 
from the de novo CNV analysis as shown in Figure 4.14. Due to the highly repetitive nature of 
the Y chromosome (and the lack of Y-chromosome DNA in the female common reference 
sample), I chose to remove Y-linked probes from all analyses. Furthermore, due to the 
combination of females and males compared against a female reference, the X-chromosome 
was also removed from analysis, but retained as a QC measure to check sex (as described 
above).  
 









Figure 4.14 - Example of Inherited and De Novo CNV in a Trio of Mice 




4.5.1 Data Description 
The first result of note is the overall high number of CNVs observed in both the breeders 
and offspring. As the mice were an inbred strain, obtained from the same breeding stock, the 
number of CNVs observed between individuals was expected to be relatively low. Regardless 
of paternal age, CNVs were seen in most individuals, and in most cases we observe one or 
more CNV. In 60 samples we see the incidence of 780 CNVs, 93 in female breeders, 292 in 
male breeders, and 395 in all offspring, 383 of which were non-overlapping CNVs. Taken 
together, we observed an overall higher average number of CNVs in the male breeders (Figure 








4.15), where the average number of CNVs per individual was 29, compared to the offspring 
and female breeders where the average number of CNVs was 10 (F (2, 58) = 5.07, p = 0.0094). 
Since my experimental design meant that the samples were randomised across microarrays, it 
is unlikely that this elevated number is due to a technical artefact. Furthermore, none of the 
male breeder samples appeared to be experimental outliers in stringent QC measures 
described in section 4.4.8. 
 
Figure 4.15 – Number of CNVs by Breeder or Offspring 
 
The total number of CNVs for each individual sample is shown in Figure 4.16. Here it can 
be seen that several samples are clear outliers for their total burden of CNVs, including PA02 
(Figure 4.17) (91), which reached 3 SDs above the mean and PA16B (66), PA23B (64), PA04B 
(60) and PA06B (68), which reached 2 SDs above the mean. Even though these arrays are of 
good quality based on QC measures, these samples (predominantly old male breeders) were 
removed from the CNV analyses presented below.  









Figure 4.16 - All CNVs by Family and Group 
Plot of all CNVs in all individual samples. Grey dotted line indicates mean, black dotted 
lines indicates standard deviations above the mean. 
 
 
Figure 4.17 – Plot of Log2 Ratio of Sample over Reference 
Plot of PA02 which has a large number of CNVs with some examples of CNVs indicated by 
arrows. The array is of good quality: signal intensities are high, there is no ‘waviness’ and the 
sex chromosomes show the correct dosage. 
 
The CNV abnormalities in certain male breeders do not appear to be manifest in the 
germline of these individuals, as the high burden is not seen in their offspring, suggesting a 
somatic event potentially restricted to the spleen. Of note, the high number of CNVs could be 
caused by lymphomas in the spleen which are known to occur sporadically in mice and 








especially with advanced age (Murphy 1968). In fact, a major cause of natural death in 
C57BL/6 mice is lymphoma (Brayton, Treuting et al. 2012). If these CNVs in the breeders were 
also seen in other tissues, especially the sperm, we would expect a higher number to be 
inherited by the offspring, and in all cases except PA02, the number of CNVs is significantly 
lower in their offspring. Once these samples were removed, we see an average of 8 (+/- 7) 
CNVs per individual. It is worth noting that this estimate is likely to be slightly inflated due to 
CNVs occurring in the reference sample (as exemplified in Figure 4.9); however since I 
removed overlapping CNVs these should each only be counted once in assessments across all 
samples. 
 
Other studies looking at CNVs in populations of ‘genetically identical’ inbred mice have 
also observed a notable CNV burden. In one study using a lower resolution CGH array (385k), 
for example, 38 CNVs were observed between 14 colonies of C57BL/6 inbred mice (Egan, 
Sridhar et al. 2007). While the majority of these CNVs were rare, private events, some are 
common – for example a CNV in the Ide gene has been shown to be present in 64% of mice 
assayed (Watkins-Chow and Pavan 2008). Compared to other studies in inbred mouse strains, 
however, we see an overall higher rate of CNV burden across the genome, although this may 
be a result of the higher-resolution arrays used in our study compared to previous published 
reports.  
 
Some CNVs appear to be highly recurrent between individuals suggesting these may 
actually represent a CNV in the common reference sample. Some examples of this are shown 
in the male of Figure 4.9. As these CNVs occurred in at least one parent per family, they were 
removed from analysis of de novo CNVs.  To investigate whether some chromosomes had an 
abundance of CNVs across all individuals, all non-overlapping CNVs were separated by 
chromosome. The mean number of non-overlapping CNVs per Mb was 0.06. No chromosome 
reached three SDs above the mean but chromosome 12 had a number of CNVs more than two 
SDs above the mean (Figure 4.18) suggesting it may be more prone to the occurrence of CNVs. 
Looking at non-overlapping de novo CNVs (i.e. those present in the offspring but not parents 
in informative families) by chromosome, the mean number of CNVs per Mb was 0.05, with the 
highest rate observed on chromosome 3. 








Figure 4.18 - Number of Non-Overlapping CNVs by Chromosome in all Animals 
Plot of non-overlapping CNVs per Mb plotted by chromosome with outliers removed. Black 
dotted line indicates mean, grey dotted lines indicates standard deviations above the mean 
a) All non-overlapping CNVs 




To look for regions of the genome that are enriched for CNVs, I also divided the CGH data 
by discrete chromosomal bands. The mean number of all non-overlapping CNVs per Mb 
including all chromosomal bands in the genome was 0.08, so to investigate whether certain 
chromosome bands contained more CNVs, a value of two SDs above the mean was used as an 
arbitrary threshold (0.41 per Mb); these were classed as “CNV rich”. Eight bands reached the 
mean plus 2SD threshold (2qA3, 4qC2 7qF5, 9qA5.2, 12qA1.3, 15qB2, 15qD2 and 15qD3, 

























This implies that these regions may be more prone to CNVs as they occur more commonly in 
these bands than the rest of the genome. These regions are shown in Figure 4.19. 
 
Figure 4.19 - CNVs by Chromosome Band 
Plot of non-overlapping CNVs per Mb plotted by chromosome band. Black dotted line 




















To identify chromosome bands with a higher frequency of de novo CNVs, all non-
overlapping de novo CNVs were split by band and divided by band size in Mb to give CNVs per 
MB by band. The mean value of CNVs per Mb including all chromosomal bands in the genome 
was 0.05. 1qE2.2, 3qF2.1, 3qF2.3, 6qF2, 9qA5.3, 15qF3, 17qD and 18qB2 all exceeded a level 
three SDs above the mean (0.39 CNVs per Mb) and 16 bands reached a value 2SDs above the 
mean (0.28 CNVs per Mb) (Figure 4.20), suggesting that these regions may be more prone to 
the occurrence of de novo CNVs.  
 








Figure 4.20 – De Novo CNVs by Chromosome Band 
Plot of non-overlapping de novo CNVs per Mb plotted by chromosome band. Grey dotted 



















Comparing the CNVs identified in our sample with CNVs from other studies carried out on 
the C57BL/6 strain, we see some notable overlap in CNV locations (Figure 4.21, Figure 4.22 
and Figure 4.23), suggesting again that certain regions of the genome are particularly prone to 
duplications/deletions. Three CNVs overlapped with a previous paternal age study in mouse, 
one in chromosome 4 and two in chromosome 14 (Flatscher-Bader, Foldi et al. 2011). In 
Flatscher-Bader et al’s study, these CNVs were only seen in the offspring of old fathers but we 
observe a less clear-cut distribution, with instances of these CNVs also seen in the offspring of 
young fathers.  While the chromosome 4 CNV was only seen in the offspring of old fathers and 
not young fathers, we also observe it in two of the breeders suggesting this is not a de novo 
event linked to advanced paternal age. Furthermore, we see that both the CNVs on 
chromosome 14 occur in the offspring of both old and young fathers as well as some of the 
breeders. Both CNVs identified in the genome-wide study using low-resolution SNP arrays by 
Egan et al were also observed in our sample (Egan, Sridhar et al. 2007), as were four of the 38 
CNVs identified between 14 colonies of C57BL/6 mice by Watkins-Chow et al (Watkins-Chow 
and Pavan 2008). These observations suggest that mice are likely to be polymorphic for CNVs 
at these locations (at least in the strains tested), and act to validate the array-CGH data 
produced in this study, indicating that we are detecting real changes in copy number that are 






Figure 4.21 - CNVs which Overlap with Flatscher-Bader et al 



































                          






Figure 4.22 - CNVs which Overlap with Watkins-Chow et al 
‘All CNVs’ track is CNVs observed in our study 
 
Figure 4.23  - CNVs which Overlap with Egan et al 
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4.5.2  CNVs and Paternal Age 
4.5.2.1 Total CNV Burden and Paternal Age 
First we examined the affect of paternal age on total CNV burden. This analysis 
assessed inherited and de novo CNVs in all offspring (offspring of young fathers, n = 18; 
offspring of old fathers, n = 22) except PA02 which was excluded as an obviously 
extreme outlier. Figure 4.24 shows a family of three male offspring plotted with their 
parents showing the inheritance of CNVs and the occurrence of all CNVs. CNVs in other 
families are shown in Appendix 1. 
 
Figure 4.24 - Family 2 All CNV Karyotype from Partek 
 
 
The average number of CNVs by group and family is shown in Figure 4.25. The total 
number of CNVs was not significantly different between the offspring of young and old 
fathers (t = -0.82, d.f. = 38, p = 0.42), although it was nominally higher in the offspring 
old fathers at 8.3 compared to 6.7 in the offspring of young fathers.  









Figure 4.25 – Number of CNVs 
a) By Group 
b) By Family 
 
The average size in kbps of the CNVs by groups and family is shown in Figure 4.26. 
There was no significant difference between groups in the average size of CNVs (t = 1.00, 
d.f. = 38, p = 0.33) with the average size in the offspring of young fathers being 99.6kbps 




Figure 4.26 – Size of CNVs (kbps) 
a) By Group 
b) By Family 
     a)                                                                           b)  
     a)                                                                           b)  








The average number of genes affected per CNV by each group and family is shown in 
Figure 4.27. There is no significant differences observed in the number of genes per CNV 
between the offspring of young and offspring of old fathers (t =1.48, d.f. = 38, p = 0.16) 
with the average in the offspring of young fathers being 3.0 genes per CNV and the 
average in the offspring of old fathers being 1.8 genes per CNV. The average in the 
offspring of young fathers is inflated by an outlier in family 16 (PA25) which had an 
average of 14 genes per CNV affected as one of the CNV is very large, spanning 94 genes. 
 
 
Figure 4.27 – Number of Genes per CNV 
a) By Group 
b) By Family 
 
The total number of genes affected by the total burden of CNVs in an individual split 
by group and family is shown in Figure 4.28. There is no significant difference in the total 
number of genes between the offspring of young fathers and offspring of old fathers (t 
=1.00, d.f. = 38, p = 0.33) with the average in the offspring of young fathers being 31.8 
and the average in the offspring of old fathers being 15.0. The large difference in total 
genes affected is again inflated by PA25 in family 16 who had 284 genes affected by 
CNVs. 
 
a)                                                        b) 









Figure 4.28 – Total Number of Genes affected by CNVs 
a) By Group 
b) By Family 
 
The number of CNVs split by type (deletions or duplications) by groups and family is 
shown in Figure 4.29. There was no significant difference between the offspring of 
young fathers and of offspring of old fathers in the number of types of CNVs they have 
(duplications (t =-0.70, d.f. = 38, p = 0.49), deletions (t =-0.95, d.f. = 38, p = 0.35)). The 
average number of deletions and duplications in the offspring of young fathers was 0.5 
and 6.7 respectively and the average number of deletions and duplications in the 




a)                                                         b)  









Figure 4.29 – Number of Deletions and Duplications 
a) By Group 
b) By Family 
 
4.5.2.2 Inherited CNVs Ingenuity Pathway Analysis 
The genes affected by all non-overlapping CNVs were subjected to IPA analysis to 
investigate networks which were enriched for CNVs with paternal age (Table 4.4). No 
networks associated with aging or the psychiatric conditions associated with paternal 
age were highlighted in the IPA analysis. Most of the genes highlighted in IPA were 
associated with gene expression. The genetic disorders highlighted are colon cancer and 
muscular dystrophy. 
 




Table 4.4 – Networks identified in IPA of Gene Affected by CNVs 
    CNVs from all offspring                      CNVs from offspring of young fathers         CNVs from offspring of old father 
Genes Top Functions  Genes Top Functions  Genes Top Functions 
26 
Genetic Disorder, Neurological Disease, Molecular 
Transport 
 26 
Gene Expression, Cellular Development, Protein 
Synthesis 
 20 Molecular Transport, Cancer, Gene Expression 
25 
Carbohydrate Metabolism, Molecular Transport, 
Small Molecule Biochemistry 
 24 
Drug Metabolism, Endocrine System 
Development and Function, Lipid Metabolism 
 18 
Cellular Development, Hematopoiesis, Gene 
Expression 
25 
Cell Morphology, Infectious Disease, Cell-To-Cell 
Signalling and Interaction 
 24 
Cellular Assembly and Organization, DNA 
Replication, Recombination, and Repair, Post-
Translational Modification 
 18 
Endocrine System Disorders, Gastrointestinal 
Disease, Genetic Disorder 
23 
Cell Cycle, Cellular Assembly and Organization, 
DNA Replication, Recombination, and Repair 
 24 
Free Radical Scavenging, Cell Death, Cellular 
Development 
 16 
Carbohydrate Metabolism, Molecular Transport, 
Small Molecule Biochemistry 
22 
Cell Signalling, Nucleic Acid Metabolism, Small 
Molecule Biochemistry 
 23 
Cellular Development, Hematopoiesis, Cellular 
Growth and Proliferation 
 14 
Cell-To-Cell Signalling and Interaction, Cellular 
Growth and Proliferation, Cell Death 
21 
Infectious Disease, Cell-To-Cell Signalling and 
Interaction, Haematological System Development 
and Function 
 19 
Cellular Assembly and Organization, Cellular 
Compromise, Cell-To-Cell Signalling and 
Interaction 
 13 
Cell-To-Cell Signalling and Interaction, Nervous 
System Development and Function, Cell 
Morphology 
20 
Cellular Growth and Proliferation, Cell Death, 
Cellular Development 
 16 
Gene Expression, Lipid Metabolism, Nucleic Acid 
Metabolism 
 7 
Cell Signalling, Vitamin and Mineral Metabolism, 
Cell-To-Cell Signalling and Interaction 
20 
Antigen Presentation, Cell-To-Cell Signalling and 
Interaction, Haematological System Development 
and Function 
 15 
Free Radical Scavenging, Cellular Movement, 
Cellular Development 
 6 
DNA Replication, Recombination, and Repair, 
Energy Production, Nucleic Acid Metabolism 
16 
Cell Morphology, Tissue Development, Cellular 
Movement 
 14 
Cell-To-Cell Signalling and Interaction, 
Haematological System Development and 
Function, Hematopoiesis 
 1 
Embryonic Development, Organismal 
Development, Cellular Development 
15 
Cell-To-Cell Signalling and Interaction, Cellular 
Development, Nervous System Development and 
Function 
 14 
Lipid Metabolism, Molecular Transport, Small 
Molecule Biochemistry 
 1 
Cell Cycle, Reproductive System Development 
and Function, Cell Death 
15 
Cell Signalling, Genetic Disorder, Neurological 
Disease 
 14 
Genetic Disorder, Skeletal and Muscular 
Disorders, Developmental Disorder 
 1 
Carbohydrate Metabolism, Cell-To-Cell Signalling 
and Interaction, Cellular Growth and Proliferation 
14 
Embryonic Development, Organ Development, 
Organ Morphology 
 13 
Cell Cycle, Cellular Development, Connective 
Tissue Development and Function 
 1 


































                          







Post-Translational Modification, Genetic Disorder, 
Haematological Disease 
 13 
Cell Morphology, Cellular Assembly and 
Organization, Cellular Function and Maintenance 
 1 
Post-Translational Modification, Cell-To-Cell 
Signalling and Interaction, Reproductive System 
Development and Function 
14 
Cellular Function and Maintenance, Connective 
Tissue Development and Function, Cellular Growth 
and Proliferation 
 11 
Carbohydrate Metabolism, Lipid Metabolism, 
Small Molecule Biochemistry 
 1 
Antigen Presentation, Cell-To-Cell Signalling and 
Interaction, Haematological System Development 
and Function 
14 
Molecular Transport, Protein Synthesis, Protein 
Trafficking 
 11 
Gene Expression, Cell Cycle, Skeletal and 
Muscular System Development and Function 
 1 
Genetic Disorder, Metabolic Disease, 
Neurological Disease 
13 
Cell-To-Cell Signalling and Interaction, Cellular 
Assembly and Organization, Reproductive System 
Development and Function 
 11 
Genetic Disorder, Metabolic Disease, Neurological 
Disease 
 1 
Carbohydrate Metabolism, Drug Metabolism, 
Small Molecule Biochemistry 
13 
Cell Signalling, Vitamin and Mineral Metabolism, 
Genetic Disorder 
 11 
Cell-To-Cell Signalling and Interaction, 
Reproductive System Development and Function, 
Cellular Development 
 1 
Cell Morphology, Cell-To-Cell Signalling and 
Interaction, Cellular Assembly and Organization 
13 
Cell Morphology, Cellular Function and 
Maintenance, DNA Replication, Recombination, 
and Repair 
 10 
Cellular Development, Connective Tissue 
Development and Function, Haematological 
System Development and Function 
   
13 
Cancer, Cell Cycle, Connective Tissue Development 
and Function 
 10 
Developmental Disorder, Genetic Disorder, 
Skeletal and Muscular Disorders 
   
13 
Cell Cycle, DNA Replication, Recombination, and 
Repair, Genetic Disorder 
 10 
Carbohydrate Metabolism, Cellular Assembly and 
Organization, DNA Replication, Recombination, 
and Repair 
   
12 
Endocrine System Development and Function, 
Lipid Metabolism, Molecular Transport 
 5 
Post-Translational Modification, Protein 
Degradation, Protein Synthesis 
   
11 
Carbohydrate Metabolism, Molecular Transport, 
Small Molecule Biochemistry 
 1 
Cell Cycle, Reproductive System Development 
and Function, Cell Death 
   
10 Behaviour, Gene Expression, Neurological Disease  1 
Genetic Disorder, Immunological Disease, Cellular 
Development 
   
10 
Cellular Growth and Proliferation, Endocrine 
System Development and Function, Reproductive 
System Disease 
 1 
Embryonic Development, Organismal 
Development, Organ Development 
   
8 
Cell Morphology, Cardiovascular System 
Development and Function, Organismal 
Development 
 1 
Post-Translational Modification, Cell-To-Cell 
Signalling and Interaction, Reproductive System 
Development and Function 
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4.5.2.3 De Novo CNVS and Paternal Age 
Data in this section includes array data from three families of the offspring of young 
fathers and three families from the offspring of old fathers for whom both parental and 
offspring high-quality CGH data was obtained. As discussed in section 4.5.1, data from 
families 16, 1, 4 and 6 were removed from de novo CNV analysis due to an unusual CNV 
profile in the breeders, potentially resulting from malignancy in the spleen. De novo 
CNVs from all individuals, split by group and family and arranged by chromosome, are 
shown in Appendix 1. As already described, de novo CNVs are generally distributed 
evenly throughout the genome with some exceptions (Figure 4.20). The number of de 
novo CNVs in both the offspring of old fathers and offspring of young fathers is shown in 
Figure 4.30a, and split into families in Figure 4.30b. There is no significant association 
with number of CNVs and paternal age (t = 0.06, d.f. = 18.68, p-value = 0.95) with the 
average number per individual in the offspring of young fathers being 5.5 and the 
average number per individual in the offspring of old fathers being 5.4. 
 
 
Figure 4.30 - Number of De Novo CNVs 
c) By Group 
d) By Family 
 
The average size of de novo CNVs between the offspring of old fathers and offspring 
of young fathers is shown in Figure 4.31a, and presented split by family in Figure 4.31b. 
There is no significant association with number of CNVs and paternal age t = 0.60, d.f. = 
a)                                                         b)  








14.65, p-value = 0.56) with the average in offspring of young fathers being 67.8kbps and 
in offspring of old fathers being 59.2kbps.  
 
 
Figure 4.31 – Average Size of De Novo CNVs (kbps) 
a) By Group 
b) By Family 
 
The average number of genes spanned by de novo CNVs in the offspring of old 
fathers and offspring of young fathers is shown in Figure 4.32a, and presented split by 
family in Figure 4.32b. There is no significant association between the number of CNVs 
and paternal age (t = 0.28, d.f. = 14.79, p-value = 0.78), with the average in offspring of 
young fathers being 2.1 and in offspring of old fathers being 1.9.   
 
 a)                                                           b) 









Figure 4.32 - Number of Genes per De Novo CNV 
a) By Group 
b) By Family  
 
The number of genes affected by all CNVs per individual in the offspring of old 
fathers and offspring of young fathers is shown in Figure 4.33a, and presented split by 
family in Figure 4.33b. There is no significant association with number of CNVs and 
paternal age (t = 0.56, d.f. = 13.85, p-value = 0.58), with the average in offspring of 
young fathers being 12.8 and in offspring of old fathers being 9.8. 
 
 
Figure 4.33 - Total Number of Genes Affected by CNVs across the Genome 
a) By Group 
b) By Family  
  a)                                                         b)  
  a)                                                         b)   









The number of de novo deletion and duplication events between the offspring of old 
fathers and offspring of young fathers is shown in Figure 4.34a, and presented split by 
family in Figure 4.34b. No significant differences were observed between the groups in 
the number of duplications (t = -0.06, d.f. = 18.54, p-value = 0.95), with the average 
being 5.0 in the offspring of young fathers and 5.1 in the offspring of old fathers. 
Similarly, no significant difference in the number of deletions was observed (t = 0.48, d.f. 
= 18.91, p-value = 0.63), with the average in offspring of young fathers being 0.5 and in 
offspring of old fathers being 0.3.  
 
 
Figure 4.34 - Number of Deletion and Duplication De Novo CNVs 
a) By Group 
b) By Family 
 
The number of de novo CNVs occurring by chromosome and the number of times 
they occur in each group is shown in Table 4.5. No association was seen with paternal 




 a)                                        b)   








Table 4.5 – De Novo CNVs by Chromosome and Group 
Chr Chr Count Young Chr Count Old Chr Count p-value t-value 
Chr1 10 5 5 1.00 0.00 
Chr2 18 8 10 0.75 0.32 
Chr3 5 3 2 0.63 -0.48 
Chr4 9 4 5 0.69 0.41 
Chr5 4 2 2 1.00 0.00 
Chr6 6 3 3 1.00 0.00 
Chr7 12 4 8 0.27 1.14 
Chr8 4 1 3 0.30 1.08 
Chr9 5 2 3 0.63 0.48 
Chr10 7 4 3 0.72 -0.36 
Chr11 7 4 3 0.75 -0.32 
Chr12 5 3 2 0.70 -0.39 
Chr13 7 3 4 0.75 0.32 
Chr14 3 1 2 0.56 0.56 
Chr15 3 1 2 0.56 0.56 
Chr16 3 2 1 0.56 0.56 
Chr17 10 6 4 0.50 -0.67 
Chr18 5 2 3 0.63 0.48 
Chr19 8 6 2 0.16 -1.48 
 
The number of CNVs, genomic size, and number of genes affected were correlated 
with the behavioural measures discussed in (section 3.5), but no behavioural 
phenotypes were significantly correlated with any of these measures.  
 
4.5.2.4 De Novo CNV Ingenuity Pathway Analysis 
Genes affected by CNVs were subjected to Ingenuity Pathway Analysis (IPA) and the 
pathways identified for all de novo CNVs and in de novo CNVs by group using this 
approach is shown in Table 4.6. All networks were unrelated to aging or the psychiatric 




Table 4.6 – Networks Identified in IPA of Gene Affected by De Novo CNVs 
CNVs from all offspring                      CNVs from offspring of young fathers        CNVs from offspring of old fathers 
Genes Top Functions  Genes Top Functions  Genes Top Functions 
22 
Cell Cycle, Cell Morphology, Carbohydrate 
Metabolism 
 24 
Cell Cycle, Cell-mediated Immune Response, Cellular 
Development 
 21 
Cell Death, Haematological System 
Development and Function, Gene Expression 
22 
Decreased Levels of Albumin, RNA Post-
Transcriptional Modification, DNA Replication, 
Recombination, and Repair 
 18 
Cell Morphology, Cellular Development, Cellular 
Growth and Proliferation 
 16 
Developmental Disorder, Neurological Disease, 
Cancer 
16 Cellular Development, Hematopoiesis, Cell Signalling  16 
Cellular Function and Maintenance, Lipid 
Metabolism, Molecular Transport 
 12 
Gene Expression, DNA Replication, 
Recombination, and Repair, Cell Morphology 
15 
Cellular Assembly and Organization, Cellular Function 
and Maintenance, Cellular Compromise 
 13 
Cellular Growth and Proliferation, Cell Cycle, Cellular 
Development 
 11 
Inflammatory Response, Cell Cycle, Cellular 
Function and Maintenance 
14 
Metabolic Disease, Lipid Metabolism, Molecular 
Transport 
 12 
Tissue Morphology, Cellular Development, 
Haematological System Development and Function 
 9 
Cellular Development, Nervous System 
Development and Function, Behaviour 
14 
Cell-To-Cell Signalling and Interaction, Cellular 
Assembly and Organization, Cellular Function and 
Maintenance 
 12 
Molecular Transport, Protein Trafficking, Lipid 
Metabolism 
 1 
Carbohydrate Metabolism, Cell-To-Cell 
Signalling and Interaction, Cellular Growth and 
Proliferation 
13 
Cell Morphology, Connective Tissue Development 
and Function, Haematological System Development 
and Function 
 1 
Cellular Assembly and Organization, Post-
Translational Modification, Molecular Transport 
 1 
Cell Death, Genetic Disorder, Skeletal and 
Muscular Disorders 
13 
Lipid Metabolism, Nucleic Acid Metabolism, Small 
Molecule Biochemistry 
 1 
Cell Cycle, Reproductive System Development and 
Function, Cell Death 
 1 
Molecular Transport, RNA Trafficking, RNA Post-
Transcriptional Modification 
12 
Antigen Presentation, Cell-To-Cell Signalling and 
Interaction, Inflammatory Response 
 1 
Cell Death, Cell Morphology, Digestive System 
Development and Function 
 1 
Antigen Presentation, Cell-To-Cell Signalling and 
Interaction, Haematological System 
Development and Function 
11 
Cellular Development, Haematological System 
Development and Function, Hematopoiesis 
 1 
Cellular Function and Maintenance, Dermatological 
Diseases and Conditions, Embryonic Development 
 1 
Genetic Disorder, Metabolic Disease, 
Neurological Disease 
9 
Cell Death, Nervous System Development and 
Function, Genetic Disorder 
 1 
Post-Translational Modification, Cell-To-Cell 
Signalling and Interaction, Reproductive System 
Development and Function 
 1 
Carbohydrate Metabolism, Drug Metabolism, 
Small Molecule Biochemistry 
8 Cellular Movement, Tumour Morphology, Cell Death  1 
Cell Cycle, Reproductive System Development and 
Function, Cancer 
 1 
Cell Morphology, Cell-To-Cell Signalling and 
Interaction, Cellular Assembly and Organization 


































                          




Function, Cell Death Cellular Assembly and Organization Organization, Cellular Compromise 
1 
Cell Death, Genetic Disorder, Skeletal and Muscular 
Disorders 
 1 
Genetic Disorder, Neurological Disease, Skeletal and 
Muscular Disorders 
 1 
Cellular Assembly and Organization, Lipid 
Metabolism, Small Molecule Biochemistry 
1 
Molecular Transport, RNA Trafficking, RNA Post-
Transcriptional Modification 
 1 
Cell Cycle, DNA Replication, Recombination, and 
Repair, Dermatological Diseases and Conditions 
 1 
Developmental Disorder, Genetic Disorder, 
Metabolic Disease 
1 
Post-Translational Modification, Cell-To-Cell 
Signalling and Interaction, Reproductive System 
Development and Function 
 1 
Cellular Movement, Cellular Assembly and 
Organization, Cellular Function and Maintenance 
 1 
Carbohydrate Metabolism, Small Molecule 
Biochemistry, Cellular Assembly and 
Organization 
1 
Antigen Presentation, Cell-To-Cell Signalling and 
Interaction, Haematological System Development 
and Function 
 1 
Cancer, Reproductive System Disease, Connective 
Tissue Disorders 
   
1 
Cell Cycle, Reproductive System Development and 
Function, Cancer 
 1 
Cell Morphology, Cellular Assembly and 
Organization, Cellular Growth and Proliferation 
   
1 
Post-Translational Modification, Protein Synthesis, 
Cellular Assembly and Organization 
      
1 
Genetic Disorder, Neurological Disease, Skeletal and 
Muscular Disorders 
      
1 
Cell Cycle, DNA Replication, Recombination, and 
Repair, Dermatological Diseases and Conditions 
      
1 
Cancer, Reproductive System Disease, Connective 
Tissue Disorders 
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In this Chapter, I used CGH in combination with high-resolution microarrays to examine 
whether advanced paternal age is associated with an increased burden of CNVs in an inbred 
mouse model using the C57BL/6 strain. The analyses suggest that the offspring of older mice 
are not characterised by an increased incidence of de novo or total number of CNVs. 
Furthermore, the number of genes affected by CNVs and the proportion of deletions to 
duplications is not different between the offspring of young fathers and the offspring of old 
fathers. In this sample, therefore, there is no obvious association between advanced paternal 
age and the occurrence of de novo CNVs or their attributes. Furthermore, pathway analysis of 
the genes disrupted by the CNVs discovered highlights no obvious functional networks that 
can explain the paternal age behavioural differences seen in the old father group (see Chapter 
3). Furthermore, by looking at the genes affected by CNVs in our sample, we see no overlap 
with the recurrent human CNVs implicated in ASD, schizophrenia or BD – three 
neuropsychiatric disorders epidemiologically linked to advanced paternal age and previously 
associated with an increased CNV burden. Since this study is about paternal age and the risk 
of psychiatric disease, we had hypothesised that some homologous regions of the genome 
may be affected by CNVs, especially given the social and exploratory behavioural deficits 
observed in these animals (see Chapter 3). As the mouse genome is not exactly homologous 
to the human genome in terms of sequence or the relative location of genes, and given that 
our behavioural measures did not map exactly on to human neuropsychiatric conditions, it 
may be that different loci are at risk for disruption in our model. Repetitive regions and 
regions close to centromeres and telomeres are expected to be more at risk of de novo CNVs 
in humans, however because mouse chromosome are acrocentric they have centromeres at 
the end of the chromosomes and so have different regions at risk to the mechanisms 
underlying structural variation. Unfortunately, because of their often highly repetitive nature, 
the regions most prone to CNVs are not often represented on the microarrays used in our 
experiments making comparisons with other studies difficult.  
 
Of note was the overall number of CNVs observed in our sample regardless of paternal 
age given that we were using an inbred mouse strain (thus presumed to be ‘genetically 
identical’) obtained commercially from the same supplier. In addition to the actual burden of 
CNVs we observe considerable polymorphism across animals, which has obvious implications 
for rodent behavioural/environmental studies which are often assumed to be performed on 




genetically-identical inbred animals. To date, only a few other studies of copy number 
variation in mice have been published (Egan, Sridhar et al. 2007; Watkins-Chow and Pavan 
2008), but as described previously in this chapter, these also report evidence of polymorphic 
CNVs within inbred strains. Although the burden of CNVs (and rate of de novo events) we 
observe in our study is higher than in other mouse studies within C57BL/6, this may be a 
function of the more sensitive high-resolution array platform used in our study, and the 
limited number of animals assessed in any single study yet performed. In this study, we 
observe a higher incidence of duplications than deletions in both inherited (268:20) and de 
novo CNVs (121:10). This is contrary to previous studies in humans and mouse which report a 
more equal incidence of de novo duplications and deletions (Itsara, Wu et al. 2010) (Egan, 
Sridhar et al. 2007). Again, these differences could reflect differences in the platforms used, 
and the relative small sample sizes employed across all studies to date.  
 
De novo CNVs have not previously been shown in human studies to be more frequent in 
the offspring of advanced age fathers, although chromosomal rearrangements and 
translocations have been shown to be more frequent in older male sperm (Thomas, Morris et 
al. 2010). It’s therefore plausible that the increased burden of genomic abnormalities in the 
sperm of older males affects embryonic viability – of note, sperm cells from infertile males 
have been shown to contain higher rates of chromosomal aberrations compared to males in 
the general population (Chandley, Edmond et al. 1975; Testart, Gautier et al. 1996), and the 
same pattern is seen in males with a low sperm count (Retief, Van Zyl et al. 1984). Even if 
sperm containing chromosomal abnormalities do manage to fertilize an oocyte, the resulting 
zygote may not be viable due to the rearrangements or anomalies being lethal. Future studies 
will be carried out to analyse CNVs and genomic rearrangements in the sperm cells from the 
breeders themselves to assess whether these are characterised by an increased burden of 
structural variation. 
 
Only one previous study has directly studied CNVs in relation to paternal age in a mouse 
model previously. In their study, Flatscher-Bader et al (2011) found seven de novo CNVs in a 
sample of six offspring sired by 2 advanced aged fathers (12 – 18 months old) compared to no 
de novo CNVs in the six offspring of 2 three month old fathers. However, two of these were 
located in the same gene adjacent to each other and so likely to be part of the same CNV. 




Further analysis of these six CNVs did not replicate the observation with advanced paternal 
age in an independent same of mice (Flatscher-Bader, Foldi et al. 2011). This study does not, 
therefore, give convincing evidence for the role of de novo CNVs in relation to advanced 
paternal age – the results could be due to one family in the older father group having an 
abundance of CNVs compared to all families, not just compared to the offspring of younger 
fathers. Taken together with the results from our study, the evidence supporting an 
abundance of CNVs in the offspring of older male mice is currently limited. 
 
The CGH microarray analyses presented in this chapter indicates that a relatively large 
number of CNVs were detected across all groups of animals, given that we utilised inbred mice 
derived from the same commercial breeding stock. A previous study using the Nimblegen 
array-based CNV detection method concluded that approximately one third of the CNVs 
detected by the 2.1M array were likely to be false positives, and it was also speculated that 
the false negative rate could be more than 50% (Agam, Yalcin et al. 2010).The problem of false 
positives and negatives is a potential confounder in many other studies of CNVs in human and 
mouse. Analysis of the same samples has yielded different findings with regard to both the 
number and location of CNVs in human studies (Conrad, Andrews et al. 2006; Locke, Sharp et 
al. 2006; McCarroll, Hadnott et al. 2006; Redon, Ishikawa et al. 2006), and in inbred mouse 
studies there is little overlap in the CNVs reported in the strains (Cutler, Marshall et al. 2007; 
Henrichsen, Vinckenbosch et al. 2009). Such inconsistencies could result from differences in 
the platforms used to discover CNVs or the types of analysis and normalization used in the 
data analysis stages. No standard definitions or protocols are available for the detection or 
analysis of CNVs, and so results are left to the interpretation of individual research groups 
(Scherer, Lee et al. 2007). For example, it has been suggested that the 23,897 CNVs identified 
in a recent analysis of healthy human control samples is likely to be an over-estimate due to 
the arbitrary approaches used to define CNV boundaries, experimental artefacts and 
incomplete quality control without verification (Alaerts and Del-Favero 2009). This variation 
makes CNV detection and investigation more complicated than other genomic approaches 
(e.g. SNP genotyping, gene expression or DNA methylation analysis, the other major 
methodologies utilised in this thesis). Due to this, the amount of false CNVs identified in this 
study is unknown, and future work will focus on verifying specific examples. Such technical 
errors, however, are likely to be largely consistent across samples and should not alter the 
overall conclusions of the analyses. Furthermore, it is reassuring that many of the CNVs shown 




to recurrently occur in the mouse genome in previous studies are observed in our data (see 
Figure 4.21, Figure 4.22 and Figure 4.23), indicating that we were detecting real changes in 
copy number. 
 
A potential reason for the higher number of CNVs we observe compared to other studies 
could be the tissue we chose to assess. We did not measure the physiological properties of 
the spleen when dissecting the animals and so it is possible the spleen in test animals may 
have had a spleen disorder resulting in abnormal cells with a large number of chromosomal 
rearrangements. This is perhaps reflected in the unusual CNV profiles generated for the 
samples removed from the analyses presented here. These samples passed all QC metrics, but 
were characterised by an unusually large burden of structural variation. As discussed above, 
there is evidence that malignant disorders such as lymphoma are potentially common in the 
spleens of certain strains of inbred mouse (Murphy 1968; Brayton, Treuting et al. 2012), and a 
recent review of diseases in inbred mouse strains concluded that the most common causes 
and contributors to death in studies of aging C57BL/6J mice are lymphoma and hematopoietic 
neoplasms, suggesting that genomic alterations in the spleen and related tissues may occur 
widely with aging in this strain (Brayton, Treuting et al. 2012). Future studies should assess 
changes occurring in other tissues (for example the brain), in addition to germline (sperm) 
cells from the fathers. As discussed previously, CNVs can be subject to tissue specificity via 
mosacism (Locke, Sharp et al. 2006; Bruder, Piotrowski et al. 2008) and so our use of DNA 
isolated from spleen could limit the interpretation of our data, especially given the 
predominance of neuropsychiatric phenotypes in the context of advanced paternal age. 
Finally, because we did not use sperm cells from the fathers themselves, we are unable to 
estimate the actual rate of CNV mutations in the germline of older males. 
 
We were somewhat restricted with regard to the number of animals we were able to 
assess in this analysis. Although we had access to the offspring of three different age fathers, 
only two ages were used in the CNV analysis presented here. As the third group were from 
fathers of 12 months old, it is plausible that the burden of CNVs may have been larger in this 
group. No DNA was available from the dam from family 16, and so the number of de novo 
CNVs from this family could not be completely ascertained as some CNVs from the offspring 
may have been inherited from the mother.  





The results of this study and the lack of evidence to the contrary from other studies, 
indicates that there is no convincing evidence for an association between the number of de 
novo CNVs or the occurrence of specific de novo CNVs and advanced paternal age in mouse. 
Although previous research has demonstrated that the sperm from older males shows higher 
rates of chromosomal abnormalities than that from younger males, our data (and analogous 
epidemiological studies in humans) suggest that these do not seem to transfer to the 
offspring, possibly because the mutations are lethal or confer infertility. The results of this 
chapter indicate that it is unlikely that the paternal age effect is mediated by CNVs, 
particularly the behavioural effect observed in the same animals in Chapter 3. Expression 
changes associated with CNVs in this chapter will be discussed in section 6.5.6. 
 
 







Chapter 5 - Epigenetic Differences Associated with 
Advanced Paternal Age in a Mouse Model 








Epigenetic changes have been observed in human studies of autism, schizophrenia and BD 
and have also been shown to accumulate over the life of an individual. One potential 
mechanism for paternal age effect is the transmission of age-associated epigenetic changes in 
the sperm of older fathers to their offspring. Epigenetic reprogramming resets the 
methylation status of the genome during gametogenesis and embryogenesis, but DMRs 
associated with imprinted loci and transposable elements appear to partially escape this 
genome wide resetting, indicating that they could be a potential vehicle for the transmission 
of methylation marks across generations. To investigate this hypothesis, global DNA 
methylation levels and DNA methylation across DMRs associated with 19 brain-expressed 
imprinted loci were assessed in the offspring of young, old and very old fathers in multiple 
tissues. The offspring of older fathers showed higher global methylation in DNA from the 
spleen and cerebellum. Three imprinted loci (Nesp, Kcnq1ot1 and Mcts2) showed consistently 
significant DNA methylation differences between the offspring of old fathers and young 
fathers in the cerebellum, and more subtle differences were observed at other DMRs. These 
results suggest it is plausible that the mechanism for the paternal age effect could be the 
transmission of age-accrued methylation marks from sperm of older fathers to their offspring. 
 
5.2 Introduction 
5.2.1 The Dynamic Epigenome 
As described in more detail in Chapter 1 (section 1.6), epigenetic mechanisms control the 
reversible regulation of gene expression mediated principally through changes in DNA 
methylation and chromatin structure occurring independently of the DNA sequence (Henikoff 
and Matzke 1997). Due to its labile nature (Rakyan, Blewitt et al. 2002), the epigenome 
represents a good candidate for mediating interactions between genetic variation and the 
environment. Its dynamic, changeable nature has been demonstrated in numerous studies 
looking at DNA methylation changes associated with a range of environmental exposures 
(section 5.2.2), and ultimately provides a potential target for the development of novel 
therapeutic treatments. Environmental influences on the epigenome have been shown to be 
particularly important during gestation but can also occur periconceptually and later in life 
(Sinclair, Allegrucci et al. 2007). Once established, epigenetic marks can be maintained stably 







through mitosis down cell lineages, potentially mediating the later-life manifestation of 
phenotypic effects (and diseases) caused by exposure to environmental factors early in 
development.  
 
5.2.2 Epigenetics and Environmental Influences 
A diverse range of environmental factors including diet, stress, air pollutants and non 
mutagenic toxic agents have been shown to influence the epigenome, both globally and at 
specific gene loci (reviewed in (Arita and Costa 2011)). For example, prenatal exposure to 
dietary factors can influence epigenetic processes, often leading to extreme changes in 
phenotype. DNA methylation at an IAP element upstream of the Agouti gene, for example, 
can be directly influenced by the intake of food supplemented with methyl donors (Dolinoy, 
Huang et al. 2007). Pregnant dams fed with a diet rich in methyl donors produce offspring 
with a high level of DNA methylation across this region, silencing expression from the cryptic 
promoter generated by the IAP element and resulting in a wild-type phenotype (brown fur). In 
contrast, pregnant dams fed with a diet low in methyl donors produce offspring with low 
levels of DNA methylation at this locus, resulting in offspring with a yellow coat (Figure 5.1), 
obesity and physiological deficits (Waterland and Jirtle 2003). Another example of the 
influence of prenatal diet on DNA methylation is observed in individuals exposed in utero to 
the Dutch Winter famine. This famine has been associated with hypomethylation across the 
IGF2 imprinting DMR relative to same-sex siblings not exposed to prenatal famine, detected 
60 years after the famine occurred (Heijmans, Tobi et al. 2008). 
 








Figure 5.1 – Coat Colour Phenotype of Avy/a Offspring  
Animals representing the five coat colour classes used to classify phenotype in the agouti 
viable yellow mouse model. The Avy alleles of yellow mice are hypomethylated, allowing for 
high expression of the mutant agouti gene. Avy hypermethylation in pseudo-agouti animals 
silences agouti expression. 
 
Maternal care has also been demonstrated to affect DNA methylation in the offspring. In 
rats, for example, the offspring of high licking and grooming mothers have a significantly lower 
level of hippocampal DNA methylation at exon 1 of the glucocorticoid receptor gene than the 
offspring of low licking and grooming mothers (Weaver, Cervoni et al. 2004). This 
hypomethylation in the offspring of high licking and grooming mothers can be reversed in the 
adult offspring by the infusion of methyl donors (Weaver, Champagne et al. 2005). Early life 
stress, simulated in mice as separation of pups from the mother, also results in pups being 
hypomethylated at a CpG island upstream of the arginine vasopressin gene, which persists 
into adulthood (Murgatroyd, Patchev et al. 2009). From these examples, it can be seen that a 
diverse range of environmental influences can have a noticeable effect on DNA methylation 
that can stably alter gene expression and phenotype over development.  
 
To date, it is not clear whether environmental influences on the father occurring 
preconception can affect his offspring via the meiotic transmission of epigenetic changes 







occurring in the germline, although preliminary evidence suggests that such effects may occur. 
Mice exposed to particulate air pollution were found to be hypermethylated in their sperm 
compared to non-exposed mice (Yauk, Polyzos et al. 2008). Furthermore, gene-specific DNA 
methylation was altered in sperm cells in mice exposed to vinclozolin (a 
common dicarboximide fungicide), and strikingly this effect appears to be transmitted to 
subsequent male offspring (Anway, Cupp et al. 2005) over several generations suggesting that 
epigenetic changes in the male germline may be potentially inherited transgenerationally. 
More information about the evidence supporting transgenerational epigenetic inheritance is 
given in section 1.6.3. Although current evidence is limited, it is plausible that the sperm of 
older males may show age-related epigenomic changes caused by the accumulation of 
developmentally-, stochastically- or environmentally-induced epimutations that are 
subsequently transmitted to the offspring. This in turn could lead to the developmental 
manifestation of phenotypic differences, potentially related to the onset of disease. The 
research presented in this chapter examines whether epigenetic differences can be observed 
between the offspring of old and young fathers as a first step in exploring this hypothesis. 
 
5.2.3 Epigenetics and Psychiatric Disease 
Aetiological studies of ASD, schizophrenia and bipolar disorder have focused primarily on 
the interplay between genetic and environmental risk factors. Although twin and adoption 
studies highlight a clear inherited component to these disorders, genetic studies are often 
characterized by non-replication, small effect sizes, and significant heterogeneity. Several 
epidemiological, clinical, and molecular peculiarities associated with these psychiatric 
conditions are difficult to explain with traditional gene- and environment-based approaches, 
including the non-complete concordance between monozygotic twins, sexual dimorphism, 
peaks of susceptibility to disease coinciding with major hormonal rearrangements, parent-of-
origin effects, and of particular relevance to this thesis, paternal age effects (Smith and Mill 
2011). These observations have led to widespread speculation about the role of non-genetic 
factors, and influence of epigenetic variation in the development of these diseases has been a 
recent focus for research. Epigenetic changes associated with the three psychiatric disorders 
strongly linked to advanced paternal age (autism, schizophrenia, and bipolar disorder) are 
briefly reviewed in this section. 
 







Autism: Although studies of epigenetic changes in autism are in their infancy, DNA 
methylation differences at several specific loci have been shown in autism. For example, 
increased DNA methylation at the MECP2 promoter has been observed in autism cases 
compared to matched controls leading to decreased MECP2 expression (Nagarajan, Hogart et 
al. 2006). This lower transcription of MECP2 leads to decreased expression of UBE1A and 
GABRB3 (Samaco, Hogart et al. 2005). Increased DNA methylation has also been shown in the 
promoter of the oxytocin receptor gene in autistic individuals compared to control samples 
(Gregory, Connelly et al. 2009). In a recent study of MZ twins discordant for autism, 73 
separate loci showed differential methylation between discordant twins (Nguyen, Rauch et al. 
2010). 
 
Schizophrenia:  Several candidate gene studies have uncovered epigenetic changes 
associated with schizophrenia. For example, the CpG island of SOX10 has been shown to be 
hypermethylated in post-mortem brain samples from schizophrenia patients compared to 
controls (Iwamoto, Bundo et al. 2005). RELN has also been shown in a number of studies to be 
hypermethylated across its promoter in schizophrenia patients (Abdolmaleky, Cheng et al. 
2005; Grayson, Jia et al. 2005; Torrey, Barci et al. 2005), and COMT exhibits hypomethylation 
at its promoter in schizophrenia patents compared to controls (Abdolmaleky, Cheng et al. 
2006). Another candidate gene study focussing on the promoter of 5HTR1A found increased 
methylation in schizophrenia patients than in control samples (Carrard, Salzmann et al. 2011). 
In a genome-wide case-control study using post-mortem frontal cortex tissue, 83 separate loci 
showed significant DNA methylation differences between schizophrenia cases and controls, 
including several loci related to brain development and neurobiological function (Mill, Tang et 
al. 2008).  In a study of MZ twins discordant for schizophrenia, DNA from patients had a 
methylation profile across the DRD2 promoter which was more similar to the affected twin 
from a different twin pair than their own unaffected co-twin (Petronis, Gottesman et al. 
2003). Finally, a recent genome-wide methylation study looking at MZ twins discordant for 
schizophrenia reported the largest disease-associated differences between affected and 
unaffected twins to be at CpG sites in PUS3, SYNGR2, KDELR1, PDK3, PPARGC1A, ACADL, 
FLJ90650 and TUBB6 (Dempster, Pidsley et al. 2011). 
 







Bipolar disorder: BD has been epigenetically assessed both individually and combined with 
schizophrenia in the context of “major psychosis”. Again, many studies have focussed on 
specific candidate genes. COMT was found to exhibit promoter hypomethylation in cases 
compared to controls (Abdolmaleky, Cheng et al. 2006) and 5HTR1A shows increased 
methylation at its promoter in BD cases compared to controls (Carrard, Salzmann et al. 2011).  
In a genome wide study 36 loci showed consistently significant DNA methylation differences 
between brain samples from affected and unaffected samples (Mill, Tang et al. 2008). A 
genome wide study in discordant MZ twin-pairs showed that the top eight loci exhibiting 
differences between affected and unaffected twin pairs were GPR24, TLE6, STAB1, PPYR1, 
CTNNA2, ST6GALNAC1, C1orf35 and IQCH (Dempster, Pidsley et al. 2011). Looking at 
candidate genes in discordant MZ twins, PIP5KL1, ARMC3, SMS and PPIEL were significantly 
different between the affected twin and unaffected co-twin. SMS and PPIEL remained 
significantly different when looking at the data in a case-control analysis (Kuratomi, Iwamoto 
et al. 2008). Finally, looking at female MZ twin-pairs both discordant and concordant for 
bipolar disorder, discordant female twin pairs showed a greater degree of skewed X-
chromosome inactivation than concordant twin pairs (Rosa, Picchioni et al. 2008). 
 
5.2.4 Epigenetics and Aging 
Epigenetic changes have been demonstrated to accumulate over the life of an individual, 
and recent studies suggest that aging is associated with profound effects on DNA methylation. 
Studies on MZ twins have demonstrated that MZ twins have a higher within-pair epigenomic 
correlation than DZ twins (Boks, Derks et al. 2009; Kaminsky, Tang et al. 2009; Wong, Caspi et 
al. 2010), but with age the epigenetic similarity between MZ twins appears to decrease (Fraga, 
Ballestar et al. 2005). DNA methylation at multiple genes has been shown to be strongly 
correlated with age (Boks, Derks et al. 2009). In Christensen et al’s genome wide methylation 
analysis across multiple tissues, over 300 CpG loci showed age-related DNA methylation 
alterations including 38 age related methylation differences in the brain (Christensen, 
Houseman et al. 2009). Bocklandt et al identified 88 sites that are correlated with age in DNA 
from saliva, 73 of which were located in CpG islands. Pathway analysis on the 80 genes 
associated with the 88 sites showed enrichment for genes involved in cardiovascular disease, 
neurological disease, and genetic disease (Bocklandt, Lin et al. 2011). In addition, Hernandez 
et al identified ten loci with significant genome-wide association with age across multiple 
brain regions (frontal cortex, temporal cortex, pons and cerebellum) (Hernandez, Nalls et al. 







2011). Of relevance to studies of paternal age, male germline cells (sperm) also show age 
related epigenetic changes, with DNA methylation in a number of genes correlating with the 
age of the donor (Flanagan, Popendikyte et al. 2006). This age-related epigenetic drift in 
sperm leads to increased inter- and intra-individual variation in DNA methylation at multiple 
gene promoters (Flanagan, Popendikyte et al. 2006). Taken together, these studies suggest 
there is considerable epigenetic drift with age in many different tissues, including in the brain 
and germline. 
 
 In terms of my research on paternal age, an interesting hypothesis is that in the sperm of 
older males the maintenance of genomic imprints breaks down over the course of multiple 
cell divisions in spermatogenesis (Malaspina, Reichenberg et al. 2005). In other constantly 
dividing cell types, subsequent cell divisions do appear to alter the pattern of imprinting; for 
example, DNA methylation at imprinted loci increases with age in colon cells (Issa, Vertino et 
al. 1996). Given the evidence for incomplete epigenetic reprogramming in 
gametogenesis/embryogenesis (discussed in section 1.6.3), it is plausible that some of these 
age-associated epigenetic changes get transmitted to the offspring of older fathers. In this 
study we assessed global levels of DNA methylation and DNA methylation across DMRs 
associated with multiple brain-expressed imprinted genes in an animal model of paternal age.  
 
5.2.5 Potential Mechanisms for Epigenetic Inheritance 
Evidence for epigenetic inheritance down the male germline has been observed in rats 
exposed to fungicides and pesticides, where epigenetic changes occur in F1 populations and 
subsequent male offspring (Anway, Cupp et al. 2005). For the paternal age effect to be 
mediated by the transmission of age-acquired epigenetic variation from fathers to the 
offspring, we have to focus on genomic elements that potentially escape epigenetic 
reprogramming during germ cell development. There are several potential targets for the 
epigenetic changes (be they environmentally-, stochastically-, or developmentally-induced) 
associated with paternal age. These include the cis-acting regulatory elements of imprinted 
genes and CpG rich regions spanning house-keeping gene promoters and transposable 
elements such as LINE-1 and Alu elements (Dolinoy and Jirtle 2008). In this study, my focus is 
on epigenetic changes occurring at imprinted genes and transposable elements. 







5.2.5.1 Imprinted Genes 
As one allele is already inactive (section 1.6.2), imprinted genes are at a greater risk than 
non-imprinted genes of inactivation by mutations, loss of heterozygosity and epigenetic 
alterations to gene expression, leading to potentially pathogenic effects (Dolinoy and Jirtle 
2008). For example, hypomethylation of the IGF2 DMR leads to biallelic expression and is a 
potential risk factor in the development of colorectal cancer (Cui, Cruz-Correa et al. 2003). 
Since sperm undergo an increasing number of cellular divisions with age, it is plausible that 
there may be a break-down in the maintenance of genomic imprinting signatures that are 
subsequently transmitted to the offspring. Evidence for such a mechanism has emerged from 
studies investigating children conceived by in-vitro fertilization (IVF) and other forms of 
assisted reproductive technology (ART). For example, some cases of children conceived by 
intracytoplasmic sperm injection developing Angelman syndrome show a sporadic imprinting 
defect at the SNRPN loci (Cox, Burger et al. 2002; Orstavik, Eiklid et al. 2003). Offspring 
suffering from Beckwith-Wiedemann syndrome conceived with ART have been shown to have 
loss of imprinting of KCNQ1OT1 (DeBaun, Niemitz et al. 2003; Gicquel, Gaston et al. 2003; 
Maher, Brueton et al. 2003) and H19 (DeBaun, Niemitz et al. 2003). Although the reasons for 
the use of ART in these cases are unknown, these observations highlight the susceptibility of 
imprinted loci to epigenetic alterations, resulting in conditions with neuropsychiatric 
phenotypes. 
 
As discussed in section 1.6.3, some regions of the genome escape complete epigenetic 
reprogramming during gametogenesis/embryogenesis (Lane, Dean et al. 2003; Popp, Dean et 
al. 2010), including some DMRs associated with imprinted genes and highly-repetitive 
sequences (Figure 1.11). As imprinted genes may also be particularly susceptible to epigenetic 
changes over the life-course in response to stochastic, developmental and environmental 
factors (Jirtle and Skinner 2007; Heijmans, Tobi et al. 2008), potentially leading to an 
accumulation of epigenetic variability with age in sperm (Flanagan, Popendikyte et al. 2006), 
the observation that some imprinting DMRs escape complete epigenetic reprogramming 
(Popp, Dean et al. 2010) suggests they could mediate the transmission of some paternal-age-
induced epigenetic changes to subsequent generations. Of note, a recent study showed that 
DNA methylation in newborn babies is correlated with both maternal and paternal age at 
numerous gene promoters, including 12 known imprinted loci (Adkins, Thomas et al. 2011). 
Furthermore, in a study assessing imprinting errors in offspring, seven out of 17 cases showed 







an identical alteration in DNA methylation detectable in the father’s sperm (Kobayashi, Hiura 
et al. 2009), providing evidence that epigenetic inheritance may be mediated by imprinted 
genes. These studies support the notion that imprinting DMRs could be a vehicle for trans-
generational epigenetic inheritance, or at least associated with paternal age.  
 
5.2.5.2 Transposable Elements 
Other elements that have been shown to escape complete epigenetic resetting during 
gametogenesis/embryogenesis include several classes of repetitive elements that are 
common in the mammalian genome. LINE-1 elements, for example, are highly repeated 
repetitive elements found throughout the eukaryotic genome (Singer 1982), accounting for 
approximately 17% of the human genome sequence (Lander, Linton et al. 2001). 
Approximately 3000–4000 copies remain in a full-length form in the human genome, some of 
which may be retrotranspositionally active (Sassaman, Dombroski et al. 1997). These elements 
make a large contribution to diversity across the eukaryotic genome, for example by acting as 
recombination hotspots and sites for insertions and deletions (Kazazian and Moran 1998; 
Eickbush and Furano 2002; Deininger, Moran et al. 2003). Recent evidence suggests that 
transposition of these elements may also occur during later development and adulthood, 
including in the brain leading to mosaicism (Baillie, Barnett et al. 2011). Human LINE-1 
encodes for two proteins (ORF1p and ORF2p) which are required for retrotransposition 
(Moran, Holmes et al. 1996). LINE-1 elements are generally highly methylated in all tissue 
types including sperm (Shen, Kondo et al. 2007) and hypomethylation leading to activation of 
sense and antisense transcripts of these elements has been associated with the development 
of cancer (Roman-Gomez, Jimenez-Velasco et al. 2005).  
 
IAP elements are another class of retrovirus-like element and are present in over 1000 
copies in the mouse genome, which actively transpose via the reverse transcription of an RNA 
intermediate (Kuff and Lueders 1988; Heidmann and Heidmann 1991).  Differential DNA 
methylation across IAP elements have been found to directly affect gene expression and 
function, famously exemplified by the Agouti viable mutant mouse in which the insertion of 
the IAP retrotransposon in the opposite orientation upstream of the agouti gene influences 
cryptic transcription, resulting from a bidirectional promoter in the 5′ long terminal repeat 
(LTR) of the IAP (Kuff and Lueders 1988). IAP and other transposable elements may need to be 







highly methylated in germ line cells because demethylation could cause dysregulation of 
nearby cellular genes and induce new mutations via replicative transposition (Yoder, Walsh et 
al. 1997). As these elements are so abundant in the genome and appear to sometimes escape 
complete epigenetic reprogramming, it is plausible that, like imprinting DMRs, they enable the 
transmission of epigenetic information transgenerationally. This chapter will therefore also 
explore the hypothesis that these regions are differentially methylated in the offspring of old 
compared to young fathers. 
 
5.3 Aims 
The aim of this chapter is to investigate epigenetic changes associated with advanced 
paternal age using the mouse model described in Chapter 3. Using samples from several brain 
regions and spleen, global DNA methylation will be assessed, in addition to DNA methylation 
across specific DMRs regulating the expression of brain-expressed imprinted genes, and 
transposable elements (IAP and LINE-1). Finally, using sperm samples obtained from young, 
old, and very old males, specific regions associated with advanced paternal age in the 




Dissected tissues were obtained from the offspring and breeder mice used in the 
behavioural analyses presented in Chapter 3, as explained in (section 3.4.8). Sperm samples 
were collected from an independent collection of C57BL/6J male mice obtained from the MRC 
Harwell unit, Harwell Science and Innovation Campus. The cauda epididymis is sliced six to 
eight times with a 30G insulin needle, and then the sperm is gently palpitated out with a pair 
of forceps. For the vas deferens, forceps are used to “walk” the sperm along the lumen and 
extrude it through the cut end. Harvested sperm from the cauda and vas were extracted into 
the lid of a petri dish, after which 50ul of PBS was added and aspirated into an eppendorf 
before freezing at -80°C. The sperm donors were not used in the breeding of offspring mice 
used for behavioural or molecular testing.  







5.4.2 Brain Tissue, Spleen and Sperm DNA Isolation 
DNA from cerebellum and hippocampus were extracted using an optimised phenol 
chloroform method outlined in detail in the general methods chapter (section 2.2.3). DNA 
extractions from spleen were performed using the Qiagen DNeasy kit (section 2.2.1), and DNA 
from frontal cortex was extracted using the Qiagen AllPrep RNA/DNA (section 2.2.2), with the 
RNA isolated from the same tissues used in the gene expression analyses presented in Chapter 
6. Again, full details on these procedures are given in Chapter 2.  
 
DNA from sperm samples was extracted using an adapted phenol-chloroform protocol. 
100µl of lysis buffer and 10µl PK at 18.5mg/ml was added to sperm samples. The samples 
were then incubated overnight (16hrs) at 50oC followed by PK deactivation at 65oC for 20mins. 
150µl of PCI was added to the PK treated samples and then mixed by inverting and spun at 
13000rpm for 20mins. The aqueous solution was pipetted off into a new eppendorf tube and 
150µl of chloroform was added and mixed by inverting then spun at 13000rpm for 5mins. The 
aqueous solution was again pipetted off into a new eppendorf tube and 150µl of chloroform 
was added and mixed by inverting then spun at 13000rpm for 5mins. The aqueous solution 
was pipetted off and 375µl of cold 100% ethanol and 4.8µl of 10M NH4AC was added and 
mixed by slowly inverting. The samples were incubated at -20oC for 1hr. After the incubation, 
the samples were spun at 13,000rpm for 20mins. The supernatant was pipetted off and 400µl 
70% ethanol was added followed by a 10min 13000rpm centrifuge. The supernatant was 
pipetted off and the resulting pellet was allowed to dry at room temperature for 1hr. Finally 
the samples were resuspended in 100µl DNase/RNase free water. Samples were quantified 
using NanoDrop NO-1000 using the DNA-50 for concentration and purity (260/280 greater 
than 1.8) and checked on a 0.8% agarose gel for DNA integrity.  
 
5.4.3 Luminometric Methylation Assay 
The LUminometric Methylation Assay (LUMA) was used to estimate global DNA 
methylation by interrogating all CCGG recognition sites across the genome (Karimi, Johansson 
et al. 2006; Karimi, Johansson et al. 2006). The method is based on the fact that both HpaII 
and MspI cut DNA at the recognition site CCGG but because HpaII is a methylation sensitive 
restriction enzyme (MSRE) it only cuts when DNA is unmethylated. MspI, on the other hand, 
cuts regardless of DNA methylation status. LUMA was run on DNA from spleen from both the 







offspring and fathers, on DNA from cerebellum and hippocampus from the offspring, and in 
sperm samples from unrelated males of different ages. In this protocol, high molecular weight 
DNA was diluted to 500ng in 17µl of DNase free water so the final concentration was 
29.4ng/µl. All samples were processed in duplicate for two separate digestions, and all 
experiments included a fully methylated and fully unmethylated control to calibrate the data 
and control for incomplete digestion. The enzyme mixes were prepared as below. 3µl of the 
Mix A was added to each of two 17µl DNA samples, and 3µl of Mix B was added to another 
two aliquots. The samples were then incubated at 37oC for 4hours (Figure 5.2). EcoRI was 
included in all reactions as a normalization reference. 
 
HpaII - Mix A   MspI - Mix B  
Tango Buffer 2µl  Tango Buffer 2µl 
EcoRI (10U/µl) 0.5µl  EcoRI (10U/µl) 0.5µl 
HpaII (10U/µl) 0.5µl  MspI (10U/µl) 0.5µl 
 
After incubation, 20µl of Pyrosequencing annealing buffer was added to each tube. The 
samples were then run on the Qiagen Q24 pyrosequencer. Since different overhangs are 
produced after DNA cleavage, i.e. both MspI and HpaII have 5‘-CG overhangs and EcoRI has 5‘-
AATT overhangs, they can be filled in by separate polymerase extensions. In the LUMA assay, 
dNTPs are added in four sequential steps: First dATPS, then the mixed dGTP + dCTP followed 
by dTTP and a final dGTP + dCTP. The incorporation of a dNTP to the sequence was 
accompanied by the release of pyrophosphate (PPi) in a quantity of moles equal to the 
amount of the incorporated nucleotide. PPi was converted to ATP in the presence of 5' 
phosphosulfate (APS) and the ATP then drives the conversion of luciferin to oxyluciferin that 
generates light in an amount proportional to the amount of ATP created. This light is detected 
by a charge coupled device (CCD) chip and seen as a peak in the raw data output. The height 
of the peak generated by the light signal is proportional to the number of nucleotides added. 
Unincorporated nucleotides and ATP were degraded after each dNTP adding step and when 
the degradation is complete, the next addition event occurs. The light peaks produced by the 
addition of both dATPS and dTTP represents the EcoRI cleavage and are therefore expected to 
be equal to in both enzyme digests and are used as an internal control for the assay. The peak 
produced by the addition of the first dGTP and dCTP represents HpaII or MspI cleavage. The 







second addition of dGTP and dCTP is used as a control to signify the completion of the first 
dGTP and dCTP addition and is expected to be close to zero.  
 
 
Figure 5.2 - LUMA Method 
DNA sample split and one aliquot incubated with HpaII and EcoRI and one aliquot 
incubated with MspI and EcoRI. The cut samples are then analysed by pyrosequencing 
 
5.4.4 LUMA Data Analysis 
After the peak heights are exported from the Pyrosequencer, the ratio of the C (HpaII or 
MspI overhang) peak is divided by the A peak (EcoRI overhang) for both HpaII and MspI 
separately (Figure 5.3). This is repeated for the duplicate sample and then the average of C/A 
is taken. The inclusion of EcoRI as an internal control provides an accurate HpaII/MspI ratio for 
each sample of which the HpaII/MspI ratio can be defined as (HpaII/EcoRI) / (MspI/EcoRI). The 
average value of HpaII ratio is then divided by the average MspI Ratio. The fully methylated 
control should be low (we generally observe a value around 0.02) and the unmethylated 
control is normally much higher (around 1.22). 
 
37oC for 4hrs 
37oC for 4hrs 









Figure 5.3 – Example Luminometric Outputs from the LUMA Assay  
Top panel shows output from HpaII and EcoRI digest and the bottom panel shows the 
output from the MspI and EcoRI digest from the same individual. The ‘S’ peak is the substrate 
peak, ‘A’ peak is from the overhang from EcoRI digest, the first ‘C’ is the C+G addition for the 
HpaII or MspI overhang. Methylation is calculated by dividing the height of the first ‘C’ peak by 
the height of the ‘A’ peak for each digest then dividing the HpaII (C/A) by MspI (C/A). For the 
output above the values would be HpaII 94.83/47.54 = 0.50, MspI 60.56/115.05 = 1.90, 
HpaII/MspI = 0.26. 
 
5.4.5 Sodium Bisulfite Treatment 
Sodium bisulfite treatment of each DNA sample was carried out using an optimised 
protocol as outlined in the Material and Methods chapter (section 2.3). 
 
5.4.6 Sequenom EpiTYPER Analysis 
A number of methods exist for the quantitative assessment of DNA methylation at specific 
CpG sites (Laird 2010). In this project, we used the Sequenom EpiTYPER platform which 
provides a method for accurately measuring methylation at CpG units based on cleavage at 
thymine residues combined with Matrix-assisted laser desorption/ionization (MALDI) time-of-
flight (TOF) (MALDI-TOF) mass spectrometry (Sequenom 2011) (Figure 5.4). Bisulfite PCR 
products are tagged with a T7 tag on their reverse strand which acts as a primer for reverse 











and the resulting cleavage pattern depends on the presence of methylated cytosine in the 
original genomic DNA. Although Sequenom EpiTYPER is one of many ways of quantitatively 
assessing DNA methylation across specific sites, it is relatively high throughput, quick and can 
provide quantitatively accurate results at multiple CpG dinucleotides within an amplicon. 
 
 
Figure 5.4 - Sequenom EpiTYPER Methodology 
Adapted from Sequenom EpiTYPER protocol (Sequenom 2011) 
a) Genomic DNA 
b) Bisulfite treatment of DNA (section 2.3) 
c) PCR and SAP treatment – Amplifies up the region of interest and incorporated as 
T7 tag to each amplicon  and SAP treatment removed unincorporated dNTPs 
d) In vitro transcription -  Carried out on the reverse strand of amplicons  
e) Uracil-specific cleavage – Base specific cleavage to create fragments for analysis 
on mass spectrometer  
f) MALDI-TOF Mass Spectrometry – Size of the fragments are measured by mass 































5.4.6.1 Sequenom EpiTYPER Primer Design 
PCR primers were designed to amplify specific target regions of interest using the 
Sequenom EpiDesigner online software (www.epidesigner.com) (Sequenom 2007). 
Bioinformatic analyses were used to obtain the genomic sequence around areas of interest, 
focussing on CpG islands known to be imprinting DMRs. The following general primer design 




Primers were selected to be designed on either the forward or reverse strands, contain at 
least five CpG sites and to analyse only T cleave reactions. It was also important that primer 
sequences contained no CG dinucleotides and no SNPs to ensure efficient and non-biased 
amplification. Where several primer-pair options were available, the set spanning the highest 
number of CpGs was selected. As the sequenom assay is based on base specific cleavage, 
some fragments may contain more than one CpG site. DNA methylation estimates are 
obtained for individual ‘CpG units’ which can contain one or multiple CpG sites. All the 
designed primers for the selected imprinting DMRs are listed in Table 5.1 (for images showing 
the location of the imprinting DMRs assessed, see Appendix 2). The assay names used in this 
chapter relate to the imprinted gene each specific DMR is associated with. Where more than 
one gene is regulated by a given DMR, as is often the case in imprinted gene clusters, only one 
name to identify the amplicon location, but other genes affected by the DMRs will be 
discussed in the relevant sections.  
 
Bisulfite-PCR primers were initially tested using a standard PCR cycling protocol (section 
2.4) (annealing temperature of 55oC for 35 cycles with 0.5µl of MgCl2). PCR primers were 
tested on pooled bisulfite treated mouse test samples to optimise assays. Products were 
visualised using agarose gel electrophoresis (section 2.5), and where necessary (i.e. where 
there was no amplification, incorrectly-sized PCR products or non-specific amplification, etc), 
were further optimised using changes to annealing temperature or adjusting the amount of 
MgCl2 added to the reaction.  
 Min Optimal Max 
Primer Tm (oC) 56 62 64 
Primer Size (bp) 20 25 30 




Table 5.1 - Imprinting DMR Primer Details 
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Primers for transposable elements are listed in Table 5.2. The primer details for both the 
IAP and LINE-1 assays were designed by and obtained from Prof. Wolf Reik’s group (Babraham 
Institute, University of Cambridge) and used previously in their published studies of these 
elements (Popp, Dean et al. 2010). Roughly 1000 copies of IAP are present in the mouse 
genome, and all are very similar in sequence regardless of their genomic location. Due to this 
the IAP Sequenom assays provide a method for assaying the majority of these sites and 
providing an average DNA methylation level. LINE-1 elements are also present in many copies, 
and the LINE-1 Sequenom assay is again designed to give an average methylation level across 
multiple LINE-1 elements throughout the genome (Figure 5.5). 
 
Table 5.2 - Transposable Element Primer Details 
* A tag of AGGAAGAGAG is added to the 5’ end,  
** A tag of CAGTAATACGACTCACTATAGGGAGAAGGCT is added to the 5’ end 








IAP ATGGGTTGTAGTTAATTAGGGAGTG ACACATAAAATAAAAAACCACCCTC 55 150 6 (8) 
LINE-1 GATTTTAAGATTTTTGGTGAGTGGA AAAAACTTATACCCCAAATCAAACC 55 119 4 (5) 
 








Figure 5.5 – Example Epigram of IAP and LINE-1 Sequenom Assay 
Individual rows relate to samples and columns are CpG units covered in the amplicon. Red 
circles indicate low levels of methylation and change on a gradient towards yellow, which 
indicates high methylation. Empty circles are CpG units not analysed. 
 
 
5.4.6.2 Polymerase Chain Reaction 
All PCRs were carried out on bisulfite converted DNA in duplicate using the protocol 
outlined in the general methods chapter (section 2.4) using the optimised annealing 
temperatures. PCR products were run on 1.5% agarose gels as described in the general 
methods chapter (section 2.5) to check specificity of PCR primers and correct size of bands 
(Figure 5.6).  
 








Figure 5.6 - PCR Amplicons 
S – Sample, N – Negative Control. All PCR products checked on a 1.5% agarose gel against 
a ΦX174 DNA-HaeIII ladder (pictured below). All PCR were carried out with a fully methylated 




    Zim2                   Zac1 (1)                 Zac1 
(2) 
Snrpn                  Nap1l5                    Mest 
    Kcnq1ot1               Mcts2                    Grb10 
      Inpp5f 
   S           N            S           N            S          N 
 
    S           N                
 
   S           N            S           N             S          N 
 
   S           N            S           N            S          N 
 
        Exon1A                            Cd81                                 XL 
   S           N                       S           N                        S            N 
 
     Nesp                               Igf2                                 Gtl2 
   S           N                       S           N                        S            N 
 
   Ube3a                            Nnat                                Sgce 
   S           N                       S           N                        S            N 
 








5.4.6.3 Sequenom EpiTYPER Protocol 
After checking PCR amplification by gel electrophoresis, unincorporated dNTPs were 
removed using SAP cleanup. The SAP enzyme solution was made according to the recipe 
below and 2µl of the SAP mix added to each well, which was then incubated on a 
thermocycler at 37oC for 40mins before the SAP was denatured at 85oC for 5mins. 
 
SAP Mix 
RNase free water   1.7µl 
Shrimp alkaline phosphatase (SAP) 0.3µl 
 
After SAP treatment, the hMC transcription/RnaseA mix was made as below and then 5µl 
of the mix was added to each well. The samples were then incubated at 37oC for 3 hours. 
 
hMC transcription/RnaseA Mix 
DNase free water   3.21µl 
5X T7 Polymerase buffer  0.89µl 
Cleavage mix (T mix)   0.22µl 
DTT (100mM)    0.22µl 
T7 R&DNA Polymerase (50U/µl)  0.4µl 
RNase A    0.06µl 
 
20µl of DNase free water was then added to each well and the plate spun down. The 
addition of resin was used to desalt the samples before being spotted on the SpectroCHIP and 
scanned. Using the 384 well 6mg Dimple Plate and scraper, each of the dimples on the plate 
was filled with resin by placing a large amount at the left side of the plate and scraping the 
resin down the plate making sure all the wells were properly filled (Figure 5.7). The plate was 
then left for 15-20mins to dry. 










Figure 5.7 - Resin Addition to 6mg Dimple Plate 
Resin addition is controlled by plating out in the 6mg dimple plate. The resin is added to 
each of the samples and the plate it rotated for 15mins (Sequenom 2011). 
 
When the resin was dry in the dimple plate the 384 well sample plate was placed upside 
down on the top of the dimple plate. The dimple plate and sample plate are turned over 
together so all the resin fell into the wells of the sample plate. The plate was then rotated 
slowly for 15mins on plate rotator at a slow speed. The plate was then centrifuged for 5mins 
at 3000rpm. The samples were then spotted on to the SpecroCHIP and scanned in the 
Sequenom MassARRAY. Positive controls, including both artificially methylated and artificially 
unmethylated samples were included in all experimental procedures. 
 
5.4.6.4 Sequenom EpiTYPER Data Analysis 
After the fragment mass is determined by MALDI-TOF MS, the EpiTYPER software 
generates a report that contains quantitative information for each analyzed fragment. All 
negative controls were checked for empty epigrams and fully methylated and fully 
unmethylated controls checked for their corresponding methylation levels (Figure 5.8). CpG 
units with low call rates (<80%) were removed from subsequent analysis, as were samples 
with less than 70% data available across the CpG unit. All data from CpG-containing fragments 
flagged by EpiTYPER as having low mass (outside MS analytical window), high mass (outside 
MS analytical window) or silent peak overlap (two overlapping peaks, one with no CpGs, 
following MS) were discarded. 
 








Figure 5.8 – Example Spectra and Epigram from EpiTYPER Software 
Spectral reading and epigram output from Sequenom EpiTYPER software showing 




Differences between groups were calculated using the student’s t-test and one-way 
ANOVA in the R statistical analysis environment. A ‘between-within’ analysis was used to test 
DNA changes in the DNA methylation pattern across the PCR-amplified regions, with parental 
age as the between factor and CpG site as the within factor. Significance level for all tests was 
set at 0.05. 
 
5.5 Results 
In all graphs shown in this section, ** = p ≤ 0.01, * p = ≤ 0.05 and + = p ≤ 0.1. Error bar in 
all graphs show the SEM. 
 








5.5.1 Global DNA Methylation Analysis using LUMA 
In this section global DNA methylation was assayed in multiple tissues from the offspring 
of young fathers (n = 18) and the offspring of old fathers (n = 23). We also assessed DNA 
obtained from the offspring of very old fathers (n = 11), although these samples were 
obtained from a different batch of animals than the other two groups, and thus the data for 
these may not be directly comparable (as described in section 3.4.1). Furthermore, the 
offspring of ‘very old’ fathers analysis group was considerably smaller than the other groups, 
and so they were also combined with the offspring of old fathers into a single analysis group 
consisting of the offspring of fathers over 10 months (n = 34). The HpaII/MspI ratio is inversely 
related to DNA methylation level, therefore a low HpaII/MspI ratio corresponds to a high 
methylation level and vice versa. 
 
5.5.1.1 Spleen 
The LUMA data from the spleen DNA from the offspring is shown in Figure 5.9a. DNA 
methylation was seen to increase with the age of the father, with the offspring of very old 
fathers being significantly more methylated than the offspring of young fathers (t = 3.95, d.f. =
20, p = 0.002) and the offspring of old fathers (t = 3.58, d.f. = 23, p = 0.002). Combining the 
offspring of old fathers and the offspring of very old fathers (i.e. the offspring of fathers over 
10 months old) again highlighted significant hypermethylation in the offspring of older fathers 
compared to the offspring of young fathers (t = 1.94, d.f. = 34, p = 0.05) (Figure 5.9b). 
 








          
Figure 5.9 - Results from LUMA on Offspring Spleen DNA 
a) Offspring of young fathers n=13, Offspring of old fathers n=14, Offspring of very 
old fathers n=9.  
b) Offspring of young fathers n=13, Offspring of fathers>10months n=23 
 
When global methylation was assayed in spleen samples from the fathers themselves, 
methylation levels were not significantly different between groups (F (2, 12) = 0.38, p = 0.69) 
(Figure 5.10). This data suggest that the association between global hypermethylation and 
advanced paternal age detected in the spleen of offspring are not reflected in somatic spleen 
cells from the fathers. 
 
Figure 5.10 - Results from LUMA on Fathers Spleen DNA 




































We next attempted to replicate this observation in an additional tissue from the same 
animals, the cerebellum. Although DNA methylation levels between the offspring of young 
fathers and the offspring of older fathers did not reach statistical significance, a near-
significant trend in the same direction in global methylation was observed as in the spleen (t =
1.77, d.f. = 25, p = 0.08) (Figure 5.11a), with the offspring of old fathers having a higher level of 
global methylation. A similar trend towards significance in the same direction is observed 
comparing the offspring of young fathers with the offspring of fathers over 10 months (t =
1.71, d.f. = 34, p = 0.08) (Figure 5.11b) 
 
              
Figure 5.11 - Results from LUMA on Offspring Cerebellum DNA 
a) Offspring of young fathers n=12, Offspring of old fathers n=15, Offspring of very 
old fathers n=9 



















a)                  b) 









In contrast, no such paternal-age associated difference in DNA methylation was observed 
in hippocampus samples from the offspring, where the global DNA methylation levels 
between groups were not significantly different either when looking at three groups 
individually (F (2, 50) = 0.14, p = 0.86) (Figure 5.12a), or when combining the offspring of old 
fathers and very old fathers (t = 0.52, d.f. = 50, p = 0.61) (Figure 5.12b). Global methylation in 
the offspring of old fathers was not significantly different than in the offspring of young males 
(t = 0.40, d.f. = 32, p = 0.69).  
 
            
Figure 5.12 - Results from LUMA on Offspring Hippocampus DNA 
a) Offspring of young fathers n=18, Offspring of old fathers n=23, Offspring of very 
old fathers n=11  

















a)           b) 









Global methylation was assayed in the sperm from males of different ages unrelated to 
the mice used in the rest of the study. No differences in global methylation were seen 
between the young, old and very old males (F (2, 22) = 0.005, p = 0.99) (Figure 5.13a), or 




Figure 5.13 - Results from LUMA on Sperm DNA 
a) Young males n=6, old males n=10, very old males n=8  
b) Young males n=6, males >10months n=18 
 
Figure 5.14 shows the average HpaII/MspI value from LUMA across all tissues assayed. 
DNA from cerebellum has the lowest HpaII/MspI value and so the highest level of global 
methylation. Global methylation levels are similar in hippocampus, spleen and sperm samples. 
The global methylation in cerebellum was significantly higher (lower HpaII/MspI) than in the 
spleen (t = -6.35, d.f. = 102, p = 2.65E-08), hippocampus (t = -4.55, d.f. = 102, p = 2.14E-05) and 
sperm (t = -4.52, d.f. = 74, p = 6.90E-05). There were no significant differences between global 
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Figure 5.14 – Average HpaII/MspI in All Assayed Tissues from LUMA 
Average HpaII/MspI across all groups in all tissue assayed using LUMA combined with 
pyrosequencing. 
 
5.5.2 DNA Methylation at DMRs of Brain-Expressed 
Imprinted Genes 
In this section, DNA methylation levels across DMRs associated with brain-expressed 
imprinted genes were assayed in tissues from the offspring of young fathers (n = 18), the 
offspring of old fathers (n = 23), and the offspring of very old fathers (n = 11). As before, the 
offspring of old fathers and offspring of very old fathers were also combined (n = 34). In 
addition, sperm DNA samples from male mice of two (young), ten (old) and twelve (very old) 
months old were also assessed at several loci. These mice, although from the same inbred 
mouse strain (i.e. C57BL/6), were not directly related to our test mice. 
 
** 









Again, our initial experiments were carried out on cerebellum samples, in which we 
assessed DMRs and CpG islands associated with 15 known brain-expressed imprinted loci. The 
cerebellum was selected as the tissue for our primary analyses due to its postulated role in 
the development of autism, one of the neuropsychiatric disorders strongly linked to advanced 
paternal age (Martin and Albers 1995; Schmahmann 2000; Sparks, Friedman et al. 2002; 
Brambilla, Hardan et al. 2003). As expected for DMRs associated with the monoallelic 
expression of imprinted genes, most regions were found to be hemi-methylated (~50%) 
(Figure 5.15). Assays associated with Cd81, Ube3a and Igf2 showed much lower average 
methylation, and so were not run across the entire sample as they did not appear to be DMRs.  
 
 
Figure 5.15 –Average Methylation across All Sequenom Assays 
Average methylation across all amplicons and all cerebellum samples run on Sequenom 
EpiTYPER.  
 
First, looking at amplicon averaged levels, there was a modest (~3%) but significant 
decrease in DNA methylation in the offspring of old fathers compared to the offspring of 
young fathers in two DMRs: Kcnq1ot1 (t = 2.47, d.f. = 39, p = 0.02) and Mcts2 (t = 2.09, d.f. = 
39, p = 0.05). Furthermore, a non-significant trend for amplicon-averaged hypermethylation in 
DMR 








the offspring of old versus young fathers was observed for three DMRs: Gnas-Nesp (t = -1.84, 
d.f. = 39, p = 0.07); Sgce (t = -1.72, d.f. = 39, p = 0.09) and Zac1 (CpG island 2) (t = -1.90, d.f. = 
39, p = 0.06). In addition, many individual CpG sites across the 16 DMRs had significant (or 
trends towards significant) differences between groups defined by paternal age as 
summarised in Figure 5.16 and Table 5.3. 
 
Figure 5.16 - Methylation of Imprinted Genes in Cerebellum samples 
Average methylation in all DMRs and methylation levels across 16 imprinted DMRs in 
offspring of young fathers (n = 18), offspring of old fathers (n = 23) and offspring of very old 




Figure 5.16 Continued 
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The results for the analyses comparing the offspring of young fathers to the offspring of 
fathers over 10 months are shown in Figure 5.17. There was a significant increase in the 
average DNA methylation across the PCR amplicon for two DMRs; Gnas XL (t = -2.03, d.f. = 50, 
p = 0.05) and Zac1 DMR 2 (t = -2.10, d.f. = 50, p = 0.04), with a trend towards lower 
methylation across the Kcnq1ot1 DMR (t = 1.68, d.f. = 50, p = 0.10). Again many individual CpG 
sites showed a significant (or a trend towards a significant) difference in DNA methylation 
between groups and these are summarised in Table 5.3. Based on these findings in the 
cerebellum, Gnas-Nesp, Kcnq1ot1 and Mcts2 DMRs were subsequently assessed in other 
tissues as they showed the most consistent changes in DNA methylation across the entire or 
the majority of their DMR between the offspring of young fathers and offspring of old fathers. 
 
Figure 5.17 - Methylation of Imprinted Genes in Cerebellum samples II  
Average methylation in all DMRs and methylation levels across 16 imprinted DMRs in the 




Figure 5.17 Continued 
 
 












































                          






























































                          






Figure 5.17 Continued 
 

















































                          

















































                          














































                          

















































                          







Table 5.3 - Summary of Paternal-Age Associated Differences in DNA Methylation across Imprinting DMRs in the Cerebellum 
Numbers refer to CpG unit, p = p-value, t = t-value, ‘Direction’ refers to direction of change in methylation from first group listed to second group 
listed (e.g. Offspring of Young (n = 18) vs. Old Father (n = 23) is direction of methylation change for old fathers from methylation in the offspring of 
young fathers). Filled in boxes indicate where there were no significant or trend towards significance in the results. 
DMR 
Offspring of Young (n = 18) vs. Offspring of Young (n = 18) vs. Offspring of Old (n = 23) vs. Offspring of Young vs. 
Old Father (n = 23) Very Old Father (n = 11) Very Old Father (n = 11) >10 Months Father 
Finding p t 
% 
Direction Finding p t 
%  
Direction Finding p t 
%  
Direction Finding p t 
%  
Direction 
Change Change Change Change 
Sgce 
Trend in average 0.09 -1.72 2 ↑           Trend in 16 0.06 2.03 2 ↓ Trend in average 0.10 -1.67 2 ↑ 
                              Trend in 9-10 0.08 -1.79 3 ↑ 
Exon1A 
Trend in 2 0.06 -1.99 2 ↑ Significant in 7-8 0.05 -2.07 3 ↑ Trend in 2 0.1 1.73 1 ↓ Trend in 2 0.1 -1.68 1 ↑ 
          Significant in 23 0.01 -2.64 1 ↑ Significant in 18-19 0.05 -2.05  2 ↑ Trend in 7-8 0.09 -1.75 3 ↑ 
                    Trend in 23 0.07 -1.92 1 ↑ Trend in 32-33 0.09 -1.76 3 ↑ 
                                        
Gnas-Nesp 
Trend in average 0.07 -1.84 3 ↑           Trend in 1-2 0.07 1.9 3 ↓ Trend in 1-2 0.09 -1.73 2 ↑ 
Significant in 1-2 0.03 -2.33 3 ↑           Trend in 13-14 0.06 2.01 3 ↓ Significant in 4 0.05 -2.06 3 ↑ 
Significant in 4 0.03 -2.3 4 ↑           Trend in 25 0.09 1.78 3 ↓ Trend in 15-17 0.07 -1.89 3 ↑ 
Trend in 9 0.1 -1.7 3 ↑                     Trend in 25 0.07 -1.87 3 ↑ 
Significant in 13-14 0.04 -2.17 4 ↑                               
Significant in 15-17 0.03 -2.23 4 ↑                               
Trend in 22-24 0.1 -1.67 4 ↑                               





























                          







Trend in average 0.1 -1.7 3 ↑ Trend in average 0.09 -1.76 2 ↑ Trend in 7 0.09 -1.79 4 ↑ Significant in average 0.05 -2.03 3 ↑ 
Trend in 4 0.09 -1.78 3 ↑ Trend in 2-3 0.09 -1.8 3 ↑           Significant in 4 0.05 -2 2 ↑ 
Significant in 5-6 0.03 -2.23 3 ↑ Trend in 10 0.06 -1.99 2 ↑           Highly significant in 5-6 0.01 -2.54 3 ↑ 
Trend in 11 0.06 -1.93 3 ↑                     Trend in 11 0.06 -1.98 2 ↑ 
Trend in 19-20 0.09 -1.79 4 ↑                     Trend in 19-20 0.07 -1.87 3 ↑ 
Trend in 21-22 0.1 -1.71 6 ↑                     Trend in 21-22 0.07 -1.87 4 ↑ 
Trend in 23 0.1 -1.72 6 ↑                     Trend in 23  0.07 -1.86 4 ↑ 
Nnat 
Trend in 8 0.07 -1.85 3 ↑           Trend in 2-4 0.1 1.71 2 ↓           
                    Significant in 8 0.04 2.14 3 ↓           
                    Trend in 14-15 0.06 1.96 4 ↓           
Gtl2 
Trend in 4 0.09 -1.77 2 ↑ Trend in 3 0.07 -1.95 5 ↑           Significant in 4 0.03 -2.28 3 ↑ 
Trend in 29 0.09 -1.77 2 ↑ Significant in 4 0.02 -2.47 3 ↑           Trend in 5 0.08 -1.79 2 ↑ 
          Trend in 6 0.07 -1.95 5 ↑            Trend in 28 0.08 -1.79 2 ↑ 
          Trend in 10 0.07 -1.87 2 ↑            Significant in 29 0.03 -2.28 3 ↑ 
          Significant in 12-13 0.05 -2.06 3 ↑                     
          Significant in 29 0.02 -2.47 3 ↑                     
Grb10                                         
Inpp5f           Trend in 3 0.06 2 3 ↓           Trend in 3 0.08 1.83 2 ↓ 
Kcnq1ot1 
Significant in average 0.02 2.47 2 ↓           Significant in average 0.04 -2.22 2 ↑ Trend in average 0.1 1.68 1 ↓ 
Significant in 1 0.02 2.36 3 ↓           Significant in 3 0.02 -2.46 3 ↑ Significant in 1 0.03 2.29 2 ↓ 
Significant in 3 0.02 2.44 2 ↓           Significant in 4 0.03 -2.3 2 ↑           
Trend in 4 0.06 1.91 2 ↓           Significant in 5-6 0.02 -2.46 2 ↑           
Significant in 5-6 0.05 2.04 2 ↓           Significant in 8 0.03 -2.49 2 ↑           
Significant in 8 0.03 2.26 2 ↓           Significant in 11 0.03 -2.49 2 ↑           
Significant in 11 0.03 2.26 2 ↓                               
Mest Trend in 4 0.06 1.96 3 ↓                     Trend in 4 0.07 1.84 2 ↓ 





























                          






Zac1 (1)                                         
Zim2 
Significant in 7-8 0.04 2.14 3 ↓                               
Trend in 11-12 0.08 1.81 4 ↓                               
 Trend in 13 0.1 1.71 3 ↓                               
Mcts2 
Significant in average 0.05 2.09 3 ↓                     Trend in 4 0.09 1.75 2 ↓ 
Trend in 1-3 0.09 1.75 3 ↓                     Trend in 5 0.06 1.91 3 ↓ 
Trend in 4 0.08 1.8 3 ↓                               
Significant in 5 0.03 2.25 4 ↓                               
Significant in 13 0.05 2.07 3 ↓                               
Trend in 14 0.06 1.92 3 ↓                               
Nap1l5                                         
Zac1 (2) 
Trend in average 0.06 -1.9 2 ↑ Trend in 4 0.07 -1.91 4 ↑           Significant in average 0.04 -2.1 2 ↑ 
Highly significant in 4 0.01 -2.66 4 ↑ Trend in 12 0.07 -1.91 4 ↑           Highly significant in 4 0.01 -2.77 4 ↑ 



































                          






Figure 5.18 – Offspring of Young Fathers vs. Offspring of Old Fathers in 
Cerebellum 
Three DMRs which showed consistent methylation changes across the 
entire PCR region as well as schematic of the region. Greyed out boxes are 
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Based on the results from the 16 DMRs assessed in the cerebellum, we next examined the 
tissue-specificity of differences by examining three specific regions (Mcts2, Gnas-Nesp and 
Kcnq1ot1) in spleen, frontal cortex, and hippocampal tissue obtained from the same individual 
animals. Furthermore, we examined these regions in sperm DNA samples obtained from 
young, old, and very old males. Average levels of DNA methylation across the 3 DMRs in the 
different tissues are shown in Figure 5.19 
 

































Compared to other tissues, Mcts2 was observed to be significantly hypermethylated in the 
spleen (Figure 5.19). This concurs with information showing that it is expressed at a very low 
level in this tissue (EuropeanBioinformaticsInstitute 2011). The results for the Gnas-Nesp and 
Kcnq1ot1 DMRs are shown in Figure 5.20, comparing the offspring of young fathers to the 
offspring of old fathers. There was no significant difference between overall DNA methylation 
for either amplicon (Gnas-Nesp (t =  -0.16, d.f. = 39, p = 0.87) and Kcnq1ot1 (t = -0.81, d.f. = 39, 
p = 0.43)). In the latter, only one CpG unit (5-6) showed a difference between groups (t = -
2.59, d.f. = 39, p = 0.02) with the offspring of old fathers having a higher level of methylation 
at this site, which is the opposite direction seen in the cerebellum. No significant differences 
were observed between individual sites in Mcts2 or in average methylation across the PCR 
regions (t = 0.27, d.f. = 39, p-value = 0.79). 
 












The results of the analysis of the analysis between advancing paternal age and DNA 
methylation at the Mcts2, Gnas-Nesp and Kcnq1ot1 DMRs in the hippocampus are shown in 
Figure 5.21 (for offspring of young fathers, offspring of old fathers and offspring of very old 
fathers). There were no significant differences between groups for either individual CpG sites 
or average DNA methylation across any of the regions between all three groups (Kcnq1ot1 (F 
(2, 50) = 0.32, p = 0.73), Mcts2 (F (2, 50) = 0.26, p = 0.77) or Gnas-Nesp (F (2, 50) = 1.11, p = 
0.34)). Only unit 13-14 in Gnas-Nesp showed a trend towards significance between the 
offspring of young fathers and offspring of old fathers (t = -1.69, d.f. = 39 p = 0.098). The 





























than in DNA from cerebellum (Figure 5.16) although the group differences aren’t significant in 
the hippocampus. 
 




Likewise, there were no significant differences between the offspring of young fathers and 
offspring of fathers over 10 months for any individual CpG units or amplicon-averaged DNA 
methylation for any of the DMRs (Kcnq1ot1 (t =  0.75, d.f. = 50, p = 0.46), Mcts2 (t =  -0.68, d.f.




























Figure 5.22 – Methylation of Imprinted Genes in Hippocampus Samples II 
































5.5.2.4 Frontal Cortex 
The results of the analysis of the analysis between advancing paternal age and DNA 
methylation at the Gnas-Nesp, Kcnq1ot1 and Mcts2 DMRs in the frontal cortex are shown in 
Figure 5.23 (for the offspring of young fathers, offspring of old fathers and offspring of very 
old fathers). Interestingly, average DNA methylation was significantly different between 
groups across the Kcnqot1 DMR (F (2, 50) = 3.43, p = 0.04) and the Mcts2 DMR (F (2, 50) = 
3.34, p = 0.04), but there was no significant different across the Gnas-Nesp DMR (F (2, 50) = 
1.44, p = 0.25). Of note, the negative correlation between paternal age and DNA methylation 
observed across the Mcts2 DMR reflects the patterns seen in the cerebellum. 
 







* * * * 
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No significant differences were seen between the offspring of young fathers and offspring 
of fathers over 10 months in individual CpG units of average methylation for Gnas-Nesp (t = 
0.68, d.f. = 50, p = 0.50), Kcnq1ot1 (t =-1.23, d.f. = 50, p = 0.22) or Mcts2 (t = 1.01, d.f. = 50, p = 
0.32). 
 




































Post mortem sperm samples obtained from mice not related to the individuals used in the 
rest of this study were analysed for DNA methylation levels at the same three DMRs 
nominated from analyses of the cerebellum. The results of DNA methylation analysis in the 
sperm from young males (two months), old males (ten months) and very old males (twelve 
months) are shown in Figure 5.25.  
 
Strikingly, there was a highly-significant decrease in average DNA methylation across both 
the Gnas-Nesp DMR (F (2, 20) = 17.43, p = 4.15 x 10-5), and across the Mcts2 DMR (F (2, 20) = 
12.623, p = 2.85 x 10-4). Although there was no significant difference in average DNA 
methylation between the groups across the Kcnq1ot1 DMR (F (2, 20) = 1.50, p = 0.25), three 
CpG sites were significantly different between young males and old males (sites 2, 7 and 9). 
These results are further summarised in Table 5.4. Sperm samples from the young fathers 
were then compared to the combined data from old males and very old males to make the 
males over ten months old group, paralleling our analysis on tissue from the test animals. 
Again, there was a significant decrease in DNA methylation across the Gnas-Nesp DMR (t = 
4.39, d.f. = 21, p = 1.64 x 10-3) and the Mcts2 DMR (t = 3.97, d.f. = 21, p = 3.93 x 10-3). There 
was no significant difference in the level of average DNA methylation across the Kcnq1ot1 
DMR (t = 1.66, d.f. = 21, p = 0.13). This data in shown in Figure 5.26 and summarised in Table 
5.5.  








Figure 5.25 – Methylation of Imprinted Gene DMRs in Sperm Samples Obtained from 
Young, Old and Very Old Mice 
 



























Table 5.4 – Results of Methylation Analysis on Sperm Samples 
Numbers refer to CpG unit, p = p-value, t = t-value, ‘Direction’ refers to direction of change in methylation from first group listed to second group listed 
(e.g. Young (n = 18) vs. Old Male (n = 23) is direction of change in methylation for old males from methylation in young males) 
DMR 
Young (n = 6) vs. Old Male (n = 10) Young (n = 6) vs. Very Old Male (n = 7) Old (n = 10) vs. Very Old Male (n = 7) 
Finding p t % Change Direction Finding p t % Change Direction Finding p t % Change Direction 
Gnas-Nesp 
Significant in Average 0.01 3.2 11 ↓ Significant in Average 2.35E-04 5.65 20 ↓ Significant in Average 0.01 3.24 9 ↓ 
Significant in 1-2  0.01 3.04 10 ↓ Significant in 1-2 3.74E-04 5.29 18 ↓ Significant in 1-2 0.01 3.14 8 ↓ 
Significant in 4 0.01 3.12 12 ↓ Significant in 3 0.03 2.8 11 ↓ Significant in 3 0.02 2.67 5 ↓ 
Significant in 5-6 0.02 2.89 10 ↓ Significant in 4 2.86E-04 5.63 22 ↓ Significant in 4 0.01 3.27 10 ↓ 
Significant in 7 0.01 3.2 14 ↓ Significant in 5-6 2.89E-04 5.33 19 ↓ Significant in 5-6 0.01 3.07 10 ↓ 
Significant in 9 0.01 2.94 11 ↓ Significant in 7 7.55E-04 4.97 22 ↓ Significant in 7 0.02 2.66 9 ↓ 
Significant in 10-11 0.03 2.58 9 ↓ Significant in 9 4.75E-04 5.11 20 ↓ Significant in 9 0.02 2.71 9 ↓ 
Significant in 13-14 0.01 3.53 12 ↓ Significant in 10-11 1.07E-03 4.88 18 ↓ Significant in 10-11 0.01 3.07 8 ↓ 
Significant in 15-17 0.01 3.34 11 ↓ Significant in 13-14 1.29E-04 5.84 22 ↓ Significant in 13-14 0.01 3.03 10 ↓ 
Significant in 18 0.02 2.9 10 ↓ Significant in 15-17 2.16E-04 5.65 21 ↓ Significant in 15-17 0.01 3.28 10 ↓ 
Significant in 19-20 0.02 2.73 10 ↓ Significant in 18 2.46E-04 5.5 21 ↓ Significant in 18 4.34E-03 3.47 11 ↓ 
Significant in 21 1.99E-04 5 13 ↓ Significant in 19-20 2.14E-04 5.97 20 ↓ Significant in 19-20 2.82E-03 3.57 10 ↓ 
Significant in 22-24 4.06E-03 3.73 12 ↓ Significant in 21 3.61E-06 8.56 22 ↓ Significant in 21 0.01 3.04 8 ↓ 
Significant in 25 0.01 3.43 12 ↓ Significant in 22-24 8.34E-05 6.1 23 ↓ Significant in 22-24 0.01 3.28 10 ↓ 
          Significant in 25 6.39E-05 6.27 23 ↓ Significant in 25 4.98E-03 3.37 11 ↓ 
Kcnq1ot1 
Significant in 2 0.04 2.51 8 ↓                     
Significant in 7 0.04 2.51 8 ↓                     
Significant in 9 0.04 2.51 8 ↓                     
Mcts2 
Significant in Average 0.01 3.04 13 ↓ Significant in Average 9.41E-04 4.68 22 ↓ Significant in Average  0.04 2.33 8 ↓ 
Significant in 1-3 0.02 2.97 13 ↓ Significant in 1-3 1.27E-03 4.49 21 ↓ Significant in 1-3  0.05 2.19 8 ↓ 
Significant in 4 0.04 2.4 12 ↓ Significant in 4 4.58E-03 3.79 20 ↓ Significant in 4  0.05 2.17 8 ↓ 
CpG_5 0.01 3.61 14 ↓ Significant in 5 4.54E-04 5.12 21 ↓ Significant in 5  0.05 2.2 7 ↓ 





























                          






CpG_9.10.11.12 0.01 3.39 15 ↓ Significant in 9-12 4.87E-04 5.1 24 ↓ Significant in 9-12  0.03 2.36 9 ↓ 
Significant in 13 0.02 2.88 13 ↓ Significant in 13 1.15E-03 4.49 22 ↓ Significant in 13  0.04 2.23 9 ↓ 
Significant in 14 0.02 2.91 14 ↓ Significant in 14 1.14E-03 4.76 24 ↓ Significant in 14  0.02 2.72 10 ↓ 





























                          













Figure 5.26 - Methylation of Imprinted Gene DMRs in Sperm Samples Obtained from Young 
and >10 Month Old Mice 
+ + + 
+ 









































Table 5.5 - Results of Methylation Analysis on Sperm Samples 
Numbers refer to CpG unit, p = p-value, t = t-value, ‘Direction’ refers to direction of change 
in methylation from first group listed to second group listed  
DMR 
Offspring of Young (n = 6) vs. 
>10 Months Father (n = 17) 
Finding p t % Change Direction 
Gnas-Nesp 
Significant in Average 1.64E-03 4.39 15 ↓ 
Significant in 1-2 2.50E-03 4.16 13 ↓ 
Trend in 3 0.08 2.1 8 ↓ 
Significant in 4 1.99E-03 4.3 16 ↓ 
Significant in 5-6 1.99E-03 4.12 14 ↓ 
Significant in 7 3.55E-03 4.13 17 ↓ 
Significant in 9 2.69E-03 4.07 15 ↓ 
Significant in 10-11 0.01 3.64 13 ↓ 
Significant in 13-14 6.99E-04 4.76 16 ↓ 
Significant in 15-17 1.47E-03 4.48 15 ↓ 
Significant in 18 2.09E-03 4.13 15 ↓ 
Significant in 19-20 2.00E-03 4.11 14 ↓ 
Significant in 21 6.92E-06 6.88 17 ↓ 
Significant in 22-24 4.45E-04 4.97 17 ↓ 
Significant in 25 3.82E-04 4.85 16 ↓ 
Kcnq1ot1 
Trend in 2 0.06 2.14 7 ↓ 
Trend in 7 0.06 2.14 7 ↓ 
Trend in 9 0.06 2.14 7 ↓ 
Mcts2 
Significant in Average 3.93E-03 3.97 17 ↓ 
Significant in 1-3 4.86E-03 3.85 16 ↓ 
Significant in 4 0.02 3.14 15 ↓ 
Significant in 5 1.68E-03 4.56 17 ↓ 
Significant in 6-8 4.46E-03 3.79 17 ↓ 
Significant in 9-12 2.04E-03 4.38 19 ↓ 
Significant in 13 4.55E-03 3.82 17 ↓ 
Significant in 14 0.01 3.84 18 ↓ 
Significant in 17 0.01 3.67 16 ↓ 








5.5.3 Transposable Elements 
DNA methylation across IAP and LINE-1 repetitive elements was assessed in DNA from 
cerebellum and frontal cortex from the offspring of young, old and very old fathers and in 
sperm samples from unrelated males of different ages. Results of average DNA methylation 
across the assay by tissue and group are summarised in Table 5.6. 
 
Table 5.6 – Results of Average Methylation from the IAP and LINE-1 Assay 
Results of the IAP and LINE-1 Sequenom EpiTYPER assay in DNA from cerebellum, frontal 
cortex and sperm. Average methylation across the assay in all samples and average 
methylation across the assay by group are displayed. P-values and t-values between groups 
are also displayed. 









Young v Old 
Young v Very 
Old 
Old v Very 
Old 















Cerebellum 94.3 94.1 94.4 94.5 94.4 0.40 -0.85 0.29 -1.08 0.71 -0.38 0.31 -1.04 
Frontal 
Cortex 
94.4 94.5 94.1 94.8 94.3 0.58 0.55 0.60 -0.53 0.27 -1.12 0.75 0.32 
Sperm 93.7 93.2 93.8 93.8 93.8 0.46 -0.78 0.46 -0.76 1.00 -0.01 0.42 -0.85 
LINE-1 
Cerebellum 76.8 77.3 76.3 76.9 76.5 0.13 1.56 0.64 0.48 0.45 -0.78 0.16 1.44 
Frontal 
Cortex 
75.6 75.9 75.4 75.8 75.5 0.23 1.23 0.94 0.07 0.24 -1.20 0.28 1.09 
Sperm 79.0 78.8 78.9 79.2 79.1 0.72 -0.37 0.33 -1.06 0.35 -0.97 0.53 -0.67 
 
Methylation in IAP and LINE-1 elements were assayed in cerebellum samples from the 
offspring. There was no significant difference between groups in either IAP or LINE-1 elements 
between the three groups (Figure 5.27a). There was also no difference between the offspring 
of young fathers and offspring of fathers over 10 months old in IAP or LINE-1 elements (Figure 
5.27b). 












DNA from frontal cortex from the offspring of young fathers, old fathers and very old 
fathers were analysed for methylation in IAP and LINE1 elements. There were no significant 
differences between groups for either element (Figure 5.28a). When data from the offspring 
of old fathers and offspring of very old fathers was combined into offspring of fathers over 10 
















a)                                                                                    b) 








Figure 5.28 - Methylation of Transposable Elements in Frontal Cortex Samples 
 
Post mortem sperm samples from mice not related to mice used in the rest of this study 
were analysed for DNA methylation levels in IAP and LINE-1 elements. The results of 
methylation analysis in the sperm from young males (two months), old males (ten months) 
and very old males (twelve months) are shown in Figure 5.29a. No significant differences were 
observed in DNA methylation across any sites in the IAP or LINE1 element assays. After 
combining the old male and young male data into the males over 10 months there were again 




























Figure 5.29 - Methylation of Transposable Elements in Sperm Samples 
 
5.6 Discussion 
5.6.1 Summary of Results 
A summary of the results from the experiments presented in this chapter is given in Table 
5.7. An increase in global methylation, measured by LUMA, was observed in spleen and 
cerebellum samples with advancing paternal age but was not observed in somatic tissues from 
the male breeders themselves or the sperm samples from unrelated males of different ages. 
Initial DNA methylation analyses focussed on the cerebellum, a region of the brain that has 
been consistently linked with the development of autism and (to a lesser extent) psychosis 
(Martin and Albers 1995; Schmahmann 2000; Sparks, Friedman et al. 2002; Brambilla, Hardan 
et al. 2003), both of which have been shown to be epidemiologically-associated with 
advanced paternal age in humans. From the investigation of DMRs associated with brain 























expressed imprinted genes in the cerebellum, multiple individual CpG units/sites among the 
other 16 amplicons investigated showed altered DNA methylation with advancing age; 
however only three DMRs (Gnas-Nesp, Kcnqot1 and Mcts2) showed consistent significant 
changes across the entire PCR region (Figure 5.18). Interestingly, Gnas-Nesp showed an 
increase in DNA methylation with increased paternal age and is expressed from the maternal 
allele (paternally imprinted) and Kcnq1ot1 and Mcts2 showed a decrease in methylation and 
are expressed from the paternal allele (maternally imprinted). This pattern is not seen across 
the other investigated DMRs, which were not as consistent in their DNA methylation 
differences. For example, Gnas XL and Zac1 are both expressed from the paternal allele 
(maternally imprinted) but rather than experiencing a decrease in methylation like Mcts2 and 
Kcnq1ot1 in DNA from the cerebellum, they both showed an increase in methylation with 
increasing age, although this could be due to the inconsistency in methylation pattern across 
the PCR region. Gnas-Nesp, Kcnq1ot1 and Mcts2 were subsequently assessed in several other 
tissues from the same individuals, and sperm from an independent sample of males of varying 
age. No significant differences were observed in spleen or hippocampus DNA, but in frontal 
cortex significant DNA methylation changes were observed with paternal age in all three 
assays. In sperm samples from males of different ages, Gnas-Nesp and Mcts2 showed an 
apparent highly significant decrease in DNA methylation with increasing male age. This is an 
interesting observation showing that the inheritance of the expressed allele could affect the 
change in DNA methylation differently. No significant changes in DNA methylation levels 












Table 5.7 – Summary of Results from Chapter 
Results of groups compared to offspring of young fathers or young males (sperm) 






Old Father  No differences  
Very Old 
Father 
Highly significant increase in 
methylation compared to 




Significant increase in 
methylation compared to 











Significant increase in 
methylation compared to 
offspring of young fathers 
Gnas-Nesp, Kcnq1ot1 and Mcts2 
showed consistent significant 
differences across the DMR. 
Nine other DMRs showed 
significant or trend towards 
significant differences compared 




 Five DMRs showed sites which 
had significant or trend towards 





Trend towards increase in 
methylation compared to 
offspring of young fathers 
Gnas-Nesp showed consistent 
methylation differences 
between groups across the PCR 
region. Eight other DMRs had 
significant or trend towards 











s Old Father No differences No differences  
Very Old 
Father 
No differences No differences  
Father >10 
months 











 Kcnqot1 showed trend towards 
significance in average 





 Trend in methylation differences 
in Gnas-Nesp compared to 
offspring of old and young 
males. Kcnqot1 showed 
consistent significant decreased 
in methylation across DMR 
compared to old fathers. 
Consistently significantly lower 
level of methylation in Mcts2 
compared to offspring of young 










No differences Highly significant decrease in 
methylation across DMRs of 





No differences No differences 
Father >10 
months 
No differences Highly significant decrease in 
methylation across whole DMR 
of Gnas-Nesp and Mcts2 
No differences 









5.6.2 Gene Functions 
The three DMRs demonstrating the most consistent differences in DNA methylation 
between groups in multiple tissues were Gnas-Nesp, Kcnq1ot1 and Mcts2. The Gnas-Nesp 
DMR regulates the expression of Nesp55 and covers exon 1A of the Gnas gene. Of note, 
Nesp55 knockout mice show a change of behaviour in novel environments (Plagge, Isles et al. 
2005), which was also observed in behavioural analysis from Chapter 3 in the offspring of 
advanced paternal age mice in the holeboard task (Smith, Kember et al. 2009) (section 3.5.4). 
The Kcnq1ot1 DMR controls the imprinting status of Kcnq1ot1 and Cdkn1c (Engemann, 
Strodicke et al. 2000), regulating bidirectional gene silencing and the spread of DNA 
methylation on the paternally inherited chromosomes. This locus has been associated with 
many types of cancers and also Beckwith-Wiedemann syndrome (Biliya and Bulla 2010). Mcts2 
is a relatively uncharacterised gene, resulting from the duplication of Mcts1, an X-linked gene 
that originated by retrotransposition into the fourth intron of H13.  
 
5.6.3 Epidemiological Implications 
As described, the epidemiological evidence linking advanced paternal age to a number of 
neuropsychiatric conditions, particularly autism, in humans is well-established (Frans, Sandin 
et al. 2008; Hultman, Sandin et al. 2010) (section 1.2.2). In Chapter 3 we reported that in the 
offspring of older fathers, there was reduction in exploratory and social behaviour compared 
to the offspring of young fathers (Smith, Kember et al. 2009). Epigenetic alterations to the 
regulatory regions of several imprinted loci are particularly interesting in this regard, given 
recent links between altered imprinting in disorders including autism (Badcock and Crespi 
2006) and schizophrenia (Mill, Tang et al. 2008; Pun, Zhao et al. 2011). 
 
The paternal age associated differences in DNA methylation could be mediated by several 
mechanisms. First, there is evidence for an increased prevalence of de novo mutations and 
epigenetic drift in the sperm of older males (Walter, Intano et al. 1998; Thomas, Morris et al. 
2010). In humans it is estimated that there are 30 mitotic cell divisions of germ-cells before 
puberty then a further 23 divisions every year. There are also a further four mitotic and two 
meiotic divisions before the sperm are fully mature. In total, this equates to 610 chromosomal 








replications by the age of 40 and 840 replications by age 50 (Crow 2000). It is possible 
therefore that the maintenance of imprinted marks breaks down through successive divisions 
leading to DNA methylation changes which are then passed on to the offspring. As there was a 
decrease in methylation of the three DMRs investigated in sperm as the age of the mice 
increased, this could be a possible explanation although additional work is required to explore 
this hypothesis. Many point mutations occur to convert methylated cytosine to thymine 
(Coulondre, Miller et al. 1978; Bird 1980), which may also alter the levels of DNA methylation 
across CpG-rich regions. 
 
Compared to the fidelity of the DNA sequence which is relatively stable over many mitotic 
divisions, the inheritance of epigenetic marks are much less stable, with stochastic changes in 
DNA methylation shown to accumulate over subsequent cell divisions (Bork, Pfister et al. 
2010). Previous studies have shown that there is increased intra- and inter-epigenetic 
variability in the sperm of older males (Flanagan, Popendikyte et al. 2006), and it is 
hypothesised that such changes could accumulate over the lifetime due to the effects of 
developmental, environmental, and stochastic factors. Since the environments of the fathers 
were consistent between groups in this study, our findings are unlikely to be due to an 
accumulation of environmentally-induced epigenetic changes, although factors such as 
environmental toxins are known to alter the epigenome (Yauk, Polyzos et al. 2008) and may 
be important in an epidemiological context. An example was reported by Anway et al where 
pregnant rats were exposed to fungicides and pesticides. The resulting male offspring 
presented spermatogonial cell deficits and subfertility in the F1 generation and subsequent 
generations. Possible causative methylation changes were mapped to 6q32 and 8q32 (Anway, 
Cupp et al. 2005). This provides strong evidence that epigenetic alterations can be transmitted 
across generation down the male germline. 
 
Emerging evidence exists for age-related epigenetic drift in mammals, with DNA 
methylation being significantly correlated with age at specific loci (Bjornsson, Sigurdsson et al. 
2008; Rakyan, Down et al. 2010; Bocklandt, Lin et al. 2011; Hernandez, Nalls et al. 2011; Koch, 
Suschek et al. 2011). Studies of MZ twins indicate that epigenetic differences between twins 
increase with age (Petronis, Gottesman et al. 2003; Fraga, Ballestar et al. 2005). Furthermore, 
aged mammalian tissue shows lower global methylation compared to younger tissue (Wilson 








and Jones 1983), and several age-related cancers are caused by age-associated changes in 
DNA methylation (Issa, Vertino et al. 1996).  
 
Although age-related epigenetic changes may accumulate in the germline, it has been 
traditionally believed that the epigenome is totally reset and re-established during 
gametogenesis and embryogenesis to ensure cellular totipotency (Reik, Dean et al. 2001) 
(section 1.6.3), preventing the meiotic transmission of such changes to subsequent 
generations. Recent data, however, indicates that transgenerational epigenetic inheritance 
may be possible (Daxinger and Whitelaw 2010; de Boer, Ramos et al. 2010), and because 
several imprinted regions appear to escape germ-line epigenetic reprogramming (Popp, Dean 
et al. 2010), these elements could provide a vehicle for the transmission of the paternal age 
effect, enabling the epigenetic changes accumulating during the longer development of the 
sperm cells in the father to be transferred to the offspring. A recent study has shown that DNA 
methylation in newborn babies is correlated with parental age at over 1000 genes, including 
several known imprinted loci (Adkins, Thomas et al. 2011). As we detect some evidence that 
the global methylation level is also increased with increasing father’s age, albeit only 
detectable in certain tissues, the changes to DNA methylation could be more widespread than 
just imprinted loci, which account for a small proportion of the genome.  
 
5.6.4 Limitations 
There are several limitations to this study. We were unable to examine sperm DNA from 
the fathers of the offspring used in the rest of the study, so we are unable to conclude that 
epigenetic changes observed in the offspring are reflected by changes occurring in their 
fathers’ sperm. Of note, however, we observe DNA methylation differences in two DMRs in 
sperm from age matched male mice from another source, providing some plausibility to the 
theory that the paternal age effect could be mediated by epigenetic inheritance via the male 
germline. These results should, however, be treated with some caution given that we were 
unable to obtain 100% pure populations of sperm cells. Only three ages of fathers were 
analysed; it would be interesting to examine DNA methylation differences in the offspring of 
even older fathers to see if more dramatic changes are observed. Our study only focused on 
specific genomic features (i.e. DMRs associated with several brain-expressed imprinted genes) 
and so we cannot say anything about epigenetic changes in other regions of the genome. Only 








DNA methylation was assessed at these loci, and it is plausible that other epigenetic 
mechanisms (i.e. histone modifications and non-coding RNAs) may also be altered in this 
context. The IAP and LINE-1 element assays were designed to cover many genomic locations 
which share a consensus sequence. However, due to variations in the genomic sequences in 
these elements, the assays do not cover all instances of these features across the genome. As 
these assays provide an estimate of average DNA methylation across the genome, it is 
possible we are missing differences in gene-associated elements. 
 
5.6.5 Conclusions 
In summary, we used a rodent model of advanced paternal age, previously shown to 
exhibit behavioural phenotypes related to deficits observed in human neuropsychiatric 
disease, to identify changes in DNA methylation across DMRs associated with several brain-
expressed imprinted genes in the offspring of older fathers as well as global methylation and 
methylation at transposable elements. Our results provide a potential mechanism for the 
paternal age effect seen in neuropsychiatric disorders such as autism and schizophrenia, and 
suggest that epigenetic alterations to the expression of imprinted loci could be involved in the 
aetiology of these disorders.  








Chapter 6 - Genome Wide Analysis of Gene Expression in a 
Mouse Model of Advanced Paternal Age  









Previous studies of gene expression in autism, schizophrenia and bipolar disorder have 
identified widespread transcriptomic changes associated with these diseases. In autism, for 
example, evidence suggests that genes involved in cell signalling pathways are differentially 
expressed in the brain. Expression changes have also been observed in studies of aging, 
especially in genes associated with inflammatory response and DNA repair. In this chapter, I 
examined frontal cortex gene expression differences between the offspring of young and old 
male mice using Illumina Mouse Ref8 V2 BeadChips, targeting approximately 25,600 RefSeq 
transcripts. Numerous genes with nominally significant differential expression between 
groups were identified, although the overall magnitude of differences observed was small. 
Interestingly, pathway analysis on these differentially expressed genes shows enrichment for 
genes associated with cell signalling (as in autism) and inflammatory response and DNA repair 
(previously associated with aging). 
 
6.2 Introduction 
6.2.1 Gene Expression and Paternal Age 
As discussed in relation to DNA methylation (section 5.2.4), the transcriptional profile of a 
cell is characterised by significant age-related changes. Expression changes associated with 
aging in the brain have been investigated largely in terms of neurodegeneration and 
Alzheimer’s disease (Colangelo, Schurr et al. 2002), although aging in general has been 
associated with widespread transcriptional changes. In a mouse study of aging, for example, 
brain samples from cerebellum and neocortex displayed increased expression of genes related 
to inflammatory and stress response and decreased expression of genes associated with 
growth and trophic factors, protein turnover, DNA synthesis and repair and neurotransmission 
(Lee, Weindruch et al. 2000). Age-associated changes are observed in numerous tissue- and 
cell-types, including the germ-line. Of relevance to my investigations of paternal age, an 
expression study of spermatocytes from rats of different ages identified over 2800 loci that 
are differentially expressed in spermatocytes from older males (18 months) compared to 
spermatocytes from young males (4 months); of note, many genes associated with base 
excision repair, nucleotide excision repair, mismatch repair and double strand break repair 
were altered in spermatocytes from older males (Paul, Nagano et al. 2011). Another study by 
Kokkinaki et al investigated RNA from the spermatogonial stem cells of mice of four different 








ages (6 days, 21 days, 60 days and 8 months old) using microarrays. 2819 genes showed 
differential expression between the age groups (p<0.05, fold change >2) including genes 
previously identified in gene expression studies of aging in stem cells (Kokkinaki, Lee et al. 
2010). Pathway analysis on these genes highlighted an enrichment of genes involved in DNA 
repair and oxidative stress. Given the known increase in DNA damage in the spermatozoa of 
older males (section 1.4.1), this is an interesting finding. To date, however, only one study has 
looked at gene expression changes in association with paternal age (Alter, Kharkar et al. 
2011). In this study of paternal age and autism, a decrease in the overall variance in gene 
expression was observed in the offspring of older fathers, in addition to a down regulation of 
genes involved in gene transcription (Alter, Kharkar et al. 2011).  
 
6.2.2 RNA Expression and Psychiatric Disorders 
Changes in gene expression have been observed in many psychiatric disorders, including 
those associated with advanced paternal age. Cerebellum samples from autism cases showed 
15 up-regulated and 11 down-regulated genes compared to control cerebellum samples 
including members of the glutamate system which were significantly increased in cases 
(Purcell, Jeon et al. 2001). Reelin (RELN) has been shown to be down-regulated in autistic 
patients compared to controls (Fatemi, Snow et al. 2005), an interesting observation given 
that polymorphisms in RELN have been previously associated with autism (Zhang, Liu et al. 
2002). MZ twins discordant for autism severity displayed multiple gene expression differences 
including the serotonin transporter gene (5HTT), tumour necrosis factor (TNF) and other 
cytokine genes (Hu, Frank et al. 2006). Cell-line samples from autism cases and controls 
showed 30 up-regulated and 18 down-regulated genes in cases compared to controls, 
including genes involved in metabolism and the regulation of metabolic pathways, cell growth 
and maintenance and cell proliferation (Baron, Liu et al. 2006). In blood samples from autistic 
children and controls, 55 genes showed differential expression with the top pathway showing 
expression differences between groups being the natural killer cell signalling pathway (Gregg, 
Lit et al. 2008). Expression of Sp1, CD38, ITGB3, MAOA, MECP2, OXTR, and PTEN all showed 
significant elevation in expression and GABRB3, RELN, and HTR2A showed significant 
reductions in expression in a study of brain tissue from autism patients compared to controls 
(Thanseem, Anitha et al. 2011). Finally, in Voineagu et al’s study of post-mortem brain 
samples, 444 genes were shown to be differentially expressed between autism cases and 
controls in cerebral cortex samples. In this data they found common transcriptomic signatures 








across cases after modulating the data into co-expression networks (Voineagu, Wang et al. 
2011)  
 
Numerous transcriptomic studies have been performed in schizophrenia, and multiple 
genes have been found to display altered expression in cases compared to controls. These 
include DTNBP1, which has been shown to be decreased in post-mortem brain samples from 
schizophrenia patients compared to controls (Weickert, Straub et al. 2004). NRG1 expression 
is increased (Hashimoto, Straub et al. 2004) and RGS4 is significantly reduced in schizophrenia 
patients (Mirnics, Middleton et al. 2001). Expression of CHRNA7 was reduced in multiple brain 
regions in schizophrenia patients (Freedman, Hall et al. 1995; Court, Spurden et al. 1999; 
Guan, Zhang et al. 1999; Marutle, Zhang et al. 2001) and Akt1 expression in reduced in blood 
samples from schizophrenia patients (Emamian, Hall et al. 2004). Expression of the 5HT2A 
receptor has been shown to be reduced in schizophrenia patients (Harrison 1999) as well as a 
reduction in expression of glutamate receptors such as GluR1 and GluR2 (Eastwood, 
McDonald et al. 1995; Eastwood, Kerwin et al. 1997).  Expression of TGF1-β1 has been 
observed to be higher and IL-4 lower in schizophrenia patients than controls (Kim, Myint et al. 
2004). Finally, reductions in oligodendrocyte-related and myelin-related genes (Tkachev, 
Mimmack et al. 2003), reduced expression of mitochondria related genes (Altar, Jurata et al. 
2005), and lowered transcription of GABAergic neuron markers (Kuromitsu, Yokoi et al. 2001; 
Pongrac, Middleton et al. 2002) have all also been observed in post mortem brain samples of 
schizophrenia patients compared to controls. 
 
BD has also been associated with altered transcription at multiple loci. Up regulation of 
5HTT and NFkB2 (Sun, Zhang et al. 2001) and NFkB (Spiliotaki, Salpeas et al. 2006) were 
observed in BD patients. In genome-wide studies several genes demonstrate altered 
expression in bipolar patients compared to controls (Bezchlibnyk, Wang et al. 2001; Iwamoto, 
Kakiuchi et al. 2004; Jurata, Bukhman et al. 2004) including down regulation of 
neurotransmitter related genes (Iwamoto, Kakiuchi et al. 2004), increased expression of stress 
response genes (Iwamoto, Kakiuchi et al. 2004; Jurata, Bukhman et al. 2004), increased 
expression of chaperones (Jurata, Bukhman et al. 2004), decreased expression of 
mitochondrial related genes (Konradi, Eaton et al. 2004; Sun, Wang et al. 2006; Vawter, 
Tomita et al. 2006) and changes to expression in GABAergic genes (Choudary, Molnar et al. 








2005) and glutamate receptor genes (Iwamoto, Kakiuchi et al. 2004; Nakatani, Hattori et al. 
2006).  
 
Many overlapping genes and gene pathways have been identified in schizophrenia and 
BD. TGF1-β1 displays altered expression in both disorders (Bezchlibnyk, Wang et al. 2001; Kim, 
Myint et al. 2004) although it is reduced in BD patients and increased in schizophrenia 
patients. Down regulation of oligodendrocyte related genes have been observed in genome 
wide studies on post mortem brain samples from both schizophrenia and BD patients 
(Tkachev, Mimmack et al. 2003). Finally, down regulation of mitochondrial genes has been 
observed in studies of both BD (Konradi, Eaton et al. 2004) and schizophrenia (Altar, Jurata et 
al. 2005).  
 
6.2.3 Relationship between DNA Methylation and Gene 
Expression 
As discussed in Chapter 1, DNA methylation at gene promoters is often inversely 
correlated with the level of gene expression (Jaenisch and Bird 2003). Highly methylated 
promoter regions bind methyl-CpG-binding domain proteins (MBDs), which can act as 
adaptors between methylated DNA and histone-modifying enzymes and chromatin 
remodelling proteins. MECPs recruit histone-modifying enzymes to regions of methylated 
DNA (Hendrich and Tweedie 2003). The resulting closed and compacted chromatin structure 
(heterochromatin) blocks the binding of transcription factors and thus represses gene 
transcription (Jenuwein and Allis 2001). Conversely, low DNA methylation at gene promoters 
leads to an open chromatin structure (heterochromatin) that is not associated with the 
recruitment of histone-modifying enzymes. DNA methylation levels are often variable by 
tissue allowing for tissue specific transcriptomic patterns to be established during 
development. Recent data, including from our group (Davies, Volta et al. Under Review), 
suggests that non-promoter CpG islands may be even more important for establishing tissue-
specific gene expression than promoter CpG islands, especially those located intergenically 
(located in areas of no genes) or intragenically (located within the gene-body). As discussed in 
section 1.6.2, allele-specific DNA methylation at key DMRs and ICRs plays a crucial role in 
establishing the monoallelic expression patterns associated with imprinted genes. DNA 








methylation is dynamically regulated and variable by developmental stage and age, allowing 
coordinated transcription of genes required during different developmental stages (Paulsen 
and Ferguson-Smith 2001). Given my findings related to epigenetic changes in the context of 
advanced paternal age in Chapter 5, it is plausible that wider alterations to the transcriptome 
may be detected in the offspring of older fathers. 
 
6.3 Aims 
The aim of this chapter is to identify genes and transcriptomic pathways that are 
differentially expressed in mouse between the offspring of young fathers and offspring of old 
fathers using genome-wide gene expression microarrays on RNA extracted from a region of 
the brain (frontal cortex) previously implicated in the neuropsychiatric disorders 
epidemiologically-associated with advanced paternal age in humans.  
 
6.4 Methods 
6.4.1 RNA Extraction and Sample Selection 
RNA was extracted from frontal cortex samples from the offspring of young fathers and 
offspring of old fathers. The frontal cortex was chosen for expression analysis due to its role 
language and social and emotional functions (Stuss and Knight 2002). Frontal cortex has been 
shown to develop abnormally in children with autism (Kemper and Bauman 1998; Carper, 
Moses et al. 2002), and alterations to expression and protein levels observed in frontal cortex 
from schizophrenia and BD patients (Johnston-Wilson, Sims et al. 2000). 36 samples were 
selected (16 offspring of old fathers, 16 offspring of young fathers) to represent all families 
from the offspring of young fathers (two months old) and old fathers (ten months old). RNA 
from frontal cortex was extracted using Qiagen AllPrep RNA/DNA as described in detail in 
section 2.2.2. Stringent quality control was carried out on the RNA so that all samples had a 
260/280 ratio of ≥ 1.9 and a clear 23S and 16S fragment on a 1.5% agarose gel with minimal 
degradation (Figure 2.2). RNA integrity was further assessed by running samples on the 
Agilent Bioanalyzer 2100 using the RNA 6000 Pico Assay (Figure 6.1). The RNA integrity 
number (RIN) is a value provided by the Agilent Bioanalyser software to estimate the integrity 
of total RNA samples. This assesses the entire electrophoretic trace of the RNA sample 








including the presence or absence of degradation products. A RIN number of 10 indicates a 
hypothetically 'perfect' RNA sample; a RIN number of 5 indicates partially degraded RNA and a 
RIN of 1 totally degraded RNA. All samples used in this experiment reached a RIN number of 
greater than 7 except one sample (PA31) which had a RIN number of 6.1. This sample was still 
included in the Illumina array experiment, but was flagged for caution in the subsequent 
analyses. 
 
Figure 6.1 – Example Electropherograms from Bioanalyzer Agilent RNA Pico Labchip  
Sample PA02, RIN Score 8.4. Intact total RNA is represented by two strong ribosomal peaks 
representing 28S and 18S species.  
 
 
6.4.2 IlluminaTotalPrep-96 RNA Amplification Kit 
The IlluminaTotalPrep-96 RNA amplification kit was used to generate biotinylated 
amplified RNA for hybridization with Illumina arrays. 300ng of quantified RNA was used for 
each sample and the protocol carried out as in the manufacturer’s instructions (Figure 6.2). 
 
 








Figure 6.2 - Illumina® TotalPrep™-96 RNA Amplification Procedure Overview 
a) Reverse Transcription to Synthesize First Strand cDNA 
b) Second Strand cDNA Synthesis 
c) cDNA Purification 
d) In Vitro Transcription to Synthesize Biotin-labelled cRNA 
e) cRNA Purification 
 
 
6.4.3 Whole-Genome Gene Expression Direct Hybridization 
RNA samples were analysed using Illumina Mouse Ref8 V2 BeadChips. The Illumina Mouse 
Ref8 V2 array targets approximately 25,600 RefSeq transcripts and over 19,100 unique genes 
derived from the NCBI database (build 36/mm8) supplemented with probes derived from the 



























Mouse Exonic Evidence Based Oligonucliotide (MEEBO) set as well as exemplar protein-coding 
sequences described in the RIKEN FANTOM2 database. Eight samples were run in parallel on 
each chip and samples randomised and distributed across the arrays to ensure a balance of 
samples from both groups. Whole-Genome Gene Expression Direct Hybridization Assay was 
carried out as in manufacturer’s instructions (Figure 6.3), and BeadChips were scanned using 
the Illumina iScan System. 
 
Figure 6.3 – Direct Hybridization Assay 
A 50 bases gene-specific probe linked to a short address. The probe is hybridized to 
labelled cDNA derived from total RNA  
 
 
6.4.4 Data Analysis 
6.4.4.1 LUMI 
Data was normalized and initially analysed using the “lumi” R package (Du, Kibbe et al. 
2007; Du, Kibbe et al. 2008; Lin, Du et al. 2008) (R scripts used for the lumi package are shown 
in Appendix 3). Briefly, lumi first log2 transforms all intensity data then implements an 
optimised normalization procedure. Pre-normalized expression values and data description 
are shown in Figure 6.4 and Table 6.1. As expected, the mean signal intensity, standard 
deviation and the detection rates were somewhat variable across samples, but there were no 
obvious extreme outliers indicative of poor data quality. The sample with the slightly lower 
RIN score (PA31), showed no obvious abnormalities in terms of raw data distribution 








Figure 6.4 - Prenormalization Plots of Array Intensities 
a) Density Plot of Intensities 
b) Cumulative Distribution Function 
c) Boxplot of Microarray Intensities 
 
 

































Table 6.1 - Prenormalization Values of Illumina Microarray Data 
 Sample PA01 PA02 PA04 PA05 PA07 PA08 PA10 PA11 PA13 PA14 PA16 
mean 6.696 6.717 6.573 6.57 6.555 6.532 6.549 6.619 6.678 6.651 6.668 
standard deviation 1.047 1.1 1.035 1.049 0.9928 0.9911 1.006 1.068 1.147 1.102 1.125 
distance to sample mean 27.41 26.1 43.45 43.37 49.1 51.36 49.13 34.05 23.63 27.66 24.95 
            
Sample PA17 PA19 PA22 PA25 PA26 PA28 PA29 PA30 PA31 PA32 PA34 
mean 6.678 6.803 6.832 6.741 6.78 7.158 7.141 7.075 6.945 6.946 6.805 
standard deviation 1.143 1.198 1.209 1.189 1.238 1.109 1.175 1.214 1.119 1.2 1.121 
distance to sample mean 24.1 21.67 27.42 24.84 26.24 62.13 60.04 51.58 29.65 33.15 18.06 
            
Sample PA35 PA37 PA38 PA42 PA43 PA46 PA48 PA49 PA51 PA52  
mean 6.926 6.938 6.929 6.804 6.818 6.822 6.86 6.735 6.825 6.801  
standard deviation 1.196 1.218 1.222 1.132 1.185 1.133 1.171 1.093 1.168 1.171  
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To normalise across arrays, variance stabilizing transformation was performed; this is a 
standard data transformation which stabilizes the variance within each microarray (Lin, Du et 
al. 2008). The next step of normalization employed robust spleen normalization (RSN), which 
is unique to the lumi package and combines features of quantile normalization and loess 
normalization. This combination allows the preservation of small differences between groups 
and ensures the rank order of genes remains unchanged across samples. RSN calibrates each 
array to one reference array (in this case PA01). First the data is quantile normalised then the 
fold change of a gene is measured based on the quantile normalised data.  Postnormalization 
array data is shown in Figure 6.5 and Table 6.2. As expected, after normalization the means, 
standard deviations and detection rates were much more uniform across the samples. Results 
from the lumi analysis are described in section 6.5.1.1.  
 








Figure 6.5 - Postnormalization Plots of Array Intensities 
a) Density Plot of Intensities 
b) Cumulative Distribution Function 
c) Boxplot of Microarray Intensities 
 



































Table 6.2 - Postnormalization Values of Illumina Microarray Data 
Sample PA01 PA02 PA04 PA05 PA07 PA08 PA10 PA11 PA13 PA14 PA16 
mean 7.05 7.05 7.049 7.049 7.05 7.048 7.05 7.049 7.05 7.048 7.049 
standard deviation 1.024 1.024 1.024 1.024 1.024 1.025 1.024 1.025 1.024 1.025 1.024 
distance to sample mean 16.07 20.69 18.55 19.99 18.21 18.08 19.46 15.69 13.27 14.2 13.64 
            
Sample PA17 PA19 PA22 PA25 PA26 PA28 PA29 PA30 PA31 PA32 PA34 
mean 7.049 7.05 7.049 7.05 7.049 7.05 7.05 7.05 7.049 7.05 7.05 
standard deviation 1.025 1.023 1.025 1.024 1.025 1.024 1.024 1.024 1.024 1.024 1.023 
distance to sample mean 14.24 14.77 18.33 18.13 13.65 14.86 14.44 13.17 13.27 13.84 15.52 
            
Sample PA35 PA37 PA38 PA42 PA43 PA46 PA48 PA49 PA51 PA52  
mean 7.049 7.049 7.049 7.05 7.049 7.05 7.049 7.049 7.049 7.049  
standard deviation 1.024 1.024 1.024 1.024 1.024 1.024 1.025 1.024 1.025 1.025  
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6.4.4.2 Correcting for Array Batch Effects using ComBat 
After normalization, principal components analysis (PCA) indicated that the data was 
potentially characterized by a strong batch effect (Figure 6.6), as widely reported for Illumina 
gene expression arrays. As my hybridization experiment was designed to ensure that samples 
were randomly assigned to arrays and balanced for the number of samples from each group 
on each array, it is unlikely that this batch affect will mask any true expression differences (or 
create false positives) between groups. However, batch affects were adjusted for using the R 
ComBat package. This package uses parametric and nonparametric empirical Bayes 
frameworks for adjusting data for batch effects (Johnson, Li et al. 2007). After ComBat 
correction had been applied, the lumi package analysis was rerun (section 6.5.1.2).  
 
Figure 6.6 – Results of Principal Components Analysis 
Plot of 2nd against 3rd principal component coloured by array the sample was run on. 
Samples show a strong batch effect as indicated by clustering of samples. 
 
6.4.4.3 Weighted Gene Co-Expression Network Analysis  
Weighted Gene Co-Expression Network Analysis (WGCNA) (in R) looks for relationships 
between measured transcripts that are detected by pair-wise correlations between genes 

























(Langfelder and Horvath 2008) (R scripts for WGCNA is shown in Appendix 3). WGCNA has 
been previously employed to identify clusters (or modules) of highly co-expressed genes from 
large transcriptomic datasets. WGCNA starts from the level of thousands of genes, identifies 
phenotypically interesting gene modules, and uses intramodular connectivity to identify key 
genes in functional pathways for further validation.  
 
WGCNA was used to construct sample dendrogram and trait heat-maps across the 
expression dataset, identify co-expression networks and detect modules of co-expressed 
genes. Constructing a weighted gene network entails the choice of the soft thresholding 
power to which co-expression similarity is raised to calculate adjacency. The soft-thresholding 
power was selected by plotting the scale-free fit index as a function of the soft-thresholding 
power. The power 6 was chosen to construct the network which is the lowest power for which 
the scale-free topology t index reaches 0.90. The gene network and identifying modules were 
then run using a minimum module size of 100 genes. After the networks were constructed, 
the data was split by WGCNA into 22 different modules. 
 
 
Figure 6.7 - Analysis of Network Topology for Various Soft-Thresholding Powers  
The left panel shows the scale-free fit index (y-axis) as a function of the soft-thresholding 
power (x-axis). The right panel displays the mean connectivity (degree, y-axis) as a function of 
the soft-thresholding power (x-axis).  
 








6.4.4.4 One Sample Student’s T-test 
We next compared the expression of genes encompassed by CNVS (from Chapter 4). As 
most of the CNVs identified in our analyses are rare events, generally private to specific 
individual animals, a standard t-test is not appropriate to assess the effect of a CNV on 
expression of the genes they span. In this case, a one sample t-test was used within the R 
statistical environment to compare locus-specific gene expression in CNV carriers (designated 




6.5.1.1 Pre-Batch Correction 
Probes for 18,097 genes were detected at a high enough level to be considered expressed 
by lumi and so were used for further analysis. Comparing frontal cortex gene expression in the 
offspring of old versus young fathers, 371 genes reached an uncorrected p-value of less than 
0.05. Genes with a p-value <0.001 are shown in Table 6.3 and the top ten most significantly 
differentially expressed genes are shown graphically in Figure 6.8. The false discovery rate 
(FDR) was used to correct for multiple comparisons and generate q-values. The FDR approach 
is optimised by using characteristics of the p-value distribution to produce a list of q-values. 
No genes in this initial analysis on non batch-corrected data had an FDR below 0.1. 
 
  








Table 6.3 - Top Differentially Expressed Genes from lumi Package Pre-Batch Correction 









MUC15 6.54 6.59 6.49 4.39 1.0E-04 
CCDC90B 7.35 7.27 7.43 -4.25 1.6E-04 
E130303B06RIK 6.73 6.78 6.68 4.02 3.0E-04 
OLFR187 6.63 6.68 6.58 4.02 3.1E-04 
ZFP35 7.10 7.16 7.04 3.96 3.7E-04 
ATP5SL 7.92 8.02 7.82 3.89 4.5E-04 
TSPAN3 9.79 9.69 9.88 -3.86 4.8E-04 
OLFR92 6.58 6.54 6.61 -3.85 0.001 
OLFR1366 6.52 6.57 6.48 3.76 0.001 
E030049G20RIK 6.61 6.64 6.57 3.57 0.001 
PSG25 6.64 6.67 6.60 3.56 0.001 
LARP4 6.55 6.58 6.52 3.46 0.001 
IER5L 7.77 7.84 7.69 3.46 0.001 
  
  








Figure 6.8 – Boxplot of Top 10 Differentially Expressed Genes Pre-Batch Correction  
Top 10 differentially expressed genes from lumi analysis. All genes show strip charts of 
offspring of young fathers and offspring of old fathers as well as box plot of expression level by 
family. Black line in box plots shows median value, edges of boxes show upper and lower 
quartiles and whiskers show the upper and lower extreme values. 
 



























6.5.1.2 Post-Batch Correction 
Interestingly, after array batch-effects had been corrected for, 876 genes (notably higher 
than in the analysis of pre-batch corrected samples) reached an uncorrected p-value of less 
than 0.05. The genes demonstrating a p-value below 0.001 from analysis between the 
offspring of young fathers and offspring of old fathers are shown in Table 6.4 and the top ten 
differentially expressed genes shown in Figure 6.9. MUC15 was the top-ranked gene (p = 7.2E-
06, q = 0.13). Of note, the rank order of genes was not largely affected by batch correction.  
 
Table 6.4 - Differentially Expressed Genes from lumi Package - Post-Batch Correction 
Genes which showed an uncorrected p-value of ≤ 0.001. The rank position from the pre-












MUC15 1 6.54 6.58 6.49 5.28 7.2E-06 
ZFP35 5 7.10 7.16 7.04 4.46 8.4E-05 
CCDC90B 2 7.35 7.28 7.42 -4.24 1.6E-04 
OLFR187 4 6.63 6.67 6.59 4.10 2.4E-04 
OLFR92 8 6.58 6.54 6.61 -4.06 2.7E-04 
E130303B06RIK 3 6.73 6.77 6.68 4.05 2.8E-04 
ZC3H18 56 7.22 7.17 7.26 -3.92 4.0E-04 
ATP5SL 6 7.92 8.00 7.84 3.91 4.1E-04 
TNFSF11 14 6.61 6.57 6.65 -3.77 6.1E-04 
TSPAN3 7 9.78 9.71 9.86 -3.76 6.3E-04 
EAR12 17 6.56 6.60 6.53 3.71 7.2E-04 
LOC100046861 20 6.63 6.66 6.59 3.70 7.5E-04 
RP9 30 8.48 8.53 8.43 3.69 7.6E-04 
VTCN1 21 6.62 6.66 6.59 3.66 8.4E-04 
OLFR1366 9 6.52 6.57 6.48 3.64 8.8E-04 
FTL2 19 6.59 6.56 6.61 -3.63 9.2E-04 
NSFL1C 31 7.85 7.93 7.78 3.61 9.6E-04 
LARP4 12 6.55 6.58 6.53 3.58 0.001 
CCL26 34 6.53 6.57 6.49 3.55 0.001 
IER5L 13 7.77 7.84 7.70 3.55 0.001 
C330005M16RIK 25 6.66 6.70 6.62 3.50 0.001 
CD177 15 6.57 6.59 6.54 3.50 0.001 
XKR8 54 6.98 6.94 7.03 -3.47 0.001 








Figure 6.9 - Boxplot of Top 10 Differentially Expressed Genes Post-Batch Correction 
Top 10 differentially expressed genes from lumi analysis after array batch correction. All genes 
show strip charts of offspring of young fathers and offspring of old fathers as well as box plot 
of expression level by family. Black line in box plots shows median value, edges of boxes show 
upper and lower quartiles and whiskers show the upper and lower extreme values. 
 




























Overall, frontal cortex gene expression profiles were highly correlated (r2 = 0.9997, p < 
2.2E-16) between groups (Figure 6.10), suggesting that there are no systemic biological (or 
technical) differences between them as expected, and that differential expression is restricted 
to specific loci. 
 
Figure 6.10 – Log2 Intensities of Offspring of Young Fathers by Offspring of Old Fathers 
Average log2 intensity values of offspring of old fathers against offspring of young fathers. 
These genes were analysed with Ingenuity Pathway Analysis (section 6.5.5). 
 
Log2 transformed fold-changes were transformed back into actual fold change and 
ranked. No genes reached a fold change of 1.5, which is the cut off for many disease-based 
gene expression studies, suggesting that the differences in gene expression between the 
offspring of young and old fathers are subtle. Genes reaching a fold change of over 1.1 are 
shown in Table 6.5 along with their p-values. The largest fold change between the offspring of 
old and young fathers was S100A8 which had an 18% reduction in expression in the offspring 








of old fathers compared to the offspring of young fathers. However, this gene did not have an 
uncorrected p-value of less than 0.05 so was not included in pathway analysis. The highest 
fold change which also had an uncorrected p-value of less than 0.05 was YWHAG with a 
reduction in expression of 14% in the offspring of old fathers.  
 
Table 6.5 - Genes with a Fold Change over 1.1 
Fold changes were calculated from log2 fold changes by calculating 2^x where x was the 
log2 fold change. P-values were calculated using lumi. 
All Genes with Fold Change ≥ 1.1  
All Genes with Fold Change ≥ 1.1 and p 
<0.05 
Gene p-value Fold Change  Gene p-value Fold Change 
S100A8 0.25 -1.18  YWHAG 0.04 -1.14 
TMEM10 0.07 -1.14  RNF166 0.01 -1.12 
YWHAG 0.04 -1.14  ATP5SL 4.08E-04 -1.12 
RGS9 0.06 -1.12  NSFL1C 9.61E-04 -1.11 
RNF166 0.01 -1.12  TSPAN3 6.29E-04 1.11 
ATP5SL 4.08E-04 -1.12  DNAJC15 0.05 1.11 
BCAS1 0.12 1.11  IER5L 1.14E-03 -1.10 
NSFL1C 9.61E-04 -1.11  CCDC90B 1.56E-04 1.10 
TSPAN3 6.29E-04 1.11     
LYPD1 0.07 -1.11     
DNAJC15 0.05 1.11     
IER5L 1.14E-03 -1.10     
GNG10 0.07 1.10     
CCDC90B 1.56E-04 1.10     
 
6.5.2 Family Based Analysis 
From plotting the top differentially expressed genes by p-value (Figure 6.9), the 
expression differences seen in the offspring of old vs. young families appear to be variable by 
family, suggesting that family-specific changes may be seen in the context of advanced 
paternal age. Due to this, the offspring of old fathers were split by family and compared to the 
offspring of young fathers. Although several genes met the threshold set in section 6.5.1.2, 
different families had differentially expressed genes. Results of this analysis are shown in 
Table 6.6. 
 








Table 6.6 – Differentially Expressed Genes by Family in Offspring of Old Fathers 
Differentially expressed genes in offspring of old father families compared to offspring of 
young fathers with p-value below 0.001 and fold change over 1.1. Rank indicates rank by p-
value in post-batch corrected analysis.  
Family 1  Family 2 
Rank Gene Fold Change p-value  Rank Gene Fold Change p-value 
20 IER5L 1.21 8.97E-05  4199 GEM 1.12 8.22E-05 
3328 TMEM183A 1.13 9.42E-05  36 QPCTL 1.10 1.54E-04 
5004 PAFAH1B3 1.14 1.06E-04  8595 RAB34 1.10 6.54E-04 
1216 SEC15L1 1.13 2.00E-04  1747 RAB11FIP5 1.11 7.28E-04 
7309 PIK3R2 1.10 2.26E-04  1509 HRASLS 1.18 7.44E-04 
606 GSK3A 1.10 2.95E-04  2157 ZFP825 1.10 7.80E-04 
11982 ACTR1B 1.14 3.44E-04  13 RP9 1.13 9.50E-04 
6046 LOC666676 1.23 3.77E-04  927 4921530G04RIK 1.12 0.001 
100 NFU1 1.13 4.24E-04  3692 THEM4 1.14 0.001 
7 ZC3H18 1.13 6.07E-04      
436 OGFOD2 1.10 6.11E-04  Family 4 
99 LOC100046163 1.11 7.62E-04  Rank Gene Fold Change p-value 
8 ATP5SL 1.17 8.73E-04  1027 TALDO1 1.13 1.66E-04 
242 EIF3G 1.19 0.001  107 RSPO4 1.12 3.72E-04 
1404 RAD23B 1.33 0.001  8518 HMG20B 1.11 7.77E-04 
2576 SLITRK2 1.11 0.001  6820 WIF1 1.10 8.93E-04 
2141 COQ7 1.14 0.001  170 MTIF2 1.11 0.001 
435 STT3B 1.18 0.001  109 SLC16A11 1.12 0.001 
707 HERPUD1 1.17 0.001      
     Family 5 
Family 3  Rank Gene Fold Change p-value 
Rank Gene Fold Change p-value  61 UGT1A10 1.14 2.79E-05 
28 PSCD4 1.16 3.67E-05  131 EPHA5 1.13 1.57E-04 
3241 KIF11 1.14 9.80E-05  8557 PDRG1 1.18 1.75E-04 
1416 PDE7B 1.15 2.06E-04  11778 ANP32A 1.11 3.94E-04 
15346 ZFP759 1.11 2.69E-04  15669 UTP6 1.10 8.48E-04 
6053 EG435391 1.12 2.84E-04  5775 FRMPD4 1.12 9.38E-04 
174 TM4SF5 1.14 3.43E-04  11982 ACTR1B 1.13 9.56E-04 
144 AMELX 1.14 3.46E-04  2481 CCDC109A 1.11 0.001 
1698 2010110P09RIK 1.12 3.66E-04  16961 VTI1B 1.13 0.001 
1750 TAC4 1.11 4.20E-04  15019 PPP1R16A 1.14 0.001 
2432 ASCL1 1.14 4.81E-04  2267 TPD52L1 1.10 0.001 
7962 PAPLN 1.11 5.01E-04      
2438 1700019L03RIK 1.11 5.40E-04  Family 6 
1503 SLC27A2 1.15 6.59E-04  Rank Gene Fold Change p-value 








1685 DUS1L 1.12 6.83E-04  469 OLFR412 1.15 2.90E-05 
13416 OLFR1298 1.10 6.99E-04  1698 2010110P09RIK 1.12 1.35E-04 
2231 LYZL4 1.14 7.82E-04  5969 ETV6 1.11 2.29E-04 
1754 PUNC 1.13 9.42E-04  4087 GAN 1.15 0.001 
259 ZFP459 1.10 0.001  17927 V1RF3 1.10 0.001 
129 RASGRF2 1.15 0.001      
1623 HAND2 1.10 0.001      
2610 4430402I18RIK 1.10 0.001      
10496 LY6G6C 1.10 0.001      
258 FCHSD2 1.12 0.001      
 
6.5.3 Relating Expression and Methylation 
Given the link between DNA methylation and gene expression where methylation is 
negatively correlated with expression throughout the genome (Bell, Pai et al. 2011) (section 
1.6), I was able to look specifically at the expression for the imprinted genes regulated by the 
DMRs assessed in Chapter 5. There were no differences between the offspring of young 
fathers and offspring of old fathers in Mcts2 DMRs in the frontal cortex (Figure 5.23), and 
when we look at the expression levels in this gene we see no significant differences between 
groups (t = -0.84, d.f. = 30, p = 0.41). Kcnq1ot showed trends towards significant DNA 
methylation differences between the offspring of young and old fathers in the frontal cortex 
and although it is non-coding it also controls expression of CDKN1C, however expression of 
CDKN1C was not different between groups (t = -0.22, d.f. = 30, p = 0.83). Gnas Nesp controls 
expression of Nesp55, but this was not covered on the Illumina Mouse Ref8 V2 BeadChips. 
 









6.5.4.1 Sample Relationships 
Sample relationships based on expression values are shown in Figure 6.11 and are 
coloured according to group (offspring of young or old father) and family membership. 
Overall, the clustering of samples does not clearly distinguish between groups of offspring as a 
function of paternal age, concurring with the lumi results presented above and confirming 
that systemic transcriptomic differences are unlikely to distinguish between groups. There are, 
however, several clusters of samples grouped by high and low paternal age. Samples did not 
appear to cluster by family. 
 
Figure 6.11 - Clustering Dendrogram of Samples  
Clustering is based on their euclidean distance and was carried out using Ward’s method 
which infers that the distance between two clusters is how much the sum of squares will 
increase when we merge them. The heat map at the bottom identifies which samples belong 
to certain groups i.e. offspring of old or young father and family. 
 
 








6.5.4.2 Identifying Modules 
WGCNA demonstrated that frontal cortex gene expression patterns were clearly modular, 
as shown previously in other gene expression datasets (Voineagu, Wang et al. 2011). Genes 
were assigned into 22 co-expression modules, with 8523 loci remaining unassigned to a 
module (Table 6.7 and Figure 6.12). Module sizes ranged from 118 to 1146 genes. 
 
Table 6.7 – Results of Network Construction in WGCNA 
Table showing the number of genes per module based on WGCNA analysis. Genes were 
split into 22 modules with 8523 remaining unassigned to a module (module 0) 
Module 
Number 
0 1 2 3 4 5 
Number of 
Members 
8523 1146 1094 1013 972 745 
Colour grey turquoise blue brown yellow green 
       
Module 
Number 
6 7 8 9 10 11 
Number of 
Members 
586 566 501 275 270 257 
Colour red black pink magenta purple greenyellow 
       
Module 
Number 
12 13 14 15 16 17 
Number of 
Members 
256 242 230 202 200 199 
Colour tan salmon cyan midnightblue lightcyan grey60 
       
Module 
Number 
18 19 20 21 22  
Number of 
Members 
197 191 159 155 118  
Colour lightgreen lightyellow royalblue darkred darkgreen  
 
 









Figure 6.12 - Clustering Dendrogram of Genes  
Dissimilarity based on topological overlap, together with assigned module colours. Data is 
divided into 22 modules (indicated by different colour) with 8523 remaining unassigned to a 










6.5.4.3 Relating Modules 
Using WGCNA analysis and looking at module trait relationships (Figure 6.13), modules 
that have significant correlations with traits of the data can be identified. After tabling the 
correlations and respective p-values to paternal age group and family traits, however, no 
module reaches a significant correlation with either. This suggests that if paternal age is 








having an effect on gene expression in the frontal cortex, then this appears to be specific to 
certain loci and not altering transcription across entire transcriptional modules of co-
expressed genes. 
 
Figure 6.13 – Module Trait Relationships 
Each row corresponds to a module eigengene, column to a trait. Each cell contains the 
corresponding correlation and p-value in brackets. The table is colour-coded by correlation of 
the module to a trait according to the colour legend on the green with red being a positive 
correlation and red being a negative correlation. 
 








6.5.5 Pathway Analysis 
Pathway analysis was carried out using Ingenuity Pathway Analysis (IPA), a powerful 
package that identifies relationships, mechanisms, functions, and pathways in experimental 
data. Pathway analysis using IPA was carried out on genes which reached an uncorrected p-
value less than 0.05 from post batch corrected lumi analysis. The number of genes which were 
below this value was 876, of which 605 were successfully mapped to annotated loci within the 
Ingenuity Knowledge database. 25 pathways were identified from the genes put into pathway 
analyses (Table 6.8 and Figure 6.14) and the top five pathways are shown in Figure 6.15. In a 
previous studies of gene expression and aging, an up-regulation of inflammatory response 
genes was observed (Lee, Weindruch et al. 2000), and we also observe differential expression 
of a gene network related to inflammatory response. Genes involved in the immune system 
appear to be over represented in those which show an expression change with increased 
paternal age with 45 different genes involved in inflammatory response. Other pathways 
highlighted by IPA are DNA replication, recombination and repair, of which gene expression 
changes in genes associated with DNA repair has been previously associated with aging in 


















Cellular Assembly and Organization, Cellular Function and Maintenance, 
Organismal Injury and Abnormalities 
38 26 Cell Death, Cell Morphology, Cellular Function and Maintenance 
34 24 Inflammatory Response, Cellular Movement, Immunological Disease 
30 23 Gene Expression, Cell Cycle, Decreased Levels of Albumin 
30 22 Post-Translational Modification, Cellular Development, Hematopoiesis 
29 22 Gene Expression, Protein Synthesis, Carbohydrate Metabolism 
27 21 Cell Signalling, Molecular Transport, Nucleic Acid Metabolism 
24 20 Cellular Movement, Cell Signalling, Molecular Transport 
22 16 
Cellular Assembly and Organization, Cell-To-Cell Signalling and Interaction, 
Cellular Function and Maintenance 
22 18 
Cell-To-Cell Signalling and Interaction, Cellular Movement, Immune Cell 
Trafficking 
21 17 
Cell Cycle, DNA Replication, Recombination, and Repair, Cellular Assembly 
and Organization 
20 19 
DNA Replication, Recombination, and Repair, Cell-To-Cell Signalling and 
Interaction, Nervous System Development and Function 
20 17 
Cellular Development, Hematopoiesis, Cell-To-Cell Signalling and 
Interaction 
20 17 
Cell Death, Haematological System Development and Function, Cellular 
Development 
19 16 Cell Signalling, Small Molecule Biochemistry, Immunological Disease 
17 15 Cell Death, Lipid Metabolism, Small Molecule Biochemistry 
16 14 
Connective Tissue Development and Function, Skeletal and Muscular 
System Development and Function, Tissue Morphology 
16 14 
Cell Cycle, Cellular Development, Connective Tissue Development and 
Function 
16 14 
Nervous System Development and Function, Carbohydrate Metabolism, 
Lipid Metabolism 
15 14 
Cellular Development, Haematological System Development and Function, 
Hematopoiesis 
15 14 
Cellular Development, Connective Tissue Development and Function, 
Skeletal and Muscular System Development and Function 
15 14 Inflammatory Response, Cell Morphology, Cellular Movement 
15 14 
Cancer, Gastrointestinal Disease, Lymphoid Tissue Structure and 
Development 
14 13 Post-Translational Modification, Protein Degradation, Protein Synthesis 
14 13 












Figure 6.14 – Networks of Most Differentially Expressed Genes  
IPA analysis of most differentially expressed genes with fold change over 1.1 
  
1. Cellular Assembly and Organization, Cellular Function 
and Maintenance Organismal Injury and Abnormalities 
 
2. Cell Death, Cell Morphology, Cellular Function and 
Maintenance 
 
3. Inflammatory Response, Cellular Movement, 
Immunological Disease 
 
4. Gene Expression, Cell Cycle, Decreased Levels of 
Albumen 
 




Figure 6.15 – Top Five Networks from IPA 
Green indicates genes which were 
significantly down-regulated in the offspring 
of old males in this study and red indicated 
genes which were significantly up-regulated in 
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6.5.6 Relating CNVs to Expression 
As CNVs have been shown to affect expression of the genes they encompass (Stranger, 
Forrest et al. 2007) (section 4.2.1), expression levels of the genes affected by CNVs identified 
in Chapter 4 were investigated. To test the hypothesis that CNVs may directly influence levels 
of gene expression, the initial analysis focused on CNVs observed that had been previously 
been reported in other mouse studies as these are more likely to be truly positive CNVs. One 
CNV from Watkins-Chow et al’s study (Watkins-Chow and Pavan 2008), was seen in six 
offspring, for whom we also had frontal cortex gene expression data (section 4.5.1). All other 
‘common’ CNVs (i.e. those reported in other studies (see Figure 4.21, Figure 4.22 and Figure 
4.23) were either i) detected in animals for whom gene expression data was not collected, ii) 
affected genes not contained on the Illumina Mouse Ref8 V2 BeadChips, or iii) were found to 
be not expressed in the frontal cortex. This duplication contains the gene Ide, which is covered 
by the Illumina Mouse Ref8 V2 BeadChips and expressed at detectable levels in the frontal 
cortex tissue examined. When comparing the log2 values for Ide between CNV carriers (n=6) 
and non-carriers (n=26), a significant difference (t = 4.75, d.f. = 31, p = 0.002) was seen, with 
duplication carriers having higher expression, with a fold change of 1.26 (Figure 6.16). 
 
        
Figure 6.16 – Expression of Ide by CNV Status 
Log2 expression between carriers and non-carriers of a CNV spanning Ide on chromosome 
















Next, genes affected by other CNVs detected in our array-CGH experiments were 
investigated which were present in 1-3 offspring individuals. The total number of genes 
affected by CNVs for which gene expression data was available was 179 across all offspring 
(section 4.4.8). Although CNVs have been shown to affect the expression of genes up to 
0.5Mb away, genes in the direct vicinity of a genomic alteration are likely to show a greater 
gene expression change (Henrichsen, Vinckenbosch et al. 2009) and because of this, the 
analysis was restricted only to genes directly encompassed by the CNV.  Strikingly, 133 genes 
out of 179 genes (74%) showed a significant gene expression difference between CNV carriers 
and non-carriers. The genes with a fold change in expression over 1.1 related to CNVs can be 
seen in Table 6.9. Expression, p-values and fold changes for all other genes are shown in 
Appendix 4. Barplots of the top 10 genes differentially-expressed CNV-associated genes are 
shown in Figure 6.17. Interestingly, although all observed deletions are associated with a 
decrease in expression, not all Duplications show an increase in expression indicating that the 
relationship between gene dosage and gene expression is not always straightforward.  
 
  




Table 6.9 – Relating CNVs to Expression 
Table showing log2 expression values between individuals containing CNVs in the listed 
genes and those without for genes which show a fold change ≥ 1.1. ‘Average’ is the average 
















PITPNM1 1 7.10 7.46 1.28 6.73 1.57E-07 ↓ Duplication 
EDF1 1 9.69 10.00 1.24 -2.10 0.044 ↓ Duplication 
IFIT3 1 7.89 7.59 1.23 1.93 0.063 ↑ Duplication 
CORO1B 1 7.61 7.85 1.18 -8.10 3.82E-09 ↓ Duplication 
CHPF 1 6.49 6.73 1.18 4.85 3.26E-05 ↓ Duplication 
D14ERTD449E 2 7.33 7.56 1.17 1.94 0.061 ↓ Deletion 
HBA-A1 1 12.80 13.00 1.15 -6.08 9.74E-07 ↓ Deletion 
CRK 1 8.81 8.62 1.14 3.97 3.93E-04 ↑ Duplication 
VEGFB 1 10.36 10.54 1.13 -4.27 1.73E-04 ↓ Duplication 
HIST1H2AO 3 10.90 10.72 1.13 -4.01 3.60E-04 ↑ Duplication 
ANXA11 2 7.63 7.80 1.13 -2.25 0.031 ↓ Deletion 
RPS6KB2 1 6.80 6.63 1.13 6.85 1.11E-07 ↑ Duplication 
TMEM198 1 8.63 8.46 1.12 -7.09 5.85E-08 ↑ Duplication 
TBC1D5 1 7.46 7.61 1.11 7.88 6.81E-09 ↓ Duplication 
PITPNM3 1 8.20 8.35 1.11 -4.37 1.29E-04 ↓ Duplication 
DBNDD1 1 7.34 7.19 1.11 7.37 2.66E-08 ↑ Duplication 
UBE3B 1 9.06 8.91 1.11 14.72 1.56E-15 ↑ Duplication 
EFNA2 1 6.65 6.50 1.11 0.00 1.000 ↑ Duplication 
CDK2AP2 1 8.12 7.98 1.10 0.05 0.963 ↑ Duplication 
MACROD1 1 7.26 7.40 1.10 2.72 0.011 ↓ Duplication 
IL4I1 1 6.65 6.78 1.10 -1.72 0.095 ↓ Duplication 
A630095E13RIK 1 6.47 6.60 1.10 5.35 7.86E-06 ↓ Duplication 
 
  




Figure 6.17 – Top 10 Fold Changes in Genes Affected by CNVs 
Log2 expression split by CNV status of the listed gene for the top 10 genes which show a 





































































6.6.1 Summary of Results 
From between group comparisons, 876 genes showed an uncorrected p-value of less than 
0.05. However, after FDR correction only MUC15 showed a q value below 0.2 and none 
showed a q-value below 0.1. Therefore no gene reached high confidence in terms of gene 
expression between groups and no genes reached a fold change of 1.5 from the offspring of 
young fathers to the offspring of old fathers. The highest fold change between groups was 
18% in S100A8; however, this gene did not have an uncorrected p-value of less than 0.05. The 
highest fold change which also had an uncorrected p-value of less than 0.05 was YWHAG with 
a reduction in expression of 14% in the offspring of old fathers and an uncorrected p-value of 
0.04. Although gene expression in the frontal cortex was shown to be modular using WCNGA, 
no modules showed significant differences between paternal age groups.  
 
Of particular interest given previous gene expression analyses of aging, pathway analysis 













































inflammatory and immunological processes. Also enriched were networks involved in cellular 
assembly and organization, cellular function and maintenance organismal injury and 
abnormalities, cell death, cell morphology, cellular function and maintenance, inflammatory 
response, cellular movement, immunological disease, gene expression, cell cycle, decreased 
levels of albumen and post-translational modification, cellular movement, hematopoiesis. 
Genes also involved in DNA replication, recombination, and repair were enriched. Finally, a 
large percentage of genes which show an expression change when contained within a CNV 
were observed.   
 
6.6.2 Previous Literature 
As mentioned in section 6.5.5, studies of aging in the brain have shown enrichment for 
genes associated with inflammatory response, and DNA repair (Lee, Weindruch et al. 2000) 
and studies on aging in spermatogonial cells also showed enrichment for changed in genes 
associated with DNA repair (Kokkinaki, Lee et al. 2010). Both these networks were also 
observed in our study. As differential expression of genes associated with DNA repair are also 
seen in spermatogonial cells, it may be that expression of these genes are affected in their 
offspring as well. Changes in expression in genes associated with DNA repair could mean that 
DNA contains more genomic alterations compared to the offspring of younger fathers. 
However, the genes in this network are a mixture of up and down-regulated genes (Figure 
6.18) as opposed to all being in the same direction, and we have no information on small 
genomic alterations. After comparing genes which have altered gene expression with other 
studies, we observe some interesting overlap. Twelve genes identified in Paul et al’s study of 
age related changed to gene expression in spermatocytes also showed altered gene 
expression between the offspring of old and young fathers (Paul, Nagano et al. 2011) and 83 
genes overlapped with those showing differential expression in Kokkinani et al’s study into 
spermatogonial cells from mice of different ages (Kokkinaki, Lee et al. 2010). There were no 
overlapping pathways between this study and Alter et al’s study of expression changes 
associated with paternal age in the brain (Alter, Kharkar et al. 2011), but this could be due to 
this study taking place in RNA from frontal cortex and Alter et al’s study being on RNA from 
hippocampus. 




Figure 6.18 – IPA Network - DNA Replication, Recombination, and Repair, Cell-To-Cell 
Signalling and Interaction, Nervous System Development and Function 
Green indicated genes which were down-regulated in the offspring of old males in this 
study and red indicated genes which were up-regulated in the offspring of old fathers in this 
study. 
 
Gregg et al’s case-control study on RNA from blood samples highlighted significant 
changes in genes associated with cell signalling, which mirrors the differences we observe in 
this study (Gregg, Lit et al. 2008). From the genes which reached an uncorrected p-value of 
less than 0.05, 31 genes were identified which have previously been associated with 
schizophrenia (ATP1A3, C5orf13, CHRNA6, CHRNB1, CLOCK, DRD5, EBF1, FXYD6, GABRA1, 
GABRP, GPR37, GRIN2A, GRIN2B, HPRT1, HTR4, HTR7, IL10, IL1B, IL4, KCNK1, LTA, NDUFV1, 
PDE3B, PMP22, PNOC, RAPGEF6, SEMA3A, SLC6A1, SLC6A4, TUBB2C, TUBD1) although these 
genes are normally only implicated in one study and so are not the most confident findings. 
Using the top genome-wide association results from genome-wide association studies for 
schizophrenia, none are significantly differentially expressed between the offspring of young 
and old fathers (Ripke, Sanders et al. 2011). Of genes which reached an uncorrected p-value of 
<0.001, only TNFSF11 has previously been implicated in the psychiatric disorders of interest 
with regards to paternal age. TNFSF11 is located at human locus 13q14 which has been 
identified in linkage studies as a shared locus of schizophrenia and BD (Maziade, Chagnon et 
al. 2009). 




6.6.3 Most Differentially Expressed Genes and Functions 
Looking at genes which showed a p-value below 0.05 and a fold change over 1.1 across all 
families, eight showed differences between the offspring of young and old male mice. YWHAG 
belongs to the family of YWHA (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation) proteins and mediates signal transduction through binding to phosphoserine-
containing proteins. Genes in this family have been widely studied for their association with 
schizophrenia because of their role in neurotransmission (Berg, Holzmann et al. 2003). 
Deletion in YWHAG has previously been associated with developmental delay and intellectual 
disability (Ramocki, Bartnik et al. 2010) and with speech delay in Williams-Beuren syndrome 
(Berg, Brunetti-Pierri et al. 2007). YWHAG also has an association with longevity in humans 
(Deelen, Uh et al. 2011). No other genes in this list demonstrate convincing evidence for their 
role in aging or psychiatric conditions in the current literature. 
 
The analysis of differentially expressed genes in individual families identified several 
neuropsychiatric candidate loci. This suggests that rare family-specific events (perhaps 
mediated by genomic alterations such as CNVs), rather than overall between-group 
differences, could be involved in the paternal age effect. From the most differentially 
expressed genes between family 1 and the offspring of young fathers, for example, several 
show previous literature for their role in aging and psychiatric conditions. PAFAH1B3 encodes 
an acetylhydrolase that catalyzes the removal of an acetyl group from the glycerol backbone 
of platelet-activating factor and shows differentially expression between controls and cases in 
BD (Nakatani, Hattori et al. 2006) and Williams-Beuron syndrome (Antonell, Vilardell et al. 
2010). PAFAH1B3 has also previously shown reduction in protein levels in brains from aging 
mice compared to their younger counterparts (Yang, Liu et al. 2008). PIK3R2 is part of the PI 3-
Kinases which are a family of lipid kinases capable of phosphorylating the 3'OH of the inositol 
ring of phosphoinositides, and has been shown to display age related changes to gene 
expression in the hippocampus (Zeier, Madorsky et al. 2011). GSK3A encodes a 
multifunctional Ser/Thr protein kinase that is implicated in the control of several regulatory 
proteins. GSK3A shows differentially expression between cases and controls in blood and 
brain samples in schizophrenia (Glatt, Everall et al. 2005) and is also located in 17q13 in 
humans which is a candidate region for schizophrenia (Francks, Tozzi et al. 2010). SLITRK2 
encodes an integral membrane protein, and rare variants in the gene have previously been 




associated with schizophrenia and autism (Piton, Gauthier et al. 2011), and SLITRK2 has also 
been shown to display differential expression in BD (Smith, Bloss et al. 2009). 
 
In family 2, the RAB11FIP5 gene, which is involved in protein trafficking from apical 
recycling endosomes to the apical plasma membrane, is of interest; a de novo balanced 
translocation in between chromosomes 2 and 9 seen in a patient with pervasive 
developmental disorder causes the disruption of this locus (Roohi, Tegay et al. 2008). In family 
3, PDE7B encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide 
phosphodiesterase family which catalyzes the hydrolysis of cAMP and cGMP to the 
corresponding 5’-monophosphates and provides a mechanism to down-regulate cAMP and 
cGMP signalling. PDE7B is located in 6q23 which has been previously associated with 
schizophrenia (Ingason, Giegling et al. 2010). In family 4, WIF1 is a WNT inhibitory factor, 
functions as a tumour suppressor gene and is located in 12q14 which is a locus previously 
associated with autism (Ma, Cuccaro et al. 2007). In family 5, EPHA5 belongs to the ephrin 
receptor subfamily of the protein-tyrosine kinase family and has been implicated in mediating 
developmental events, particularly in the nervous system. EPHA5 has been implicated as a 
novel locus in a linkage study of autism (Weiss, Arking et al. 2009). 
 
6.6.4 Limitations 
Although we had access to the offspring of three different age fathers, only two age 
groups were used in the expression analyses presented here. As the third group were from 
fathers of 12 months old, the differences in expression may be larger in this group but no 
conclusions about whether the effects are linear can be drawn, although future studies may 
utilise the available tissue from this group. Due to tissue availability and research funding 
limitations, RNA from only one tissue was assessed (i.e. frontal cortex), although it would be 
interesting to examine other tissues such as the cerebellum, in addition to sperm cells from 
fathers. This makes it difficult to compare the methylation results for the majority of the 
DMRs assayed in Chapter 5 as only the three DMRs assayed in frontal cortex can be fully 
compared. QPCR was not carried out to verify the results but is planned for future work. As 
18,097 genes were analysed and the uncorrected significance level was set as 0.05, 905 
significant differences would be expected by chance which is more than we observed 
suggesting we observed a lot less or no significant differences between groups. 





We do not observe any differences between groups which reach a genome-wide 
significance value of 2.8 x 10-6 and in light of the issue of multiple testing; all differences 
observed at a significant level of 0.05 are likely to be by chance. We observed changes in 
expression in genes associated with inflammatory response and DNA repair which have both 
been previously highlighted in expression studies of aging as well as genes previously 
associated with schizophrenia. In family based analysis, some genes which demonstrating 
group differences in gene expression have previously been associated with aging and 
psychiatric conditions associated with advanced paternal age. These findings suggest that 
there are subtle expression changes associated with paternal age in mouse, and that these 
could be potential candidates for mediating the behavioural differences observed in the 









7.1 Main Findings and Implications 
The overall aim of my thesis was to use a rodent model to investigate behavioural and 
molecular effects associated with advanced paternal age. Previous epidemiological studies, as 
discussed in Chapter 1, report that increasing paternal age is associated with an increased risk 
of developing several neuropsychiatric disorders including autism, schizophrenia and BD. In 
this final chapter I will review the results from my research and relate it back to previous 
literature, before drawing some general conclusions about the possible underlying 
mechanisms of the paternal age effect.  
 
7.1.1 Behaviour  
In Chapter 3, the main aim was to establish a mouse model and investigate behavioural 
changes associated with advancing paternal age. The focus of my behavioural analysis was on 
exploratory behaviour, anxiety related behaviour, short and long term memory and social 
behaviour, chosen to represent phenotypes related to the neuropsychiatric disorders 
associated with advanced paternal age in humans. Several behavioural differences were seen 
in the offspring of older fathers. The offspring of old fathers showed decreased exploration in 
the holeboard task than in the behaviour of the offspring of young fathers. Compared to the 
offspring of young fathers, the offspring of old fathers also showed decreased social 
interaction in the social interaction task in sniffing behaviour and overall behaviour. The 
offspring of very old fathers showed a reduction in the time spent in overall social behaviour 
compared with the offspring of young fathers. When the offspring of old and very old fathers 
were combined into the offspring of fathers over 10 months there was a significant reduction 
compared to the offspring of young fathers in time spent in sniffing behaviour, time spent 
allogrooming and time spent in all social behaviours.  
 
When comparing these results to the limited number of other rodent models, it is difficult 
to draw strong conclusions due to important methodological differences across them (section 
3.6.2). The most similar study in terms of methodology is Foldi’s et al’s study (Foldi, Eyles et al. 
2010). Their significant results were focussed on females, but our study (like most behavioural 
analyses) only used male offspring to avoid the confounding effects of hormonal factors. They 
observed increased exploration in the offspring of the older father group in the elevated plus 




observed in our study. They also observed no reduction in social behaviour; however the 
methodology of the task used in their study (as the mice in their study were unable to interact 
directly) is different to that utilised in my analyses. Overall, the main result from Chapter 3 
related to a reduction in social behaviour; taken together with the results from other studies, 
it can be concluded that there are behavioural changes associated with advancing paternal 
age although further work is required to specifically pinpoint the specific modality of these 
changes. 
 
The changes in behaviour reported in Chapter 3 support previous human epidemiological 
studies which show that regardless of disorder, offspring of older fathers (>45 years) are more 
likely than the offspring of younger fathers to suffer from social deficits (Weiser, Reichenberg 
et al. 2008). As social deficits are symptoms of all three disorders which have an increased risk 
with associated with paternal age (autism, schizophrenia and bipolar disorder), and we 
observe significant reductions in behaviour, it is reasonable to speculate further that paternal 
age is related to this common phenotype as opposed to or in addition to increasing risk for the 
development of these diseases.  
 
7.1.2 Copy Number Variation  
In Chapter 4, I explored the role of CNVs as a potential mechanism for the paternal age 
effect using CGH combined with high-resolution genomic microarrays. Overall, I observed no 
difference in the frequency, size or type of CNV between the offspring of young fathers and 
offspring of old fathers. This was true both of both inherited (section 4.5.2.1) and de novo 
CNVs (section 4.5.2.3). Some individuals (primarily breeders) were significant outliers for the 
overall burden of CNVs, potentially related to lymphoma of the spleen, and were removed 
from the analyses (section 4.5.1). 
 
Compared to the only other mouse study of CNVs and paternal age, which observed de 
novo CNVs only in their advanced paternal age group (Flatscher-Bader, Foldi et al. 2011), we 
observed a notable frequency of CNVs in both groups. Although we don’t observe a larger 
number of CNVs in the advanced paternal age group, we observe an overall higher rate of 




CNVs, that the tissue we used (spleen) is more prone to CNVs, or that there are 
methodological differences between studies (section 4.6). The occurrence of polymorphic 
CNVs in populations of inbred (and supposedly genetically identical) mice has implications for 
the use of these animals as genetic models. 
 
7.1.3 Epigenetic Differences 
In Chapter 5, I explored whether there were epigenetic differences (specifically focussing 
on DNA methylation) between the offspring of young, old and very old fathers. The results in 
this chapter comprise of three parts. First, in global methylation assayed using LUMA, there 
were significant increases in methylation with paternal age in spleen and cerebellum 
compared to the offspring of young fathers (section 5.5.1). Second, looking at DNA 
methylation levels across DMRs associated with brain-expressed imprinted genes, several 
DMRs showed paternal age related changes in methylation in cerebellum and three DMRs 
(Gnas-Nesp, Kcnq1ot1 and Mcts2) were consistently different across the PCR region. All three 
of these DMRs also showed paternal age related changes to methylation in frontal cortex 
(section 5.5.2). Third, looking at DNA methylation at the transposable elements IAP and LINE-
1, no changes in methylation levels associated with paternal age were observed in any tissue 
(section 5.5.3). 
 
No previous studies of DNA methylation have been carried out in animal models of 
advanced paternal age to date, and so our results cannot be compared to any other studies. 
Although many studies have been carried out on epigenetic changes associated with aging, 
there are currently no human studies looking at DNA methylation changes associated with 
paternal age. Imprinted loci were the main focus of this chapter: susceptibility at these loci in 
terms of methylation has been demonstrated in studies of conception by ART techniques 
leading to an increase of ASDs (Cox, Burger et al. 2002; DeBaun, Niemitz et al. 2003; Gicquel, 
Gaston et al. 2003; Maher, Brueton et al. 2003; Orstavik, Eiklid et al. 2003), they are known to 
be epigenetically labile in the context of environmental exposure, and there is some evidence 
that they may escape complete epigenetic reprogramming. Our results indicate that certain 
imprinted loci do show paternal age related changes in methylation, especially at Kcnq1ot1, 
Gnas-Nesp and Mcts2 as well as at individual sites in other DMRs. In the human ART studies, 




syndrome, a disorder characterised by ASD-related traits (DeBaun, Niemitz et al. 2003; 
Gicquel, Gaston et al. 2003; Maher, Brueton et al. 2003). This locus also appears to escape 
complete epigenetic reprogramming in primordial germ cells (Popp, Dean et al. 2010) and so 
could be a vehicle for the transmission of epigenetic information across generations. It is 
worth noting that the methylation change at this locus was not observed in our group of 
offspring from very old fathers; this could be due to the significantly lower group size and the 
fact that these animals were not produced at the same time as the other two groups with the 
potential for batch effects. More investigation into this locus is required to determine 
whether this effect is observed in the offspring of older males, as well as investigation into 
sperm samples from the actual breeders. By doing this, we could see if any changes which 
occur in the sperm are transmitted to the offspring or whether the changes occur de novo. 
Focusing on this locus in human disease cohorts as well as the offspring of fathers of different 
ages would be interesting to further investigate Kcnq1ot1’s role in the paternal age effect. 
 
7.1.4 Gene Expression Differences  
Chapter 6 aimed to investigate gene expression changes associated with advanced 
paternal age in the frontal cortex using genome-wide microarrays. We observed over 800 
genes showing nominally significant differences between the offspring of young fathers and 
offspring of old fathers, although the majority of these differences were relatively subtle and 
none reached a q-value below 0.1 (section 6.5.1.2). Ingenuity pathway analysis of the genes 
represented in these differences highlighted an enrichment of pathways involved in 
inflammatory response and DNA replication, recombination and repair (section 6.5.5). No 
previous studies of gene expression have been carried out on a rodent model of advanced 
paternal age and so our results are not able to be compared to any similar studies. Human 
studies of gene expression changes associated with aging, however, have also shown 
expression changes in genes from pathways associated with inflammatory response, and DNA 
repair (Lee, Weindruch et al. 2000; Kokkinaki, Lee et al. 2010). Of note, however, we observed 
no overlapping pathways or genes with a previous human transcriptomic study of advanced 
paternal age in individuals with autism (Alter, Kharkar et al. 2011). The changes to genes 
associated with DNA repair are interesting, as increased genomic alterations (e.g. CNVs) 
obviously represent a key hypothesis for the mediation of the paternal age effect. It would be 
interesting to investigate expression of these genes in sperm from the breeders as well as 




associated with older fathers. Finally for this chapter, we analysed expression changes 
encompassed within CNVs from Chapter 3. 74% of genes showed a significant reduction in 
expression when affected by a CNV. The 26% of genes which do not show an expression 
change could be due to false positives in CNVs, as discussed in section 4.6, or due to the CNV 
not surrounding the whole gene, with elements such as the transcription factor binding sites 
not being included in the CNV. However these expression changes provide some further 
evidence for the legitimacy of the CNV changes we observed. 
 
7.2 Beyond the Paternal Age Effect: Maternal and 
Grandparental Age 
What was not explored in this thesis was the role of advanced maternal age in the 
increased risk of developing autism, schizophrenia and bipolar disorder. In (Table 1.1, Table 
1.2 and Table 1.3), it was observed that many epidemiological studies also observe a maternal 
age effect either in combination with a paternal age effect or individually. Twelve studies 
report an association between maternal age and ASD, with many identifying a linear 
association (Grether, Anderson et al. 2009; Golding, Steer et al. 2010), and most studies 
concluding that a maternal age of over 35 results in a greater risk of the offspring developing 
ASD. The average age of mothers has also been found to be higher in ASD cases than in 
controls (Gillberg 1980). In addition to autism, at least seven studies report an association 
between advanced maternal age and an increased risk of developing other types of 
neuropsychiatric disease including schizophrenia and other forms of psychosis. For example, 
the average age of mothers in affected groups was found to be 1-2 years higher than in 
controls (Hare and Moran 1979; Kinnell 1983), and the percentage of mothers in higher age 
categories has also been shown to be larger than in control groups (Gillberg 1982; Lee, 
Malaspina et al. 2011; Naserbakht, Ahmadkhaniha et al. 2011). Interestingly, a recent study 
looked at the effect of grandparental age and found that a 10-year increment in maternal or 
paternal grandmothers led to an increased risk of autism (Golding, Steer et al. 2010). This 
gives speculation that there may be a transgenerational effect of parental age, and this is 





Maternal age was not investigated in this study, primarily because the literature in 
support of advanced paternal age’s influence on the development of psychiatric conditions is 
more consistent. Also, because maternal age and paternal age are correlated, it is difficult for 
many studies to tease apart whether one is more important than the other; a focus on 
paternal age in our model enabled us to investigate its sole influence. As males can sire 
offspring naturally for longer than females, there is more potential for a higher paternal age 
effect to become manifest. Finally, because of the difference in the amount of cell divisions 
germline cells undergo in males and females (section 1.4.1), and because male germ cells 
continue to divide throughout the life of males, paternal age was more likely to influence the 
biological mechanisms explored in this thesis. Building upon this work into the paternal age 
effect, it would be interesting to explore the maternal age effect using a similar experimental 
design and also assess parental age in general to see if effects are more pronounced with 
advanced age in both parents. 
 
7.3 Limitations 
There are several limitations to this overall strategy used in this study. First, we only 
investigated three ages of male breeders and so cannot make any conclusions as to whether 
the paternal age affect is linear or reaches a plateau. Also the ages do not reach a very old 
upper limit and the oldest breeders we used were 12 months. Although this corresponds to a 
decrease in male fertility, with older mice showing a decrease in successful matings (Kidd, 
Eskenazi et al. 2001), and is past the “retirement” age for commercial male breeders, male 
mice can be reproductively active for some time after this arbitrary age. The group size of the 
offspring of very old fathers was substantially smaller than the offspring of young and old 
fathers. This makes comparing between groups more difficult. Also the breeders from this 
group were acquired at a different time and so may show a batch effect which could influence 
the results from this group. Only male offspring were used based upon the sex ratio in autism 
and the problems of performing behavioural analyses in female mice. However, as reported in 
section 1.2.2, the sex ratio is actually more even with advancing paternal ages (1.21:1 with a 
paternal age of over 45) (Anello, Reichenberg et al. 2009), and so we might expect effects to 
be observed in both males and females. In Foldi et al’s study of paternal age related 
behaviour, the main effect they observe is in female offspring of older fathers making it more 
difficult to compared results across studies. C57BL/6J mice were used in this study as they 




only one strain of mouse in this study to limit the effects of genetic variation on the results. In 
this regard, however, our CNV data showing considerable between-individual variation is 
interesting and relevant to the interpretation of future behavioural studies on inbred mice. To 
look for robustness in the paternal age effects we observed it would be useful to have 
investigated a second strain for comparison. Although we investigated DNA methylation levels 
in sperm from different age males and looked for de novo CNVs using spleen tissue from the 
breeders used, it would have been more informative to have used sperm samples from the 
breeders themselves. First it would have enabled us to look for epigenetic inheritance by 
using DNA obtained from sperm of the actual breeders used, and second, we could have 
drawn more conclusions about whether the de novo CNVs observed in the offspring originated 
in the sperm, or occurred post-conception. The limitations of the available technologies are 
also something which should be addressed. As the cost of running genome-wide molecular 
approaches decreases, the methods within our means to use will become greater. For 
example, future studies will utilise RNA-seq and a more genome-wide approach for DNA 
methylation analysis (such as whole genome bisulfite sequencing) for more in depth analysis. 
We used genome wide approached in Chapter 4 (CNVs) and Chapter 6 (expression), however 
due to time constraints, verification of array data is not yet completed, however analysis is 
ongoing. 
 
7.4 Overall Conclusions 
From the research carried out in this thesis, it can be concluded that there is some 
evidence for behavioural changes in the offspring associated with advanced paternal age, and 
interestingly they are mainly seen in social behaviour, reflecting deficits common to autism, 
schizophrenia and bipolar disorder. Genome-wide analysis of structural genomic variation 
suggests that the offspring of older fathers are not characterised by an increased burden of 
CNVs, although I did observe some evidence for altered DNA methylation and subtle changes 
in gene expression. Whether these changes occur in the sperm of the fathers or de novo in the 
offspring however, is not clear. It is also plausible that DNA methylation changes result from 






7.5 Future Work 
It would be interesting to continue this work in many ways. First by assessing the DNA 
methylation and transcriptomic differences we observed in our mouse samples in human 
samples to investigate whether they are related to paternal age or psychiatric condition in 
humans. Second, it is important to pursue the animal research further, especially by using 
female as well as male offspring to see if the behavioural and molecular changes occur in both 
sexes. By increasing the range of ages of the fathers and taking a more quantitative approach 
we could see i) if there is a continuous effect of paternal age, ii) if the effect reaches a plateau 
or iii) whether there is a specific ‘at risk’ parental age group. In some human studies, the 
offspring of very young fathers also show an increased risk of developing psychiatric disorders, 
and this would be interesting to also assess in a rodent model. It would also be interesting to 
use breeders for multiple litters at different ages to see if offspring produced from earlier 
matings showed differences from the offspring of matings carried out later with the same 
father. Furthermore, as discussed above, it would be informative to also examine the effects 
of advanced maternal age, and extend our analyses to other strains of mouse. Finally, the use 
of methods to isolate sperm from males of different ages would enable the analysis of 
chromosomal abnormalities and methylation differences occurring in the father, to establish 
the rate of molecular changes associated with advanced paternal age. 
 
7.6 Final Word 
To date, most research into the effect of paternal age in the development of psychiatric 
disease has been epidemiological in nature and this study represents one of the first attempts 
to model this in rodents, examining both behavioural and molecular changes induced by 
advanced paternal age. As the age at which people are having children increases, the impact 
of paternal age on the risk for psychiatric disorders is likely to become more pronounced, 
highlighting the need for more research into this area. With more animal and human studies 
working towards finding a mechanism for the effect, it is my hope that we will be able to use 
this knowledge not only in understanding the effect of paternal age on the offspring, but also 
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Appendix 3 – R Scripts 
lumi 
Load in Data 
Expression <- 'ExpressionRGenesNames.txt' 
example.lumi <- lumiR.batch(Expression) 
 
Variance Stabilizing Transform 
lumi.T <- lumiT(example.lumi) 
 
RSN between Microarray Normaliazation 
lumi.N<-lumiN(lumi.T, method= 'rsn') 
 
Quality Control Estimation after Normalization 
lumi.N.Q <- lumiQ(lumi.N) 
 
Assign Group Identification to Data and by Group Analysis 
sampleType <- c('Y', 'O', 'Y', 'O', 'Y', 'O', 'Y', 'O', 'Y', 'O', 'Y', 'O', 'Y', 'Y', 'Y', 'O', 'Y', 'O', 'Y', 
'O','Y', 'Y',  'O','Y', 'O','Y', 'O','Y', 'O', 'O', 'O', 'O') 
design <- model.matrix(~ factor(sampleType)) 
 colnames(design) <- c('Y', 'O-Y') 
 fit <- lmFit(selDataMatrix, design) 





Checking data for excessive missing values and identification of outlier microarray samples 
gsg = goodSamplesGenes(datExpr0, verbose = 3); 
gsg$allOK 
 
Choose a set of soft-thresholding powers 
powers = c(c(1:10), seq(from = 12, to=20, by=2)) 
 
Call the network topology analysis function 
sft = pickSoftThreshold(datExpr0, powerVector = powers, verbose = 5, networkType = 
"signed") 
 
Constructing the gene network and identifying modules 
net100 = blockwiseModules(datExpr0, power = 10, minModuleSize = 100, 
reassignThreshold = 0, mergeCutHeight = 0.25, 
numericLabels = TRUE, pamRespectsDendro = FALSE, 
saveTOMs = TRUE, 
saveTOMFileBase = "Expr100signed", 







Recalculate MEs with colour labels 
nGenes = ncol(datExpr0); 
nSamples = nrow(datExpr0); 
MEs0 = moduleEigengenes(datExpr0, moduleColors)$eigengenes 
MEs = orderMEs(MEs0) 
moduleTraitCor = cor(MEs, datTraits, use = "p"); 





Appendix 4 – Log2 Expression Changes Associated with CNVs 
 Table showing log2 expression values between individuals containing CNVs in the listed 
genes and those without for genes ranked by fold change. ‘Average’ is the average expression 













PITPNM1 1 7.10 7.46 1.28 6.73 1.57E-07 ↓ Amplification 
EDF1 1 9.69 10.00 1.24 -2.10 0.044 ↓ Amplification 
IFIT3 1 7.89 7.59 1.23 1.93 0.063 ↑ Amplification 
CORO1B 1 7.61 7.85 1.18 -8.10 3.82E-09 ↓ Amplification 
CHPF 1 6.49 6.73 1.18 4.85 3.26E-05 ↓ Amplification 
D14ERTD449E 2 7.33 7.56 1.17 1.94 0.061 ↓ Deletion 
HBA-A1 1 12.80 13.00 1.15 -6.08 9.74E-07 ↓ Deletion 
CRK 1 8.81 8.62 1.14 3.97 3.93E-04 ↑ Amplification 
VEGFB 1 10.36 10.54 1.13 -4.27 1.73E-04 ↓ Amplification 
HIST1H2AO 3 10.90 10.72 1.13 -4.01 3.60E-04 ↑ Amplification 
ANXA11 2 7.63 7.80 1.13 -2.25 0.031 ↓ Deletion 
RPS6KB2 1 6.80 6.63 1.13 6.85 1.11E-07 ↑ Amplification 
TMEM198 1 8.63 8.46 1.12 -7.09 5.85E-08 ↑ Amplification 
TBC1D5 1 7.46 7.61 1.11 7.88 6.81E-09 ↓ Amplification 
PITPNM3 1 8.20 8.35 1.11 -4.37 1.29E-04 ↓ Amplification 
DBNDD1 1 7.34 7.19 1.11 7.37 2.66E-08 ↑ Amplification 
UBE3B 1 9.06 8.91 1.11 14.72 1.56E-15 ↑ Amplification 
EFNA2 1 6.65 6.50 1.11 0.00 1.000 ↑ Amplification 
CDK2AP2 1 8.12 7.98 1.10 0.05 0.963 ↑ Amplification 
MACROD1 1 7.26 7.40 1.10 2.72 0.011 ↓ Amplification 
IL4I1 1 6.65 6.78 1.10 -1.72 0.095 ↓ Amplification 
A630095E13RIK 1 6.47 6.60 1.10 5.35 7.86E-06 ↓ Amplification 
IMP4 1 8.12 7.99 1.09 0.09 0.930 ↑ Amplification 
BOLA1 1 7.95 7.82 1.09 -0.12 0.903 ↑ Amplification 
VTI1A 1 7.26 7.39 1.09 4.18 2.19E-04 ↓ Amplification 
TMEM134 1 8.11 7.99 1.09 -0.13 0.894 ↑ Amplification 
POLD4 1 7.76 7.64 1.09 -0.43 0.674 ↑ Amplification 
IFIT2 1 6.98 6.86 1.09 0.45 0.653 ↑ Amplification 
SPNB4 1 7.08 6.96 1.09 -0.61 0.545 ↑ Amplification 
YIPF3 1 8.39 8.51 1.09 -3.58 0.001 ↓ Amplification 
TNNC2 1 6.71 6.59 1.09 0.70 0.490 ↑ Amplification 
HIST2H3C1 2 7.37 7.25 1.09 -0.85 0.401 ↑ Amplification 
MED19 1 7.58 7.70 1.09 11.81 5.19E-13 ↓ Amplification 
RHOU 1 7.84 7.72 1.09 1.08 0.287 ↑ Amplification 
OLFR19 1 6.53 6.65 1.08 -11.53 9.66E-13 ↓ Amplification 
















IGFALS 1 6.73 6.62 1.08 -1.26 0.216 ↑ Amplification 
2310003C23RIK 1 8.75 8.64 1.08 1.36 0.182 ↑ Amplification 
TMEM101 1 7.70 7.59 1.08 -1.54 0.134 ↑ Amplification 
IVD 1 8.61 8.72 1.08 9.14 2.60E-10 ↓ Amplification 
DNM3OS 1 6.69 6.59 1.08 -1.63 0.114 ↑ Amplification 
FBF1 1 7.09 7.19 1.07 -5.48 5.43E-06 ↓ Amplification 
NUP62 1 7.66 7.56 1.07 1.77 0.087 ↑ Amplification 
ACOT8 1 7.92 7.82 1.07 1.84 0.076 ↑ Amplification 
CETN3 1 9.80 9.90 1.07 2.05 0.049 ↓ Amplification 
TFPT 1 7.32 7.42 1.07 3.58 0.001 ↓ Amplification 
HIST2H2AC 2 10.51 10.42 1.07 2.17 0.038 ↑ Amplification 
D830046C22RIK 1 6.44 6.53 1.06 8.43 1.60E-09 ↓ Amplification 
GAS8 1 6.97 7.06 1.06 3.27 0.003 ↓ Amplification 
SYT11 1 7.59 7.68 1.06 -2.89 0.007 ↓ Amplification 
MRPS34 1 11.03 10.94 1.06 -2.31 0.028 ↑ Amplification 
DNAJC4 1 7.21 7.30 1.06 2.51 0.018 ↓ Amplification 
BAHD1 1 7.58 7.67 1.06 -1.36 0.185 ↓ Amplification 
FKBP2 1 9.46 9.37 1.06 2.34 0.026 ↑ Amplification 
AIP 1 11.12 11.21 1.06 11.79 5.41E-13 ↓ Amplification 
2810403A07RIK 1 8.49 8.40 1.06 -2.49 0.018 ↑ Amplification 
AP2A1 1 8.69 8.78 1.06 2.01 0.053 ↓ Amplification 
PRPF31 1 6.60 6.68 1.06 1.17 0.250 ↓ Amplification 
CYP8B1 1 6.57 6.65 1.06 1.08 0.290 ↓ Amplification 
FERMT3 1 6.87 6.79 1.06 -2.68 0.012 ↑ Amplification 
DNM3 1 6.42 6.50 1.06 1.06 0.298 ↓ Amplification 
TULP4 1 9.44 9.36 1.06 -2.71 0.011 ↑ Amplification 
RIT1 1 9.28 9.36 1.06 -0.75 0.460 ↓ Amplification 
CNGA4 1 6.73 6.65 1.06 -2.85 0.008 ↑ Amplification 
STIP1 1 10.19 10.11 1.06 3.02 0.005 ↑ Amplification 
TRIM65 1 6.73 6.65 1.06 3.15 0.004 ↑ Amplification 
PPP1CA 1 11.12 11.04 1.05 -3.41 0.002 ↑ Amplification 
PHPT1 1 9.67 9.74 1.05 -0.31 0.756 ↓ Amplification 
HIST2H2AA1 2 7.58 7.50 1.05 3.97 3.92E-04 ↑ Amplification 
GPR146 1 6.83 6.90 1.05 -7.72 1.04E-08 ↓ Amplification 
MMP13 1 6.56 6.63 1.05 6.92 9.27E-08 ↓ Amplification 
MAFK 1 6.49 6.56 1.05 6.77 1.41E-07 ↓ Amplification 
SERTAD3 1 7.00 6.93 1.05 4.15 2.40E-04 ↑ Amplification 
HIST2H2AB 2 6.81 6.74 1.05 4.25 1.81E-04 ↑ Amplification 
CCBP2 1 7.01 6.94 1.05 -4.38 1.27E-04 ↑ Amplification 
FGFBP3 1 6.99 6.92 1.05 -4.38 1.25E-04 ↑ Amplification 
C130050O18RIK 1 6.68 6.61 1.05 4.44 1.06E-04 ↑ Amplification 
TMEM125 3 7.69 7.62 1.05 -4.75 4.40E-05 ↑ Amplification 
















HTT 1 6.77 6.71 1.05 -5.48 5.41E-06 ↑ Amplification 
BLVRB 1 8.80 8.87 1.05 6.19 7.14E-07 ↓ Amplification 
HAGH 1 10.13 10.07 1.05 -6.02 1.17E-06 ↑ Amplification 
RPS6KA1 2 7.64 7.70 1.04 -6.05 1.08E-06 ↓ Amplification 
MMP9 1 6.66 6.72 1.04 6.03 1.14E-06 ↓ Amplification 
MICALL2 1 6.60 6.66 1.04 4.95 2.50E-05 ↓ Amplification 
NUBP2 1 7.66 7.60 1.04 -6.33 4.75E-07 ↑ Amplification 
SERTAD1 1 7.08 7.02 1.04 -6.45 3.40E-07 ↑ Amplification 
APPL1 1 8.06 8.00 1.04 -6.82 1.23E-07 ↑ Amplification 
CNOT3 1 6.92 6.86 1.04 -7.77 9.17E-09 ↑ Amplification 
RAD9 1 6.70 6.76 1.04 -4.37 1.28E-04 ↓ Amplification 
INTS1 1 9.04 9.09 1.04 -3.91 4.66E-04 ↓ Amplification 
HIST2H3B 1 7.71 7.66 1.04 -7.78 8.81E-09 ↑ Amplification 
3110082I17RIK 1 6.96 7.01 1.04 3.87 5.23E-04 ↓ Amplification 
HIST2H2BB 1 6.57 6.62 1.04 -3.64 9.84E-04 ↓ Amplification 
ZFAND2A 1 9.71 9.76 1.04 -3.55 0.001 ↓ Amplification 
CDH22 1 6.74 6.79 1.03 2.73 0.010 ↓ Amplification 
UNCX 1 6.62 6.57 1.03 8.04 4.49E-09 ↑ Amplification 
CPHX 2 6.42 6.47 1.03 -2.67 0.012 ↓ Deletion 
ATP5D 1 9.96 9.91 1.03 -8.52 1.25E-09 ↑ Amplification 
TCERG1L 1 6.63 6.58 1.03 -8.94 4.32E-10 ↑ Amplification 
ACOX1 1 6.50 6.54 1.03 2.59 0.015 ↓ Amplification 
ATM 1 6.62 6.66 1.03 2.58 0.015 ↓ Amplification 
TBC1D17 1 8.39 8.35 1.03 -9.09 2.98E-10 ↑ Amplification 
NAGS 1 6.49 6.53 1.03 1.47 0.153 ↓ Amplification 
PTPN18 1 6.81 6.77 1.03 9.25 1.98E-10 ↑ Amplification 
ZCCHC7 1 6.67 6.63 1.03 -9.48 1.14E-10 ↑ Amplification 
MMAB 1 6.90 6.94 1.03 1.17 0.251 ↓ Amplification 
CABP4 1 6.53 6.57 1.03 -0.39 0.699 ↓ Amplification 
ZSWIM3 1 7.19 7.23 1.03 -0.17 0.869 ↓ Amplification 
COX19 1 9.30 9.34 1.03 -8.17 3.15E-09 ↓ Amplification 
HIST2H2BE 2 6.84 6.80 1.03 -11.29 1.64E-12 ↑ Amplification 
TGFB1 1 6.69 6.73 1.03 -5.25 1.04E-05 ↓ Amplification 
STK11 1 8.10 8.06 1.03 12.08 2.92E-13 ↑ Amplification 
PTPRCAP 1 6.45 6.49 1.03 3.91 4.65E-04 ↓ Amplification 
TRPT1 1 7.88 7.84 1.03 -14.52 2.26E-15 ↑ Amplification 
OLFR199 1 6.62 6.58 1.03 14.58 2.03E-15 ↑ Amplification 
CBL 1 6.63 6.59 1.03 -2.91 0.007 ↑ Amplification 
AKT1S1 1 8.46 8.50 1.03 -0.62 0.539 ↓ Amplification 
DOS 1 9.39 9.35 1.03 -3.87 5.31E-04 ↑ Amplification 
CUX2 2 7.22 7.26 1.03 6.44 3.55E-07 ↓ Amplification 
BICD1 1 6.63 6.66 1.02 2.17 0.038 ↓ Amplification 
















1600002K03RIK 2 7.63 7.66 1.02 12.48 1.26E-13 ↓ Amplification 
EXOC4 1 7.94 7.91 1.02 -2.67 0.012 ↑ Amplification 
MYST2 1 7.40 7.37 1.02 0.69 0.495 ↑ Amplification 
HIST1H2AN 2 7.70 7.67 1.02 -3.72 7.81E-04 ↑ Amplification 
MRPL38 1 9.91 9.94 1.02 8.47 1.43E-09 ↓ Amplification 
TMEM184A 1 6.54 6.51 1.02 -3.73 7.79E-04 ↑ Amplification 
CPT1C 1 7.24 7.27 1.02 -6.22 6.57E-07 ↓ Amplification 
ACCN4 1 6.56 6.59 1.02 6.21 6.81E-07 ↓ Amplification 
MRGPRD 1 6.57 6.60 1.02 4.23 1.92E-04 ↓ Amplification 
ZFP335 1 7.04 7.01 1.02 -9.55 9.62E-11 ↑ Amplification 
ARID1A 3 6.60 6.58 1.02 -1.38 0.179 ↑ Amplification 
ESR2 1 6.58 6.61 1.02 1.80 0.081 ↓ Amplification 
CCDC97 1 6.71 6.68 1.02 -2.91 0.007 ↑ Amplification 
CIRBP 2 8.67 8.69 1.02 -1.17 0.253 ↓ Amplification 
OLFR692 1 6.66 6.64 1.02 -3.07 0.004 ↑ Amplification 
AFG3L1 1 7.27 7.29 1.02 -0.42 0.676 ↓ Amplification 
GPR152 1 6.59 6.57 1.02 3.14 0.004 ↑ Amplification 
SNX21 1 8.42 8.44 1.02 -5.86 1.84E-06 ↓ Amplification 
BAI1 1 6.86 6.84 1.02 3.91 4.71E-04 ↑ Amplification 
PNKP 1 8.13 8.15 1.01 -2.29 0.029 ↓ Amplification 
ADAMTS20 1 6.58 6.60 1.01 -2.01 0.054 ↓ Deletion 
NUDT22 1 7.62 7.60 1.01 -5.58 4.09E-06 ↑ Amplification 
FGF14 1 6.63 6.61 1.01 6.33 4.87E-07 ↑ Amplification 
SIGLEC5 1 6.57 6.55 1.01 -6.95 8.57E-08 ↑ Amplification 
TPCN2 1 6.69 6.71 1.01 -1.19 0.242 ↓ Amplification 
LENG1 1 6.71 6.70 1.01 8.25 2.56E-09 ↑ Amplification 
CDH1 1 6.75 6.74 1.01 9.13 2.70E-10 ↑ Amplification 
MAMDC4 1 6.59 6.60 1.01 -1.05 0.301 ↓ Amplification 
ACCN1 1 7.29 7.30 1.01 -15.80 2.20E-16 ↓ Amplification 
SPSB3 1 9.01 9.02 1.01 9.01 3.67E-10 ↓ Amplification 
SCAF1 1 8.90 8.89 1.01 -9.72 6.35E-11 ↑ Amplification 
SLC12A5 1 6.55 6.54 1.01 -1.19 0.241 ↑ Amplification 
GRK4 1 6.55 6.56 1.01 8.29 2.32E-09 ↓ Amplification 
PSG28 1 6.62 6.61 1.01 -2.28 0.030 ↑ Amplification 
MIDN 2 8.62 8.61 1.01 -1.27 0.213 ↑ Amplification 
MRGPRF 1 6.78 6.77 1.01 -2.44 0.020 ↑ Amplification 
ANAPC1 1 6.54 6.53 1.01 5.52 4.79E-06 ↑ Amplification 
H2-EB1 1 6.88 6.87 1.01 -1.13 0.269 ↑ Amplification 
IRF3 1 7.54 7.55 1.01 6.96 8.37E-08 ↓ Amplification 
KIF11 3 6.61 6.60 1.01 7.32 3.09E-08 ↑ Amplification 
DIDO1 1 6.83 6.82 1.01 -8.57 1.12E-09 ↑ Amplification 
SFI1 2 6.75 6.75 1.01 -5.80 2.14E-06 ↓ Amplification 
















ADAM22 1 6.93 6.94 1.01 5.54 4.62E-06 ↓ Amplification 
TBC1D10C 1 6.73 6.72 1.01 8.20 2.92E-09 ↑ Amplification 
HIST1H4M 3 6.66 6.67 1.00 4.81 3.73E-05 ↓ Amplification 
HIST2H4 1 6.60 6.59 1.00 -0.43 0.671 ↑ Amplification 
TSPAN4 1 6.55 6.54 1.00 -0.47 0.644 ↑ Amplification 
SPACA3 1 6.51 6.51 1.00 0.89 0.381 - Amplification 
OLFR198 1 6.57 6.57 1.00 -1.45 0.157 - Amplification 
LSM12 1 7.06 7.06 1.00 1.63 0.113 - Amplification 
CCDC115 1 6.96 6.96 1.00 -2.49 0.018 - Amplification 
MED25 1 8.91 8.91 1.00 -3.00 0.005 - Amplification 
DNAJB12 1 7.43 7.43 1.00 -4.35 1.38E-04 - Amplification 
CLCF1 1 6.61 6.61 1.00 -4.34 1.42E-04 - Amplification 
HIST1H1B 2 6.70 6.70 1.00 4.15 2.39E-04 - Amplification 
 
